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ABSTRACT 
Efficacy of a Cognitive-Behavioral Treatment for Weight Loss 
in Adults with Type 2 Diabetes 
by 
Kathy Wickersham, Master of Science 
Utah State University, 2007 
Major Professor : Dr. David M. Stein 
Department: Psychology 
The prevalence of type 2 diabetes is increasing across all sociodemographic 
groups. Obesity and overweight are major risk factors in the development of the disease 
and in the development of complications. Conversely, weight loss improves glycemic 
control, which reduces likelihood of complications. Interventions combining cognitive 
and behavioral components show promise in addressing the problem of weight loss 
maintenance. The objective of this study was to test the efficacy of a cognitive-
behavioral intervention. Participants were 54 adults diagnosed with type 2 diabetes 
randomly assigned to either a treatment group or a control. The assessment measures 
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utilized in this study were the Diabetes Care Profile, the Short Form 36, and the Diabetes 
Empowerment Scale. Specific outcomes measured included Body Mass Index (BMI), 
weight, and glycosolated hemoglobin . 
A repeated measures analysis of variance revealed significant weight loss and 
reduction in BMI. Treatment effects on BMI and weight were sustained at 2-month 
follow-up. 
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CHAPTER I 
INTRODUCTION 
The prevalence of type 2 diabetes among Americans of all ages is increasing at an 
epidemic rate . Between 1990 and 1998 the prevalence of type 2 diabetes in the U.S. 
increased in men and women, across all sociodemographic groups and in nearly all states 
by about one third (Mokdad et al., 2000). According to the Center for Disease Control 
(CDC), 1 in 3 children born in the year 2000 may develop diabetes sometime during the 
course of their lives (Center for Disease Control, 2004). 
Type 1 diabetes accounts for 5% of the diabetic population and most often occurs 
in childhood and adolescence. It develops when the body's immune system destroys 
pancreatic beta cells that results in dependence on insulin replacement therapy for 
survival. Type 2, which most often occurs in adulthood, is due to insulin resistance in 
nonnally insulin-responsive cells. This resistance leads to an inability to uptake glucose 
into the cell. Individuals diagnosed with type 2 diabetes are typically initially treated with 
diet, exercise, weight loss and oral medications (American Diabetes Association, 2002). 
An uncontrolled glucose level in diabetic patients is the primary predictor of 
developing diabetic complications such as cardiovascular disease, retinopathy, 
neuropathy, and nephropathy (Klein et al., 2004). Many of these complications lead to 
disability and early death in diabetic patients. Indeed, diabetes is now the sixth largest 
killer in the United States (CDC, 2004). 
Standards of care for individuals with diabetes direct physicians to focus on 
glycemic control, suggesting it is best achieved by a combination of patient education to 
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increase knowledge about diabetes and self-care behaviors, medication management, and 
reduction of Body Mass Index (BMI) if overweight. Unfortunately, less than 50% of 
individuals with type 2 diabetes achieve glycemic control (HbA 1c < 7%) (Norris et al. , 
2002) . The HbA 1c test , a measure of a 2-3 month average blood glucose level, is often 
the preferred standard for assessing glycemic control (Goldstein, 1995). 
Further, obesity, overweight , and weight gain are major risk factors in the 
development of type 2 diabetes. Every 1 kg increase in weight is associated with a 9% 
relative increase in the prevalence of diabetes (Mokdad et al., 2000) . Obesity is also 
associated with greater risk of developing complications associated with diabetes , such as 
hypertension (Mokdad et al) . Conversely , weight loss improves insulin sensitiv ity and 
glycemic control (Sjostrom , Peltonen, Wedel, & Sjostrom, 2000) . 
A weight classification system has been put forth by the National Heart , Lung and 
Blood Institute (NHLBI; 1998) and is widely accepted as the nomenclature for describing 
overweight and obesity . This classification system, described in Table 1, is based on BMI 
that describes relative weight for height and is calculated as weight (kg)/height squared 
(m2) . For purposes of simplicity, unless specified, the classes of obesity, including 
overweight will be referred to as obesity. 
Table 1 
Classification of Overweight and Obesity by BM! 
Classification 
Underweight 
Normal 
Overweight 
Obesity 
Extreme Obesity 
Obesity class 
I 
II 
III 
BMI (kg/m) 
< 18.5 
18.5 - 24.9 
25.0- 29.9 
30.0- 34.9 
35.0 - 39.9 
~40 
Management of BMI and Obesity in Diabetes Treatment 
If patients with diabetes need to reduce BMI, physicians will typically refer 
patients to education programs for assistance with weight loss. Unfortunately, educa tion 
programs have not demonstrated outcomes oflong-term weight loss (Norris et al., 2004). 
It is possible that the obesity problem in type 2 diabetes represents a key obstacle to 
improving overall health of patients. Yet, were clinicians to attempt to address the BMI-
diabetes association by embracing weight regulation as a goal, a number of key obstacles 
to effective BMI intervention would still have to be overcome. 
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First, the obese problem among type 2 diabetics is pervasive with proximately 
85% of type 2 diabetics classified as overweight or obese. Second, there is very little 
research on effective methods for helping patients successfully decrease their weight and 
maintain this loss over time. Overall, studies incorporating appropriate follow-up periods 
tend to show a clear trend toward return to baseline weight (Avenell et al., 2004; Cooper 
& Fairburn, 2001,). In fact, longitudinal studies within the broader obesity literature 
show that 95% of those who successfully lose weight regain it within 5 years (Perri, 
Nezu, & Viegener, 1992). Wing (2002) stated that "data from a variety of weight loss 
interventions suggest that weight loss and maintenance may be an even greater problem 
for diabetic than for non-diabetic individuals" (p. 41 ). 
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This weight-rebound phenomenon after a weight loss is more distressing when the 
broader, co morbid relationships between obesity and other chronic diseases is 
considered, for example, heart disease, cancer and type 2 diabetes (Anderson , Kendall , & 
Jenkins, 2003 ; Orzano & Scott , 2004) . Given the high failure rate observed in weight 
loss treatment programs , it is perhaps not surprising that only 25% of obese patients 
receive any type of weight-loss treatment servic es from their physicians (Orzano & Scot; 
Stafford , Farhat, Misra , & Schoenfeld , 2000) . 
Empirically Support ed Treatments for Obesity in Diab etes 
Presently, health professionals can recommend three evidence-based approaches 
for treating obesity identified in clinical guidelines put forth by the NHLBI (NHLBI, 
1998): lifestyle therapy (includes dietary therapy with a low-calorie diet, physical activity 
and behavior therapy); pharmacotherapy ( only as part of a comprehensive weight-loss 
program including dietary therapy /low-calorie diet and physical activity); and bariatric 
(weight-loss) surgery (Cooper & Fairburn, 2001; NHLBI) . 
Lifestyle therapy was found to achieve the greatest likelihood of success of weight 
loss and maintenance oflost weight for > 1 year (NHLBI, 1998). Treatments for obesity 
produce an average weight loss of 10% of initial body weight. Unfortunately this is 
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almost always followed by a regain of the weight lost, with 40% being regained over the · 
first year following treatment. The rest is regained over the following 3 years (Cooper & 
Fairburn, 2001 ; NHLBI) . Without the addition of behavior therapy, long-term 
effectiveness of weight-loss therapy has not been demonstrated (NHLBI) . Cooper and 
Fairburn suggest that one factor for this disappointing outcome is the "neglect of the 
contribution of cognitive factors to weight regain ." 
Pharmacotherapy results in an average of 5-10% weight loss , however given the 
historical problems with drug safety such as fenfluramine and phentermine , physicians 
and patients are disinclined to implement drug treatment (NHLBI, 1998). Bariatric 
surgery is intend ed only for obese individuals with a BMJ >40 or BMI >35 with at least 
one comorbid health condition related to obesity. Those who qualify for this intervention 
must have documented a consistent failure to lose weight with standard treatments 
(NHLBI) . 
However , a review of the literature on outcomes of bariatric surgery found that in 
both long-term and short-term outcomes, weight loss improved or resolved diabetes in 
over 76% of cases (Buchwald et al., 2004) . Because of the dramatic impact of weight 
loss resulting from bariatric surgery, a more thorough discussion of these outcomes will 
be presented in Chapter II. 
Overall , the treatment options that physicians currently recommend have not 
produced the long term weight loss that is sought. Thus , factors associated with 
successful weight loss treatments and characteristics of successful weight loss 
maintainers have been of keen interest to researchers, as incorporating such factors into 
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future treatments may increase their efficacy (Perri et al., 1992). For example, Roter and 
colleagues (1998) found that comprehensive interventions combining cognitive, 
behavioral and affective components were more effective than single-focus interventions. 
Therefore, a cognitive behavioral weight loss program may offer the best hope for 
helping obese, type 2 diabetic adults regulate their weight and in tum their daily glucose 
levels. 
Characteristics of Successful Weight Loss Maintainers 
Better weight management programs may emerge if evaluation researchers' 
hypotheses can be guided, in part, by data derived from studies that identify the 
characteristics of successful weight loss maintainers . Kitsantas (2000) suggested that to 
enhance weight loss success, interventions must focus on strategies that optimize self-
regulation and enhance self-efficacy perceptions. Self-efficacy represents a judgment of 
one's capability to accomplish a certain level of performance and includes the confidence 
to overcome barriers . Self-efficacy has become an important concept in the treatment of 
both diabetes and obesity because of the necessity for the individual to successfully 
change behaviors . Satterfield and Davidson (2000) reviewed studies that investigated the 
relationship between self-efficacy and diabetes self-care behaviors. Studies found that 
high self-efficacy was highly predictive of diabetes self-care behaviors , including weight 
management, among adults. 
Dehahanty, Meigs, Hayden, Williamson, and Nathan (1992) found a relationship 
between baseline BMI and several psychological constructs including self-efficacy in the 
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Diabetes Prevention Study. Thus, the measurement of changes in self-efficacy may prove 
useful in identifying those treatments that will improve weight maintenance outcomes. 
Need to Measure Health-Related Quality of Life 
Another likely shortcoming of past studies of diabetes-related interventions has 
been a failure to evaluate the broad impact of the disease (and the interventions aimed to 
treat it), on patients' quality of life. Indeed more than 50 years ago, the World Health 
Organization stated that health was defined not only by the absence of disease and 
infirmity , but also by the presence of physical , mental, and social well-being (Rubin, 
2000). Thus, better evaluations of quality oflife among persons with diabetes, a 
measurable construct, will lead to more adequate evaluation of treatments for chronic 
diseases . Therefore, future studies of diabetic patients should incorporate broader 
measures of outcome, such as quality of life . 
Summary and Statement of the Problem 
In summary, the general population is evidencing an increasing prevalence and 
incidence of type 2 diabetes and the costs associated with diabetes and its treatment are 
presently very high. 
However, to date, treatment programs have not adequately incorporated 
interventions that address the well-known relationship between obesity and the 
development and maintenance of type 2 diabetes. Given the contribution of overweight 
to the development of type 2 diabetes, successful maintenance of weight loss might, in 
tum help attenuate blood glucose control problems so common among type 2 diabetes . 
Also, the need to evaluate the effect of treatment on quality oflife is of keen interest. 
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The present study sought to test the efficacy of a weight management approach for 
type 2 diabetes which incorporates a focus on long-term weight loss maintenance 
strategies. The following research questions were central to this study: 
1. Does a cognitive-behavioral treatment added to standard care-as-usual lead to a 
decrease in BMI and weight? 
2. Does a cognitive-beha vioral treatment added to standard care-as-usual improve 
glycemic control as measured by HbA 1c? 
3. Does a cognitive-behavioral treatment added to standard care-as-usual change 
diabetes-specific quality of life as measured by the Diabetes Care Profile DCP) and Short 
Form-36 (SF-36)? 
4. Does a cognitive-behavioral treatment added to standard care-as-usual improve 
diabetes related self-efficacy as measures by the Diabetes Empowennent Scale (DES)? 
CHAPTER II 
LITERATURE REVIEW 
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To place the present study in an appropriate context, a range of topics relevant to 
treatment issues in the arenas of obesity and diabetes will be discussed in the literature 
review that follows . A brief summary of the history surrounding the identification of 
diabetes as a disease and the effect of weight loss in the remission of the symptoms will 
be presented . A summary of the recent changes to Medicare policy regarding obesity 
treatment will be discussed including : (a) and the implications of the change on broader 
medical insurance coverage for obesity treatments and (b) the increased funds now 
available for obesity treatment research. Next, a brief history outlining the relationship of 
type 2 diabetes and weight-loss will be presented , and a summary of the contemporary 
standards of care for diabetes will be outlined. This latter presentation will allow the 
reader to gain a better understanding of the components found in most contemporary, 
"care-as-usual" diabetes treatment. More specifically, the key topics of interest 
associated with contemporary standards of care include: (a) procedures for attaining 
glycemic control via diet; (b) a more detailed description ofHbA 1c, the blood glucose test 
used as an outcome in this study, (c) diabetes medication management, and (d) the 
efficacy of patient education in diabetes intervention. 
Research on typical weight loss treatments including diet therapy, physical 
activity, and cognitive-behavioral modalities as well as anti-obesity medication and 
surgery for weight loss will be specifically summarized. Also, research on self-
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monitoring/assessment procedures will be specifically summarized. Showcasing the 
efficacy of treatments within the broader obesity /weight loss literature will be included; 
this discussion is important because it has implications for selecting empirically-validated 
approaches for further investigation and possible use in a type 2 diabetic population. 
Also presented in this review will be evidence supporting the role that weight loss 
treatment might play if diabetes treatments incorporated weight loss interventions with 
demonstrated efficacy . Toward this end, a review of the literature pertaining to the 
relationship between improved diabetic outcomes and weight loss will be offered. In 
addition , a discussion of the efficac y of weight loss treatments for obesity and in 
parti cular for weight loss treatments geared for those diagnosed with type 2 diabet es will 
be presented. Of particular interest is research on how bariatric surgery impacts both 
weight loss and diabetes , and the relationship between physical activity and weight loss . 
Finally, some accessory issues relevant to the treatment of type 2 diabetes are 
worthy of discussion in the present review , as they will almost certainly impact the design 
of intervention studies . For example, the importance of both discovering and integrating 
empirically-validated treatments more effectively is an important theme in this literature . 
Also, there is a need to evaluate treatment outcomes beyond simple measures of glycemic 
control and weight loss; for example, quality of life and self-efficacy indices are highly 
relevant outcome measures to patients. Diabetes and obesity certainly impact a patient's 
functional capacity and sense of effectiveness in many areas of life . Thus, the merits of 
using health-related quality-of-life measures to more accurately assess health outcomes 
will be presented in the review that follows . 
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Efficacy of Obesity Treatment and Medical Insurance Coverage 
An important issue, that of insurance reimbursement for medical treatment, 
requires evidence of empirically supported treatment (EST). Obesity treatment has not 
been covered by most insurance providers because until recently it was not considered a 
treatable condition. In 2004, in a landmark decision, the Department of Health and 
Human Services announced that the Medicare Coverage Policy would remove barriers to 
covering anti-obesity interventions if empirically supported treatments demonstrate 
efficacy in improving health outcomes (Department of Health & Human Services , 2004). 
The need is great for research to demonstrate the efficacy of obesity treatment and 
recently , a greater amount of grant money has been provided at the federal level to 
support this research - in part, because of this Medicare policy change . In fact, in 2005, 
National Institutes of Health received $440.3 million to fund obesity research. This is 
truly a landmark event because Medicare is the flagship for private medical insurance 
policy . That is, if Medicare makes a policy change to cover certain obesity treatments , 
typically private insurers follow suit (Betz, 2005). Hence , a good deal of contemporary 
research has focused on the identification of ES Ts. Given the comorbidity of obesity and 
diabetes, however, an optimal use of Medicare dollars would be to expend them on the 
newest empirically supported weight loss strategies that have been incorporated into 
treatments for type 2 diabetes . 
A Brief History of Diabetes and the Relationship of 
Weight Loss to Diabetes Treatment 
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The disease diabetes mellitus has been known since ancient times. Two Hindu 
physicians in 1000 B.C. first identified two forms of the diabetes syndrome: one 
associated with emaciation, dehydration, and excessive urination, and the other with stout 
build, excessive caloric consumption, obesity, and sleepiness. The first type was always 
fatal until the development of exogenous forms of insulin in 1921. Although the 
distinction between the two forms was described 3,000 years ago, a fonnal differentiation 
in medical nomenclature was not made until 1979 with the International Classification of 
Diseases (ICD) assignment of type I and type 2 diabetes. For more than 100 years, it has 
been known that weight loss is an effective treatment for type 2 diabetes . Historical 
accounts of the human effects of the Franco -Prussian War as well as World War I and II 
showed that food shortages and rationing caused by large scale social disruption produced 
weight loss across large portions of the population. This decrease in available food was , 
in each event, accompanied by a measurable lessening in symptomology in existing 
diabetes cases . Physicians noted that overweight patients with diabetes became 
aglucosuric (absence of glucose in urine), a sign that the severity of diabetes is 
decreasing. With the advent of more sophisticated knowledge about the etiology of 
diabetes, glucose levels are now measured in blood samples (Davidson & DiGirolamo, 
2000). 
Contemporary Standards of Care and 
Measurements for Diabetes Mellitus 
For those newly diagnosed with type 2 diabetes by a physician, medical 
management protocols typically include the prescription of an oral hypoglycemic agent 
and educational materials on topics such as how to maintain a healthy diet. It also 
commonly includes a referral to a diabetes educator or nutritionist, the initiation of self-
monitoring of blood glucose (SMBG), and screening for various complications, and 
periodic measurements of glycosolated hemoglobin (GHb; ADA, 2007). 
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First and foremost in the treatment of diabetes is continued glycemic control and 
adequate glycemic control is described as an HbA 1c measure of <7% (UK Prospective 
Diabetes Study Group, UKPDSG, 1998) . GHb is a term used to describe a series of 
stable minor hemoglobin components formed slowly and from hemoglobin and glucose 
(Goldstein, 1995) . The rate of formation of GHb is directly proportional to the ambient 
glucose concentration. Because red blood cells ate freely permeable to glucose, the level 
of GHb in a blood sample provides a glycemic history of the previous 2-3 months, the 
average red blood cell life span. The HbA 1c test, which measures GHb often the preferred 
standard for accessing glycemic control. This measure more readily predicts the risk of 
developing diabetic complications than does daily glucose monitoring (Goldstein). 
According to Harris, Eastman, and Cowie (1999), this level of control is achieved in less 
than half of persons with type 2 diabetes . 
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The UKPDSG (UKPDSG; 1998; Manley, 2003) found that the intensive treatment 
group achieved a mean HbA 1c of 7%, while the standard care group maintained an HbA 1c 
of7.9% based on a follow-up period of 10 years (p < .0001). In the control group the 
HbA 1c value steadily increased over the 10 years. In the treatment group there was an 
initial decrease in HbA 1c in the first year and then, like the control group, a similar 
increase over the 10-year period . However, this difference between groups was 
significant and translated into a 12% reduction for any diabetes complication (p = .034). 
Most of the risk reduction was due to a 25% risk reduction in microvascular endpoint 
such as retinopathy which translated into a 35% reduction in the risk of complications for 
every percentage point reduction in HbA 1c (e.g., 9% to 8%; American Diabetes 
Association , 2002) . There were no differences between groups in risk reduction for 
macrovascular ( cardiovascular) disease . 
This study initially contained a diet-only treatment group as well as several groups 
given different types of medications. The diet-only group treatment consisted of dietary 
advice from a dietician including advice to eat a diet low in saturated fat, moderately high 
in fiber and have about 50% of calories from carbohydrates. The overweight and obese 
patients were advised to reduce energy content; however, there is no report on the percent 
of participants who were overweight or obese. It can be assumed that with a study size of 
5,102 patients, the percentage overweight or obese would be similar to the typical 
reported statistics in other resources. Eighty-five percent of individuals diagnosed with 
type 2 diabetes are overweight and of those 55% are obese (CDC, 2004; Norris et al., 
2004). It is not surprising, given the lack of comprehensive treatment of obesity, that 
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none of the diet-only participants, over time, were able to control their glucose levels with 
diet only and were transferred into a medication group. This study is now frequently 
cited in diabetes treatment literature and is the benchmark for glycemic control 
parameters in treatment (American Diabetes Association, 2007). 
Glycemic Control via Diet, Medication Management, 
and Patient Education 
Standard care guidelines aimed at helping patients attain glycemic control 
typically include : (a) the prescription of diet recommendations from the American 
Diabetes Association (ADA) , or (b) a regimen of oral hypoglycemic medications along 
with the aforementioned diet recommendations . Selection of one of these initial 
treatment options appears to be based on physician preference or on severity of 
hyperglycemia (ADA, 2007). For instance, according to a Utah survey of primary care 
providers, respondents ranked diet and oral medication as the most common treatment for 
type 2 patients; diet alone ranked second. It is unclear if the survey term "diet" indicates 
endorsing a balanced and healthy diet or a combination of diet along with calorie 
restriction . This survey's poor item construction also illustrates the lack of some critical 
distinctions in the standards of diabetic care literature between healthy dietary balance of 
nutrients and healthy weight indicators (BMI, for example) (Utah Department of Health, 
Diabetes Prevention and Control Program , 2003). 
Standard recommendations for diet include educating the patient about balanced 
and healthy nutrition and, if overweight or obese, the use of caloric restriction and 
increase in energy expenditure (activity) to induce weight loss (ADA, 2004). It is also 
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common for a patient to be referred to a nutritionist or diabetes educator to receive 
assistance in losing weight. National patterns of physician activities related to obesity 
management indicate that physicians provide weight loss treatment for 25% of all obese 
patients . If an obese patient had a comorbid condition (e.g., type 2 diabetes), the 
physician provided treatment to 52% of obese patients (Stafford et al., 2000) . Barriers to 
treating obesity by medical professionals include physician knowledge of high patient 
relapse rates, lack of patient interest in obesity treatment, lack of knowledge about 
appropriate weight management interventions , and lack of educational materials 
(Timmerman, Reifsnider , & Allan , 2000). Based on literature reviews of randomly 
controlled trials for m edical patients recei ving weight loss treatm ent, medical patient 
outcomes are similar to outcomes for weight loss treatment in general. That is, patients 
experience initial weight loss followed by a trend of weight regain (Douketis, Macie, 
Thabane & Williamson , 2005; Norris et al. , 2004). 
To complicate the issues of obesity treatment in medical settings by physicians, 
extended treatment, peer support and cognitive-behavioral therapies are associated with 
better weight maintenance outcomes (NHLBI, 1998) . These strategies do not map easily 
onto physician-patient time constraints, and lack of physician knowledge about these 
treatments is a clear impediment to treatment (Stafford et al., 2000). With the apparent 
difficulty in treating obesity in the medical setting and the complexity of obesity 
treatment it may be appropriate to develop more independent multi component weight 
loss/weight maintenance programs (Perri & Corsica, 2002). 
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Oral Hypoglycemic Medication Management 
Treatment with oral medications tends to follow a predictable path that usually 
begins with the prescription of one oral medication. As glycemic control diminishes (i.e. 
blood glucose levels rise) with one medication, additional oral medications are 
prescribed . The ability of oral medication to control blood glucose levels diminishes over 
time, including combining multiple medications. Typically, tight blood glucose control 
lasts no more than 9 years with oral medications before insulin (typically injected with a 
syringe) is required for better glycemic control (Triplitt , 2007 ; UKPDSG , 1998) . 
Effic acy of Patient Edu cation in Diabetes Interv entions 
Patient education is considered to be important in cont emporary diabetes health 
interventions ; it is based on the assumption that health-promoting behaviors will likely 
occur , once patients have adequate information (Norris, Engelgau , & Narayan, 2001). 
While some physicians may offer some education during an office visit, patient education 
programs led by a nutritionist or health educator are the most common vehicle for 
providing information about diet, exercise , and other self-care behaviors known to be 
associated with better glycemic control and decreased complications (ADA , 2007) . 
Physicians will direct the patient to a diabetes education program either as an 
initial intervention strategy or if the patient continues to exhibit uncontrolled 
hyperglycemia. Patient education includes training in self-care behaviors such as SMBG , 
adherence to medication management, monitoring and management of chronic 
complications, strategies to change behavior, meal planning and weight and exercise 
management (ADA, 2004). 
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Unfortunately, the efficacy of patient education to improve glycemic control and 
other diabetes-related outcomes have not been demonstrated over time (ADA, 2004). A 
review of the literature conducted by Norris and colleagues (2001) examined the efficacy 
of diabetes education on improvement of self-care behaviors, glycemic control, and 
reduction of complications. The review concluded that most interventions increased 
patient knowledge and improved glycemic control initially, but generally failed to 
produce improvement in glycemic control long term, the maintenance of lost weight, or 
sustained increases in physical activity. 
Satterfield and Davidson (2000) acknowledge that education increases knowledge. 
However, they belie ve most educators would agree that while necessary, knowl edge is 
insufficient to stimulate the behavioral changes needed . In fact, interventions that 
improve patient compliance in a variety of health outcomes found that "comprehensive 
interventions combining cognitive, behavioral, and affective components were more 
effective than single-focus interventions (Roter et al., 1998). 
Standards of Care in Diabetes Treatment 
In summary, contemporary standards of care for helping patients attain glycemic 
control typically include the prescription of oral hypoglycemic agents, a referral to a 
patient education program and diet recommendations. Well-controlled clinical trials have 
established that the use of oral medications for glycemic control follows a predictable 
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path, for example, to eventual dependence on insulin. Also, patient education is a 
ubiquitous component of contemporary diabetes control programs. Yet the effects of 
patient education on glycemic control tend to be moderate and to decrease over time. 
More striking is the lack of significant effects of patient education on weight loss. It is 
notable that standards of care and recommendations from governing bodies, such as the 
American Diabetes Association, are often based on controlled clinical trials that evaluate 
the efficacy of medication . However, it appears these institutions tend to minimize or are 
unaware of current research regarding treatments for weight loss. Also, almost none 
appear to actively participate in new research focused on improving the efficacy of weight 
loss treatments. The implications of this body ofresearch are that heavy reliance on 
glycemic control medications and passive education programs, and the failure to address 
BMI through weight control interventions may well account for the minimal, long-term 
effectiveness of most contemporary type 2 diabetes treatment programs. The research 
points to a need to develop more effective treatments addressing obesity-diabetes 
comorbidity . 
General Efficacy of Weight Loss Treatments 
As mentioned earlier, health professionals can recommend three evidence-based 
approaches for treating obesity including: lifestyle therapy, pharmacotherapy, and 
bariatric (weight-loss) surgery ( Cooper & Fairburn, 2001; NHLBI, 1998). 
Lifestyle therapy was found to achieve the greatest likelihood of success of weight 
loss and maintenance of lost weight for > 1 year. Lifestyle therapy included diet therapy 
20 
with a low-calorie diet, increase in physical activity, and behavior therapy . Diet therapy 
consists mostly of instructing patients on how to modify their diets to achieve a moderate 
reduction in calorie intake. A decrease in calorie intake is the most important dietary 
component of weight loss and maintenance (NHLBI, 1998). Guidelines for reduction in 
calorie intake include a reduction of 500-1,000 kcal/day ( depending on individuals 
starting weight) from their maintenance calorie intake. 
In weight loss treatments, most incorporate caloric restriction as the primary 
component. In order to improve on the disappointing findings of weight loss 
maintenance , treatments have included some variation in type of caloric restriction (e.g., 
restriction of carbohydrates or fats or total calories; Avenell et al. , 2004). Of these 
treatments some may employ other regimens to enhance weight loss or to improve 
maintenance of lost weight. These regimens generally consist of behavioral or cognitive-
behavioral interventions, increases in physical activity or pharmacotherapy as adjuncts to 
a prescribed calorie-restricted diet plan , or a combination of these regimens (Ostman, 
Britton, & Jonsson, 2004). 
Behavioral therapy proves most necessary in helping patients maintain weight loss 
by modifying lifestyle behaviors upon which patients tend to return after losing weight. 
Treatments for obesity produce an average weight loss of I 0% of initial body weight. 
Unfortunately this is almost always followed by a regain of the weight lost, with 40% 
being regained over the first year following treatment. The rest is regained over the 
following 3 years (Cooper & Fairburn, 2001; NHLBI, 1998). Without the addition of 
behavior therapy, long-term effectiveness of weight-loss therapy has not been 
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demonstrated (NHLBI). Cooper and Fairburn suggested that one factor for this 
disappointing outcome was the "neglect of the contribution of cognitive factors to weight 
regain." 
It is important to note that the term behavioral therapy often contains strategies 
that would also fall under the umbrella of cognitive therapies . For example, the clinical 
guidelines for weight loss put forth by the NHLBI (1998) include behavioral therapy. 
Two of the strategies put forth in behavioral therapy are stress management, which 
involves coping strategies, and cognitive restructuring , which involves identifying and 
modifying inaccurate beliefs and self-defeating thoughts. Typical cognitive strategies 
address these same issues (Sharf, 2000). Therefore, for sake of clarity, it may be more 
accurate to term the NIH reference to behavior therapy as cognitive-behavioral therapy. 
The NIH identified seven strategies that have empirical support in cognitive -behaviora l 
therapy including: (a) self-monitoring of eating habits and activity, (b) stress 
management , (c) stimulus control, (d) problem-solving , (e) contingency management 
such as use of rewards, (f) cognitive restructuring, and (g) social support. 
Physical activity is an important component of weight loss because it expends 
additional energy and contributes to weight loss both alone and in combination with diet 
therapy . Activity may also inhibit food intake in overweight patients and may be helpful 
in maintaining weight loss (NHLBI, 1998) . Physical activity has shown to improve 
weight loss outcomes and to delay or prevent weight gain often associated with aging 
(Blair & Holder, 2002; NHLBI). Along with a low fat diet and continued self-monitoring 
of food intake, physical activity is one of three main behavioral characteristics shared 
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with those who avoid significant weight regain (Cooper & Fairburn, 2001). 
Use of anti-obesity medications (pharmacotherapy) has also shown to improve 
weight loss outcomes. Typically these medications are not indicated for continued use 
longer than 2 years, which precludes the use in the necessary long-term treatment of 
obesity. Unfortunately, upon discontinuation of medication, individuals tend to 
experience rapid regain of lost weight (Wadden & Osei, 2002). There have also been 
serious health risks associated with some of these medications (Padwal, Li, & Lau, 2003). 
Bariatric surgery is typically recommended for individuals with a BMI > 40 or 
BMI > 35 with comorbid complications related to obesity. Patients typically experience 
significant initial weight loss followed by various amounts of weight regain over time 
(Ostman et al., 2004) . A comprehensive review of the literature regarding weight loss 
maintenance was conducted by Ostman and colleagues and patients experienced more 
weight regain after 2 years and up to 10 years . In fact, patients maintained an average 
weight loss of only 16% of excess weight after an initial weight loss average of 50-75% 
of overweight. 
It appears that the invasive treatment of bariatric surgery has somewhat lower 
weight regain outcomes, but it also fails to elicit maintenance of all weight initially lost. 
However, a review of the bariatric surgery literature by Buchwald and colleagues (2004) 
found that after 12 years, a weight loss of at least 9 kg was associated with a 53% 
reduction in all obesity related-deaths. A more comprehensive dis 'cussion of bariatric 
surgery is included in the section below. 
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Several reviews of the literature on weight loss treatments found that patients can 
typically lose 5-10% of body weight within 1 year, but the majority begin regaining 
weight in the year following treatment (Avenell et al., 2004; Curioni & Lourenco, 2005; 
Douketis et al., 2005; NHLBI, 1998) . Within 3-5 years of completing treatment, the 
majority of individuals have returned to their baseline weight (Wadden, Womble, 
Stunkard, & Anderson, 2002). In fact, "the maintenance of treatment effects is the single 
greatest challenge in the long-term management of obesity" (Cooper & Fairburn, 2002). 
Efficacy of Specific Treatments for Weight Loss 
in Type 2 Diabetes 
The tendency for weight loss to be followed by weight regain is minored in 
weight loss treatments for overweight and obese patients diagnosed with type 2 diabetes 
(Wing et al., 2001). As mentioned earlier, approximately 85% of diabetic patients are 
considered overweight or obese and a BMI >27 is considered the point at which 
intervention is needed to induce weight loss in diabetic patients (Wadden & Osei, 2002). 
The NHLBI algorithm recommends an individual with a BMI > 30 or a BMI of 25.0 -
29.9 with two or more disease risk factors, attempt to lose weight by adhering to a 
lifestyle therapy program (1998). The beneficial effect of weight loss on reducing diabetic 
risk as well as improving glycemic control and reducing complications has been well-
documented in several literature reviews (Anderson et al., 2003; Anderson & Konz, 2001; 
Orzano & Scott, 2004). 
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For example, Anderson and Konz (2001) found that 1-kg of weight loss decreases 
fasting plasma glucose concentrations by -0.2 mM and a 5-kg weight loss would decrease 
fasting plasma glucose concentrations by 1 mM. This decrease is in the range produced 
by many of the oral hypoglycemic agents that are currently approved by the Food and 
Drug Administration. Orzano and Scott (2004) also found that moderate weight loss 
could positively affect glycemic control. They identified a critical threshold weight loss 
of ~ 5% of body weight to improve glycemic control. 
In a review of the literature concerning weight management in type 2 diabetes , 
Anderson and colleagues (2003) found that obesity is a major risk factor for the 
developm ent of type 2 diabetes, accounting for 60 - 90% of the variance. The authors 
reported on the findings of two studies that followed patients long-term and proved to 
have similar patient outcomes . After a 6-year period both studies found that with 
moderate weight loss of - 6% of body weight and increases in physical activity by - 50%, 
subjects in the lifestyle interv ention group had a 58% reduction in risk for diabetes 
compared to the control group. The reviewers concluded that for many obese diabetic 
individuals , an emphasis on weight management may be the most important therapeutic 
task . 
The Diabetes Prevention Program Research Group (2004) conducted a study of 
the effects of weight loss and physical activity on the development of diabetes in persons 
considered high risk for developing diabetes . The study goals were for participants to 
lose 7% of their baseline body weight and to achieve at least 150 min/wk of physical 
activity, using activities similar in intensity to brisk walking. These goals were selected 
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because they appeared achievable and likely to reduce the risk of diabetes. The entire 16-
week core curriculum was completed by 95% (1,024) of participants. Weight loss over 
the 16-week period averaged 6.5 ± 4.7 kg or 6.9 ± 4.5% of initial body weight. About 3 
years after their initial visit, participants maintained an average weight loss of 4.5 ± 7.6 
kg or 4 .9 ± 7.4% of initial body weight. This research indicated that the reduction of 
baseline weight by 7% and an increase of physical activity to 150 min/wk reduced the risk 
of diabetes by 58%. One unexpected finding from this study was that older individuals 
were particularly successful at achieving both the weight and physical activity goals and 
had the greatest reduction in diabetes incidence. This finding is particularly salient for 
the diabetes population because average age of onset of type 2 diabetes is 50 years of age . 
A dramatic demonstration of the efficacy of weight loss on diabetic outcomes can 
be found in a review of studies investigating the effect of bariatric surgery on weight loss. 
A systematic review of the literature on the impact ofbariatric surgery on weight loss 
found the mean percentage of excess weight loss was 61.2% for all patients . Diabetes 
was completely resolved in 76 .8% of patients. Further, it was resolved or improved in 
86.0% of cases (Buchwald et al., 2004). While this particular review did not report any 
follow-up data, a study of the long-term beneficial effects of maintained weight loss on 
the development of diabetes was investigated by Sjostrom et al. (2000) in an ongoing 
prospective Swedish Obese Subjects (SOS) study. This large cohort study followed 346 
patients who underwent gastric bypass surgery with 346 matched obese control subjects 
who received the customary obesity treatment at the medical centers to which they 
belonged. The gastric bypass intervention resulted in a maximum weight loss of -31.3 ± 
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13 .6 kg after 1 year. After 8 years, the maintained mean weight loss was 20.1 ± 15. 7 kg 
in the surgery group and the mean weight loss in the control group was +0 .09% . 
Although the maintained weight loss of the surgery group was equivalent to only a 16% 
reduction in weight, it had a dramatic effect on the 8-year incidence of diabetes ( odds 
ratio 0.16, 95% CI 0.07 to 0.36). Also , the incidence among control completers was 
18.5% compared to 3.65% for surgically treated completers . 
Relationship Between Physical Activity and 
Weight Loss in Type 2 Diabetes 
Persons who have been diagnosed with type 2 diabetes also benefit from weight 
loss and increases in physical activity because these changes can reduce amount of 
medications needed for glycemic control and, for some, these changes can eliminate 
diabetic symptoms entirely (ADA, 2004). Exercise alone has also been shown to improve 
glycemic control in the absence of weight loss (Swartz et al., 2003). Swartz and 
colleagues (2003) conducted a study in which participants walked an average of 4,972 
steps/day, but did not intentionally control caloric intake. This level of activity resulted in 
a decrease in blood glucose levels . 
A review of the literature on the effect of exercise on weight loss and maintenance 
found that exercise alone (without diet) produced a small weight loss of 2 kg that was 
significantly greater than the control group with a no-exercise condition (Wing, 2002) . 
Wing also reviewed several studies that compared the effects of diet, exercise, and the 
combination of diet and exercise. At 2 years, one study reported the diet and exercise 
group had lost 2 .2 kg whereas the diet-only group had lost 0.9kg. This difference was not 
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statistically significant, but the findings do reinforce the premise that a minimum amount 
of weight loss found in the treatment group is clearly better than the untreated groups who 
tend to gain weight. 
Characteristics of Successful Weight Loss Maintainers 
Better weight management programs may emerge if evaluation researchers' 
hypotheses can be guided, in part, by data derived from studies that identify the 
characteristics of successful weight loss maintainers. Kitsantas (2000) suggested that to 
enhance weight loss success, interventions must focus on strategies that optimize self-
regulation and enhance self-efficacy perceptions. Se! f-efficacy represents a judgment of 
one's capability to accomplish a certain level of performance and includes the confidence 
to overcome barriers. Beliefs about whether making the behavior change will lead to a 
particular outcome are referred to as outcome expectations . Characteristics of successful 
weight maintainers include use of two interdependent self-regulating strategies: goal 
setting and self-monitoring. Those who use goal setting, the setting of goals that are 
specific, realistic, proximal, and strategic tend to have higher self-efficacy perceptions 
and are more likely to maintain behavior change 
Self-efficacy has become an important concept in the treatment of both diabetes 
and obesity because of the necessity for the individual to successfully change behaviors . 
Satterfield and Davidson (2000) reviewed studies that investigated the relationship 
between self-efficacy and diabetes self-care behaviors. Studies found that high self-
efficacy was highly predictive of diabetes self-care behaviors, including weight 
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management, among adults. The authors suggested three strategies for increasing self-
efficacy: setting small, incremental goals; behavioral contracting, and monitoring and 
reinforcement. It is also important to help change negative outcome expectations and 
thus increase self-efficacy by helping patients to see the relationship between the desired 
behavior and the outcome. This might entail the use of creative teaching strategies (e.g., 
stories, role plays, drama). 
Dehahanty and colleagues (1992) found a relationship between baseline BMI and 
several psychological constructs including self-efficacy, perceived stress and emotional 
eating in the Diabetes Prevention Program study . The authors suggest that interventions 
that focus on how to manage stress , negative emotions and self-talk that may trigger food 
cravings will elicit improved adherence to weight loss interventions. 
Self-monitoring/ Assessment as an Adjunct 
to Weight Loss Intervention 
Self-monitoring, the act of paying deliberate attention to some aspect of one's 
behavior , is associated with behavior change (Boutelle & Kirschenbaum, 1998). In 
weight loss treatment, self-monitoring in the form of recording food eaten and comparing 
one's weight with the healthy weight listed on a BMI chart are correlated with increased 
weight loss and improved weight loss maintenance (Kirschenbaum, Germann, & Rich, 
2005; Lappalanien, Pulkkinen, Oils, Parkka, & Korhenen, 2005). Some research 
indicates that the act of self-monitoring food intake and activity levels can induce weight 
loss as well as increase physical activity (Boutelle & Kirschenbaum; NHLBI, 1998). In 
fact, even though predictors of weight loss have proven elusive, early weight loss and 
compliance with self-monitoring have been identified as the most useful predictors 
(Devlin, Yanovski, & Wilson, 2000). 
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Self-monitoring may enhance self-efficacy through the increased attention focused 
on behaviors related to goal attainment. Self-monitoring has been used as a behavioral 
technique in a wide range of programs aimed at behavioral change. It has proven 
effective in programs targeting decrease of women's cardiovascular risk, in smoking 
cessation programs, in interventions aimed at increasing physical activity in older adults 
and in improving academic skills and increasing academic engagement in children and 
adolescents (Conn , Valentine & Cooper, 2002; Krummel et al., 2001; Manske, Miller, 
Moyer, Rose, & Cameron, 2004; Rock, 2005). 
Most psychological treatments of obesity involve some measurement, assessment 
or self-monitoring to evaluate patients' progress. Self-monitoring is considered the 
cornerstone of effective techniques in behavioral treatments of obesity (Institute of 
Medicine, 1995). In summary, self-monitoring and intensive assessment procedures may 
likely enhance a weight management intervention. 
Maintenance of Weight Loss and "Moderate" 
Weight Loss as a Primary Goal 
With the evident failure rates of weight loss treatments on maintenance oflost 
weight, researchers began to focus on strategies to help maintain weight .loss long-term 
(Perri & Corsica, 2002). Such maintenance is important given the results of a number of 
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studies showing that a moderate weight loss of 5-10% was sufficient to improve health 
(IOM, 1995; NHLBI, 1998; Norris et al., 2005). The IOM issued a report on criteria to 
assess the outcome of weight management programs (IOM). Defining what is meant by 
long term maintenance oflost weight is subjective, therefore a definition of "success" 
was proposed. Successful long term weight loss is defined as maintenance of 1 year or 
more, a weight loss of 2:5% of body weight, or a reduction in BMI by 1 or more units 
(IOM). 
Perri and Corsica (2002) summarized the results of behavioral-based weight loss 
studies with follow-ups of 2 or more years and found that the net mean weight loss from 
base line was 1.8 kg. While this is a small net weight loss, they suggested that trend data 
from the large Minnesota Heart Health Program showed that the natural course of obesity 
in untreated adults entails steady weight gain. This finding indicated that maintenance of 
a small weight loss relative to weight gain may be considered a positive outcome, because 
the normative pattern of gradual, continual weight gain is arrested. 
Ayyad and Andersen (2000) reviewed studies of long-term efficacy of dietary 
treatment of obesity. Based on the authors' definition of successful weight loss 
(maintenance of all weight initially lost [ or further weight reduction] or maintenance of 9-
11 kg of initial weight loss), 15% of dietary treatments of obesity were successful. Those 
treatments deemed successful combined caloric restriction with group therapy or behavior 
modification, and active follow-up. 
Certain physiological facts also support the premise that moderate weight loss is 
an appropriate goal for treatment. Aronne (2002) suggested that weight is controlled by a 
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feedback mechanism and the lack of success in obesity treatments that focus on large 
amounts of weight loss may be the re.suit of a counterregulatory response that prevents 
more than a 5-15% reduction in initial body weight. The concept of plateau, which is 
often witnessed in weight loss trials, has been studied arid it appears there is a relationship 
between this plateau and reductions in leptin-a hormone related to the facilitation of 
weight loss beyond the plateau in animals (Aronne). 
It appears that cognitive factors are also contributing to the lack of continued 
weight loss or weight loss maintenance. Patients do not engage in behaviors necessary to 
maintain lower weight, even if this weight is not characterized as an "ideal" weight. If 
the state of obesity is viewed from a cost-benefit analysis perspective, it suggests that 
weight regain is paradoxical (Cooper & Fairburn, 2001) . Weight loss, which is achieved 
only with long-term, persistent effort , is associated with enhanced self-esteem and 
interpersonal function , and reduced body dissatisfaction and depression. Weight regain 
can be viewed as an aversive state because of its relationship to negative effects on self-
confidence, body image, and mood. 
Cooper and Fairburn (2001) also noted that behavioral therapists have attempted 
to minimize posttreatment gains with treatment components such as extended therapist 
contact, provisions of food, monetary incentives, and telephone contact. These have all 
demonstrated modest effects and tend to simply delay the weight regain. Cooper and 
Fairburn suggested that this lack of engagement in behaviors need to maintain the lower 
weight requires explanation and they posit it is likely due to cognitive factors. They 
propose that because patients do not achieve their weight loss goals, nor the anticipated 
benefits of achieving them, they abandon weight loss efforts and do not appreciate the 
need to acquire weight maintenance skills . 
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Moderate weight loss goals during the initial treatment phase appear to be the 
most promising improvement for weight loss efficacy. However, strategies to improve 
weight loss maintenance appear to be the cornerstone of best practices. Cognitive-
behavioral strategies to address the "maintenance problem" of continued adherence to the 
changes in eating and exercise patterns induced during the initial treatment phase appear 
to hold the most promise for better outcomes (Perri & Corsica, 2002). 
Maintenance methods that have been evaluated and provide beneficial effects 
include: extended treatment that provides clients the opportunity for professional 
assistance in negotiating obstacles to maintenance, skills training in relapse prevention , 
training in problem solving, social support, increase in physical activity, and 
multicomponent treatment programs . Empirically tested multicomponent programs 
include: ongoing professional contacts, training in problem-solving or relapse prevention 
skills, social suppo1i, and exercise (Fairburn & Brownell, 2002) . Motivational 
interviewing, a participant-centered approach to dealing with problems of ambivalence 
and decreased motivation to change also holds promise for increasing success in extended 
treatment (Perri & Corsica, 2002). 
While historically, the research literature paints a dismal picture regarding weight 
loss maintenance efficacy, recent studies that pursue more moderate weight loss goals and 
adopt the idea that obesity is a chronic, relapsing disease, may now be demonstrating the 
possibility that weight loss can be maintained (IOM, 1995; Perri & Corsica, 2000). With 
the limited success of treatment to induce weight loss maintenance, identification of 
treatment components for study in future research can be deduced from consistent 
recommendations from researchers. A clear set of empirically supported guidelines 
established by controlled clinical trials and empirical studies has yet to be developed. 
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In summary, researchers recognize that effective treatments for obesity need to 
pursue realistic, moderate weight loss goals. They also recognize that treatments must 
include strategies to help maintain weight loss once it is achieved . Currently, the research 
has identified the potential value of multicomponent treatment programs that include : 
moderate weight loss goals, self-monitoring, strategies to increase self-efficacy, extended 
treatment, physical activity, and relapse prevention. It is necessary for future researchers 
to carefully evaluate these components in order to identify efficacious treatments for 
weight loss in adults with type 2 diabetes , given its high comorbidit y with obesity. 
Manualized Cognitive-Behavioral Treatment of Obesity 
Cooper , Fairburn , and Hawker (2003) have proposed a new approach to the 
treatment of obesity that is designed to minimize the weight regain that generally follows 
weight loss. They have created a manual to facilitate treatment of obesity and this manual 
will be employed in this research study. An outline of the treatment intervention is 
provided in Appendix A. This treatment focuses on overcoming psychological obstacles 
to the acquisition of and long term adherence to effective weight control behavior. The 
authors suggest that three issues need to be addressed: first, there is a need to help 
patients accept and value the weight loss they have achieved; second, it is necessary to 
encourage the adoption of weight stability not necessarily weight loss as their goal ; and 
third, there is a need to help patients acquire and use behavioral skills and cognitive 
responses required for successful weight control. 
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The treatment advanced by Cooper and colleagues (2003) includes weight loss 
and weight maintenance phases. During the weight loss phase, patients both lose weight 
and address the potential obstacles to subsequent weight maintenance . It includes a 
moderate change in calori c intake and a moderate increase in energy expenditure along 
with an expectation that this moderate approach will be represented by a loss in weight of 
approximately 1 lb/wk. This moderate approach to weight loss will help address the 
problem s found with typic al weight loss strategies (e.g., low self-efficacy, depression, and 
hopelessness) , which are frequent outcomes for patients undergoing more radical shifts in 
caloric-intake and exercise (Perri et al. , 1992). The maintenance phase is characterized 
by focusing on weight stability and the frame of mind and behaviors needed for 
successful weight loss maintenance. 
The use of treatment manuals has become central in the effort to determine if the 
efficacy of treatment is due to the specific intervention used (Weiner et al., 2006) . 
According to McMurran and Duggan (2005), "the advantages of manualized 
psychological treatment include: the promotion of evidence-based practice; the 
enhancement of treatment integrity; the facilitation of staff training, and the potential 
replicability of treatment" (p. 23 ). 
Other Considerations in Optimizing Treatment 
for Type 2 Diabetes 
When planning future research into effective treatments for type 2 diabetes, it is 
important to emphasize a number of accessory measurement issues and procedural 
themes. Measurement issues include the need to evaluate outcomes more broadly (i.e. 
beyond blood sugar levels, weight loss per se ), such as overall quality of life , and the 
general need to integrate treatments, given the multiplicity of problems in diabetes e.g., 
obesity. 
Need for Treatment Integration : Moderate Weight Loss Goals 
in Obesity Within Diabetes Treatment 
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As has been noted previously in the present review, research is justifying a need to 
redefine weight loss for obesity in more moderate tenns. Unfortunately, this new focus 
on more efficacious, moderate weight loss goals is not translating into practice. The 
UKPDS study which has provided a benchmark for diabetes treatment, investigated the 
benefits of a diet-only approach compared to medication-only to improve glycemic 
control. All participants in the diet-only group were eventually moved to the medication 
treatment group because of deterioration in glycemic control. This study is often quoted 
in research regarding treatment recommendations. However, this study did not include 
intensive weight loss treatment intervention in the diet-only group, only intensive 
medication intervention; therefore, only data on medication management has been 
disseminated. 
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The Utah Diabetes Practice Recommendations (Utah Department of Health, 2006) 
do not include BMI as a key treatment target. It describes a medical management 
protocol that does not include diet, exercise, or weight loss as an initial goal of treatment. 
It does suggest that diet and exercise be "optimized" if glycemic control is not adequate 
with oral medication. These recommendations were partly based on the UKPDSG study 
(1998), yet with all the literature available that supports the premise that weight loss and 
physical activity are cornerstones of diabetes management, it appears that mainstream 
treatment is circumventing this treatment option. In a survey of national patterns of 
physician activities related to obesity management, 55,858 physician office visits were 
analyzed, and it was found that based on known obesity rates, physicians were reporting 
obesity in only 38% of their obese patients . Of the obese patients who visited a 
physician , only 25% received counseling for weight loss, and diet and exercise treatment 
(Stafford et al., 2000). 
Perri and colleagues (1992) have also proposed a continuous care model for the 
treatment of obesity. Their model is similar to the chronic care model proposed for the 
treatment of diabetes. Individuals who have lost weight often struggle to sustain the 
substantial degree of psychological control necessary to override compensatory biological 
mechanisms. The authors believe that obesity treatment must be supplemented with 
programs of ongoing care and skills training in relapse prevention . The intervention 
would include components aimed at enhancing patients' problem-solving abilities, so 
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they can cope more effectively with stressful life circumstances. The authors suggested it 
is crucial that therapists orient obese patients to understand and accept the long-term 
implications of weight management. 
Summary 
Taken together, recent research suggests that moderate weight loss goals, self-
monitoring/assessment and an increased focus on empirically validated treatments for 
weight loss/maintenance are likely critical to successful weight maintenance outcomes . 
Research has also demonstrat ed that overweight adults with type 2 diabete s are better able 
to control their disease through moderate weight loss. Given that diabetes is a chronic 
disease requiring ongoing monitoring and treatment , and the addition of weight 
loss/maintenance interventions to treatment, or at the very least avoidance of the pattern 
of continual weight gain, has been demonstrated to improve outcomes for adults with 
type 2 diabetes , it becomes apparent that the maintenance of weight is critical to the long 
term management of the disease . 
Both type 2 diabetes and obesity can be viewed as chronic diseases requiring 
continuous care. The cornerstones in the management of obesity are weight loss followed 
by successful weight maintenance. Because weight loss in overweight patients leads to 
improved glycemic control and reduced risk of complications there is significant overlap 
in the continuous care models of both type 2 diabetes and obesity. However, current 
diabetes treatment regimens do not adequately include weight loss or weight maintenance 
as treatment goals. Typically, most individuals can lose weight during a committed 
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weight loss phase; unfortunately, most regain lost weight within 3 years. Research 
indicates weight loss treatments that emphasize cognitive-behavior techniques, extended 
treatment, and relapse prevention training, lead to better weight loss maintenance. Thus, 
it would be useful to evaluate the relative efficacy of diabetes programs that strongly 
emphasize such weight management interventions. 
It should be noted that in the study conducted by the present author, a primary 
justification was recognition that the problem of poor weight loss maintenance requires 
investigation. Relatedly however, with no clear evidence that a multicomponent 
empirically based treatment exists , it was deemed necessary to use the Cooper and 
colleagues (2003) manual even though empirical evidence demonstrating its efficac y is 
not yet available. 
Cooper and colleagues (2003) have undertaken a large scale study to evaluate the 
long-term efficacy of their treatment manual in a randomized controlled trial. Because 
these data have not been disseminated, this research study is considered a pilot or 
feasibility study to evaluate the efficacy of the manual. This pilot study can certainly 
enhance the findings of Cooper and colleagues and help establish the feasibility of using 
this treatment manual with a subset of the overweight and obese population (i.e., adults 
with type 2 diabetes). Teijlingen and Hundley (2001) stated that the complete findings of 
pilot studies are rare in the research literature. Often researchers report only what they 
learned from the pilot study and not many details. They suggested much can be learned 
regarding processes and outcomes from both the successful and failed pilot study. 
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Upon contact of Dr. Cooper, one of the manual authors, it was found that they will 
be disseminating the findings in a paper presentation at the World Congress of 
Behavioural and Cognitive Therapies in Barcelona, Spain in July, 2007. Unfortunately, 
she is unable to disclose the findings before the conference (personal communication , 
June 20, 2007). 
The authors developed the treatment manual based on extensive successful 
experience in treating eating disorders. They became aware that some of the problems 
that are successfully addressed in the context of treating bulimia nervosa and anorexia 
nervosa were also relevant to patients with obesity. Issues included binge eating , 
dissatisfaction with body shape and weight, and issues concernin g control over eating . 
They were also aware of the problems with existing obesity treatments , particularl y the 
problem of weight regain after successful weight loss. With careful clinical observat ion, 
the theory of the psychological processes involved in weight regain was developed and 
then gradually the treatment protocol in the manual was fully developed. 
The present study specifically examined the efficacy of successively adding self-
monitoring/assessment and cognitive-behavioral treatments to standard care-as-usual to 
improve the range of diabetes outcomes including: BMI, HbA 1c, diabetes-specific quality 
of life, and diabetes-specific self-efficacy . 
CHAPTER III 
METHODS 
Participants 
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Participants were recruited by conducting physician presentations during monthly 
physician meetings at the 7 participating University of Utah Community Medical Clinics 
(Appendix A). Flyers were displayed in clinic waiting rooms and in treatment rooms 
(Appendix B). Public service announcements were made on three local radio stations and 
run over the course of 2 months (Appendix C). 
Physicians were given business cards with the researcher name and phone number 
and were asked to refer patients to the study. Flyers provided a brief description of the 
study, participant requirements (i.e., type 2 diabetes diagnosis and BMI 2: 27), and 
information about ways to contact the researcher by phone. The newspaper ad was 
similar in that it provided a brief description of the intervention , participant requirements , 
and a researcher phone number. 
Participants who contacted the researcher and who met inclusion criteria: (a) a 
diagnosis of type 2 diabetes, (b) a BMI 2: 27, ( c) secure permission from physician to 
participate in study where they might lose weight and increase activity level (Appendix I), 
and (d) ability to commit to participation in a 12-week study, were invited to participate 
in the study. Participants were then scheduled for an initial intake appointment. Fifty-
four participants who contacted the researcher by phone were found eligible to participate 
in the study. Two potential participants were not eligible for the study because they did 
not have a diagnosis of type 2 diabetes. 
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Upon arrival, for this first meeting with researchers, all subjects were given a 
consent form that detailed all necessary information for them to make an informed 
decision regarding their participation . During this appointment, participants were 
informed that the process would take approximately 1 hour and all agreed to complete the 
consent forms and the three outcome measures. Once informed consent procedures were 
finished, the participants completed the initial assessment measures and had their weight 
and height measured to calculate BMI. Initial assessment measures included having 
blood drawn at the hospital lab or signing a release of information for current HbA 1c 
measure (taken within prior 2 weeks) and for the researchers to have access to their final 
HbA 1c measure. The subjects also completed two self-report measures including: a 
diabetes specific quality of life (QOL) measure, a general measure of QOL embedded in 
the diabetes specific QOL measure, and a measure of diabetes-related psychosocial self-
efficacy, all three of which are described in the measures section below. The subjects 
were then randomly assigned to their respective groups and told they would again 
complete the outcome measures in 12 weeks. Participants assigned to the CB treatment 
group were scheduled for an appointment the following week. Paiticipants in the control 
group were told they would be contacted in 12 weeks for the next appointment. All 
participants were informed that they would be contacted for a 2-month follow-up 
appointment after the 12-week intervention to measure their weight and BMI only. 
An agreement was reached with the Utah Health Research Network (UHRN), the 
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committee approving research at the University of Utah Community Clinics (Appendix 
J). The committee would grant access to the community clinic patients if researchers 
would hold the treatment appointments at each participant's respective clinic. The 
UHRN had concerns about potentially losing patients to the Utah Diabetes Center (UDC), 
the site which was originally planned to conduct the study. They were concerned that 
patients might transfer their care to physicians at the UDC. They also had concerns about 
the cost of transportation for patients living longer distances from the UDC. The 
participants were scheduled for the initial assessment appointment. 
The size of this study was limited by the number of therapist hours available for 
individual sessions in the Cognitive Behavioral (CB) treatment group. It was determined 
that a maximum number of 27 participants per group (N = 54) would be enrolled in the 
study. A power analysis was calculated in order to determine what power the study 
would have in identifying a significant interaction effect. A repeated measures power 
analysis calculated that in order to obtain power of .8 with a sample size of 54 and an 
alpha level of 0.05, effect sizes of .43 for the main time by group interaction would be 
expected . 
Design 
This study featured a two-group randomized controlled design, including a wait-
list comparison group, with pretest-posttest assessment points. The relative contributions 
of successively adding self-monitoring and a manualized CB treatment to a care-as-usual 
(CAU) approach to weight loss in adults with type 2 diabetes was examined in the study. 
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Participants were randomly assigned to one of two groups: (a) the CB+CAU intervention 
or (b) the standard CAU intervention group . Participants in the CB intervention group 
were provided manualized treatment for the reduction of BMI based on the Cognitive-
Behavioral Treatment of Obesity manual (Cooper et al., 2003). 
Directly addressing the body weight issues by examining the efficacy of a 
cognitive-behavioral treatment for obesity was of fundamental interest. The CB treatment 
needed to be contrasted with contemporary standards of care, for example, care-as-usual, 
to assess whether treatment augmented the effectiveness of usual care. Thus, a CAU 
group served as the reference group for the CB intervention. A true control group 
involving no intervention was not practical because the American Diabetic Association 
directs physicians to address issues of overweight and obesity in their patients with type 2 
diabetes. 
With regard to the outcome measures, assessment points varied depending on the 
measure and these time points are delineated in Table 2 below . In effect, for the primary 
outcome measures of BMI and weight, a 2 (group) by 3 (time) design was applied. For 
the secondary outcome measures (HbA 1c, DCP, SF-36, and DAQ) a 2 (group) by 2 (time) 
design was applied. The strength of this design is that only the posttest change scores of 
the intervention group were attributed to the effects of treatment. The comparison group 
would control extraneous variables that may have brought change in scores due to reasons 
other than the actual treatment. The comparison group also allows for better assessment 
of treatment efficacy because comparison groups represent what might occur in clinical 
practice (Douketis et al., 2005). 
Table 2 
Assessment Time Points of Outcome Measures 
Outcome 
measures 
BMI 
Weight 
Hbalc 
DCP/SF-36 
DAQ 
Baseline 
time point 1 
X 
X 
X 
X 
X 
Assessment time points 
Treatment end 
time point 2 
X 
X 
X 
X 
X 
2-month 
follow-up 
time point 3 
X 
X 
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During the intake appointment, participants were randomly assigned to either the 
treatment group or the comparison group. A set of 54 random numbers was generated by 
the author using a website that provided a random number generator. The website, 
randomizer.org, uses the "Math.random" method within the JavaScript programming 
language to generate its random numbers (Urbaniak, & Prous, 2007). Participant names 
were recorded on a master list and those participants identified as random number 1 to 27 
were assigned to the treatment group and random number 28 to 54 were assigned to the 
comparison group. The comparison group was constructed as a waitlist group, which 
underwent an equivalent treatment as soon as the treatment group had completed the 
intervention. By the end of treatment both the treatment and control group had 7 
participants withdraw . Participants were informed that individuals who completed the 
study would have their names entered in a drawing for a $100 cash prize at the end of the 
intervention . 
45 
Procedure 
Cognitive-Behavioral Treatment 
During the intake session, each participant was given a food diary, a calorie-count 
reference book, a pedometer, and written instructions to record all food consumed, calorie 
content of food, and daily steps. Participants were also told to not change food intake or 
activity for first week in order to get a baseline measure of a typical week of food intake 
and activity. 
The intervention consisted of 12 weekly individual cognitive-behavioral treatment 
sessions. Each session was approximately 45minutes in length. Treatment consisted of a 
12-week cognitive-behavioral treatment module , which is outlined in Appendix D. 
During the treatment module, participants met individually with a treatment provider 
once a week to complete the current week's agenda topics . 
The treatment providers were two upper-level doctoral students in psychology. 
One of the doctoral students was also the author of this study. The author provided 
treatment to 16 (80%) participants and the second student treatment provider provided 
treatment to 4 (20%) participants. The treatment modules are described in detail in the 
manual, therefore the students completed a thorough review of the manual and became 
well-versed in the procedures . A mock treatment session was conducted prior to 
commencement of the treatment study and the student researchers were evaluated for 
adequacy of implementing a treatment module by each other and a research assistant. 
During an actual treatment session, both student researchers were assessed for treatment 
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integrity by each other and a research assistant every 4 weeks. An outline of the session 
was provided to the evaluators and adherence to the outline was discussed after the 
treatment session . Any needed adjustments were made to ensure the student investigators 
implemented the manualized treatment appropriately. 
Each treatment session followed a basic outline which included: (a) weighing the 
patient and recording weight; (b) jointly review self-monitoring records; ( c) setting 
agenda for session collaboratively ; (d) working through agenda topics; (e) agreement on 
homework assignments, and; (f) summary of the session . While the collaboration on 
creating an agenda allowed participants to include personally relevant issues, the bulk of 
the agenda consisted of the cognitive-beh avioral treatment focus for that session. 
Once per week , a research assistant called partic ipants to gather the food and daily 
steps data. This procedure was implemented to address the likelihood of recall bias 
inherent in retroactive reporting, which is known to decrease accuracy of self-report 
records (Jain, 2004). 
The student researcher collected this data via phone calls using a phone script that 
is included in Appendix E. The student researcher received training regarding what 
questions to ask and was coached in how to ask and/or refer questions from participants 
regarding research participation. Participants were instructed to submit their food and 
exercise record at the end of the study. 
Care-as-usual (CA U) Treatment Within Comparison 
and Treatment Groups 
Participants in both groups received the CAU treatment and complete d all pre-
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posttest evaluations . None of the elements of the CAU treatment were influenced or 
managed by the present investigator, because this "treatment" represents contemporary 
medical practice for type 2 diabetes as it naturally occurs in regional clinics. That is, it 
represents physicians' clinical judgment regarding how they should implement 
recommendations of the American Diabetic Association regarding type 2 diabetes 
treatment. Therefore this treatment may have included physician referral to a nutritionist , 
referral to additional education classes that may include weight loss treatment , or direct 
management by the physician of weight loss treatment. However, it is possible that no 
weight loss treatment will be initiated by the physician. Because physician-directed 
weight loss treatment or patient referral is idiosyncratic, the present investigators offer no 
clear description of weight loss treatments in the CAU intervention . Also, physicians 
who provided care as usual were "blind" to assignment of subjects and only gave 
participants permission to participate in a weight loss treatment study. 
In order to identify if the two groups differed regarding the use of other weight 
loss interventions , all participants were asked at both baseline and treatment end if they 
were engaging in any weight loss activities or taking any weight loss medications. All 
participants reported no current weight loss activities other than participation in this study 
and no use of weight loss medications. 
Participants in the comparison group completed the initial assessment and were 
then told they had been placed on a waiting list. They were instructed to return in 12 
weeks to complete the post intervention measures which are described below. Upon 
completion of th~ 12-week intervention all participants completed two post-treatment 
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self-report measures, had BMI measured and provided the results of the HbA 1c measure. 
Initially the research design included three groups: the cognitive-behavioral 
intervention, the monitoring-only intervention and the care-as-usual wait list group. 
During the early stages of enrollment, 8 participants had been randomly assigned to the 
monitoring-only group. However, within three weeks, two participants dropped out and 
the investigator discovered that three other participants were not completing their 
monitoring records. When briefly interviewed, these five participants reported the 
monitoring was too time consuming. The three participants not completing records 
subsequently dropped out of the study leaving three participants enrolled in the 
monitoring-only intervention group. Therefore, due to slow rates of enrollment, high 
initial attrition, and low adherence in the monitoring-only group, the decision was made 
to omit the monitoring group from the research design. Thus, two remaining 
comparisons groups were the cognitive-behavioral treatment group and the wait-list 
group. This left only one participant in the study from the monitoring-only group. This 
last monitoring-only participant was moved to the cognitive-behavioral treatment group. 
Because of the limited client hours available, the number of participants enlisted 
in the CB group could not be increased. It was determined that 27 participants could be 
enrolled in the CB treatment group, thus changing the total number of stud¥ participants 
to 54. 
49 
Materials 
Participants in the CB group received a folder with blank food diary pages, 
instructions on how to record entries as well as two samples of food diary entries. They 
were instructed to bring the folder to the weekly treatment appointments in order to return 
diary pages weekly and to place handouts in the folder. Participants were also given a 
calorie counting guide and a pedometer to record daily steps. Throughout the study, the 
CB group received handouts regarding specific treatment topics discussed in session and 
these a:re contained in Appendix F. 
Outcome Measures 
For clarity, a listing of all outcome variables for this study is provided in Table 3. 
The primary outcome measure was body mass index calculated as follows: [ weight in 
pounds / (height in inches)2] * 703. Secondary measures included changes scores on the 
Diabetes Care Profile (DCP), Short-Form 36 (SF-36) and Diabetes Empowerment Scale 
DES). These three outcome measures were selected to evaluate the effect of treatment 
based on either their widespread use in the literature or their merits as an instrument for 
measuring the construct under investigation based on their reliability and validity data as 
well as their fit with the needs of the study. These measures are more fully described 
below. Two of the three outcome measures were diabetes specific measures which also 
assess global functioning of people with diabetes. 
Table 3 
Listing of Study Variables : Descriptive and Outcome Variables 
Demographic and diabetes-related variables 
Demographic variables 
Gender 
Age 
Marital status 
Employment status 
Annual income 
Ethnicity 
Diabetes-related variable 
Year of diagnosis 
Use of oral medications 
Use of insulin 
Glucose monitoring 
Diabetes education 
Dr. Advice to follow food plan 
Dr. Advice to follow exercise plan 
Do you follow a meal plan 
Outcome variables 
Body Mass Index/weight 
HbAlc 
Diabetes Care Profile 
Understand management 
Support needs 
Support received 
Support attitudes 
Control problems 
Social and personal factors 
Positive attitude 
Negative attitude 
Care ability 
Importance of care 
Self-Care adherence 
Diet adherence 
Long-term care benefits 
Exercise barriers 
Monitoring barriers 
Diabetes Attitude Questionnaire-
!. Managing psychosocial aspects 
of diabetes 
II. Dissatisfaction and readiness to 
change 
III. Setting and achieving 
diabetes goals 
Short Form-36 
Physical function 
Role-physical 
Bodily pain 
General health 
Vitality 
Social Functioning 
Role-emotional 
Mental health 
Physical component 
summary 
Mental component summary 
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Diabetes Care Profile (DCP) 
The DCP is a self-administered questionnaire containing 234 items, which include 
demographic information, self-care practices, and 116 questions divided into 15 profile 
scales with 4 to 19 questions per scale. It takes approximately 30 to 40 minutes to 
complete. The DCP assesses social and psychological factors related to diabetes and its 
treatment. The 15 profile scales assess control problems, social and personal factors, 
positive attitude, negative attitude, self-care ability, importance of care, self-care 
adherence, diet adherence, medical barriers, exercise barriers, monitoring barriers, 
understanding management practice , long-term care benefits, support needs, support, and 
support attitudes (Appendix G). The item responses on the scales vary between yes/no, 
multiple choice and Likert scales. A sample question is "In general , would you say your 
health is:" and the question responses include: 1 = excellent, 2 = very good, 3 = good, 4 = 
fair, 5 = poor. The 15 primary scales each yield weighted average scores but the DCP 
does not yield a total score. Table 4 provides a sample item from each scale, the scoring 
ranges, the interpretation of the end points and the number of items for each scale . 
Watkins and Connell (2004) reported that investigations of the internal consistency of the 
DCP have reported Cronbach's alphas ranging from .60 - .95. The scale reliabilities 
range from .68 to .96. The DCP demonstrated significant correlations (2: .30) to support 
concurrent and construct validity (Fitzgerald, et al., 1996). 
Short-form-36 (SF-36 version 1) Health Survey 
Given this study's emphasis on health-related components, it was important to 
Table 4 
Scoring and Sample Items for the Diabetes Care Profile Scales 
Diabetes Care Profile scale 
Understanding Management 
Practice 
Support Needs 
Support Received 
Support Attitudes 
Control Problems 
Social and Personal Factors 
Positive Attitude 
Negative Attitude 
Self-care Ability 
Importance of Care 
Self-Care Adherence 
Diet Adherence 
Long-Term Care Benefits 
Exercise Barriers 
Monitoring Barriers 
Scoring 
Good Poor 
5 1 
5 
5 
5 
1 
5 
1 
5 
5 
5 
5 
5 
l* 
5 
5 
5 
5 
5 
Item (n) 
13 
6 
6 
6 
19 
13 
5 
6 
4 
4 
4 
4 
4 
5 
11 
Sam_Ele Item 
How do you rate your understanding of diet for blood sugar control? 
I want a lot of help and support from my family and friends in following 
my mean plan. 
My family and friends help and support me a lot to follow my meal plan. 
My family and friends accept me and my diabetes. 
During the past year, how often have you had changes in your blood sugar 
(too high) because you were feeling stressed. 
How often has your diabetes kept you from doing your normal daily 
activities during the past year? 
I feel satisfied with my life 
I am afraid of my diabetes. 
I am able to keep my blood sugar in good control. 
I think it is important for me to keep my blood sugar in good control. 
I keep my blood sugar in good control. 
How often do you follow a meal plan or diet? 
Taking the best possible care of my diabetes will delay or prevent kidney 
problems. 
How often do you have trouble getting enough exercise because you are 
too busy? 
When you don't test for sugar as often as you have been told, how often is 
it because you forgot? 
*No prefened score exists for the Support Needs scale because the scale is an assessment (5=needing more support and 1-needing less support) 
V, 
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select a measure that would provide indicators that would take into account physical 
aspects as well as psychological adjustment. 
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A measure of comprehensive health status is the Short Form-36 (SF-36), which 
has been used in a variety of studies including those that have studied chronically patients 
(Ware, Snow, Kosink & Gandek , 2000). This outcome measure was an embedded 
section in the Diabetes Care Profile as Section II (Appendix G). This inventory is 
designed to assess the participant's general level of health along eight different 
dimensions and asks about changes in these areas over the past month, in addition to 
longer time frames . These dimensions include physical functioning, role limitations due 
to physical problems, social functioning, bodily pain, general mental health , role 
limitations due to emotional problems, vitality, and overall health perception. Two 
additional summary scales are derived from the initial eight scales and represent the 
findings of factor analytic studies which revealed two distinct clusters. These two scales, 
the mental and physical component summary scales, were identified based on the amount 
ofrespective physical or mental health variance each of the eight primary scales had in 
common (Ware et al.). 
All eight primary scales and the two component summary scales were utilized in 
this study . The physical functioning scale , consists of 10 items, rated on a 3-point Likert 
scale and asks participants about limitations to physical activities due to health (1 = yes, 
limited a lot; 2 = yes, limited a little; 3 = no, not limited at all). The total score range of 
this scale is from 10-30. The role-physical scale consists of four items rated on a 5-point 
Likert scale and asked participants about problems with work and daily activities due to 
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health (1 = all of the time, 2 = most of the time, 3 = some of the time, 4 = a little of the 
time, 5 = none of the time). The total score range of this scale is from 4-8. The bodily 
pain scale consists of two items rated on a 6- and 7-point Liker scale, respectively, and 
asked participants about amount of pain over the past 4 weeks (1 = none, 2 = very mild, 3 
= mild, 4 = moderate, 5 = severe, 6 = very severe) and limitations due to pain (1 = not at 
all, 2 = a little bit, 3 = moderately, 4 = quite a bit , 5 = extremely). The total score range 
for this scale is 2-12. The general health scale consists of five items rated on a 5-point 
Likert scale asking participants about their perception of their general health (1 = 
definitely true, 2 = mostly true, 3 = don't know, 4 = mostly false, 5 = definitely false). 
The total score range for this scale is 5-25. The vitality scale consists of four items rated 
on a 5-point Likert scale asking participants about the amount of energy they have 
experienced over the past month (1 = all of the time, 2 = most of the time, 3 = some of 
the time, 4 = a little of the time , 5 = none of the time) . The total score range for this scale 
is 4-24. The social functioning scale contains two items on a 5-point Likert scale. The 
questions assess the degree to which a participant's physical and emotional difficulties 
have interfered with his/her social activitites ( question 1; 1 = not at all, 2 = slightly , 3 = 
moderately, 4 = quite a bit, 5 = extremely; questions 2; 1 = all of the time, 2 = most of the 
time, 3 = some of the time, 4 = a little of the time, 5 = none of the time). The total score 
range for this scale is 2-10 . The role-emotional scale consists of three items rated on a 5-
point Likert scale asking participants the degree to which they have experienced problems 
with work or other daily activities as a result of emotional problems (1 = all of the time, 2 
= most of the time, 3 = some of the time, 4 = a little of the time, 5 = none of the time). 
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The score range for this scale is 3-6. The final primary scale is the mental health scale, 
which contains five items and is rated on a 5-point Likert scale and asks participants to 
what extent they believe their mental health has improved over time (1 = all of the time, 
2 = most of the time, 3 = some of the time, 4 = a little of the time, 5 = none of the time). 
The total score range for this scale is 5-30. 
In studies ofreliability, the SF-36 has shown to have test-retest reliability ranging 
from .43 to .90 (Ware et al., 2002) . Internal consistency studies using Cronbach's alpha 
have shown median reliability coefficients equal to or exceeding .80. All eight primary 
SF-36 scales as well as the two component summary scales were utilized as outcomes in 
this study. In a psychometric and clinical test of validity conducted by McHomey, Ware , 
and Raczek (I 993 ), seven of the eight scales demonstrated strong construct validity (r2: 
0.70). 
Diabetes Empowerment Scal e (DES) 
The DES is a self-administered 28-item questionnaire (Appendix H). The DES 
questions cover general demographic infonnation such as age and gender as well as 
diabetes-related psychosocial self-efficacy . Most items contain a 5-point Likert scale 
asking participants to the degree to which they agree with statements (I = strongly agree, 
2 = agree, 3 = neutral, 4 = disagree, 5 = strongly disagree) . A sample question is "In 
general, I believe that I know what part of taking care of my diabetes I am ready to 
change". 
The DES has demonstrated adequate construct validity with correlation 
coefficients ranging from .32-.59. The DES has sufficient test-retest reliability 
correlation of .79 (Anderson, Fitzgerald, Funnell & Marrero, 2000). 
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CHAPTER IV 
RESULTS 
Patient Variables 
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Fifty-four individuals who met the criteria for inclusion in this study completed 
the intake process including the consent form, the two initial surveys, and measurement 
of weight to calculate BMI. All individuals obtained written physician approval to 
participate in the study and either recently completed an HbA 1c blood test or agreed to 
return to their primary care physician to have the blood test done. Twenty of the 27 
participants assigned to the treatment group completed the posttreatment assessment. 
Also, 20 of the 27 participants assigned to the control group completed the posttreatment 
assessment. This 26% attrition rate is within the range of attrition rates reported in other 
weight-loss treatment studies (Grave et al., 2005). 
Preliminary Analyses 
Demograhic Variables 
For convenience, a list of all descriptive and outcome variables are provided in 
Table 3. To determine if the control and treatment groups were equivalent at pretest, 
descriptive statistics were computed for demographic variables including: age, gender, 
marital status, ethnicity, education, employment, annual income, insurance, living 
arrangements and number of people living with participant. Diabetes-specific variables 
were also collected including years since diagnosis, use of oral medications; use of 
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insulin; weekly glucose monitoring; receipt of formal diabetes education; advice from 
health care providers to follow exercise or meal plan and; actually following a food plan. 
Independent sample t tests were utilized for continuous variables and -1 analyses 
for dichotomous variables. Refer to Table 5 for the results of these analyses. Not all 
variables initially qualified for -1 analysis due to several variables yielding empty cells. 
Categories were collapsed to the degree needed for the variable to yield a minimum cell 
count for the analysis. 
The mean ages of the treatment and control groups were not significantly different 
(treatment group x =55.95; control group x = 50.50; p = .160). Gender distribution was 
equal between groups with 90% female and 10% male in both groups. Marital status was 
also equivalent in groups with 50% of the treatment group reporting being manied versus 
60% in the control group. 
With regard to ethnicity, 90% of the treatment group paiiicipants were white as 
were 70% of the control group. However, this percentage was not statistically significant 
(p= .114). 
A majority of the participants in both the control group and the treatment group 
reported attending some college (85% and 75%, respectively). The control group also 
reported more participants as employed full-time (55%) while the treatment group 
reported 35% working full-time . This difference was not statistically significant (p = 
.059). There was, however, no notable or significant differences between categories of 
income for groups (p = .112). 
When considering the participants living anangements, almost all lived in a home 
Table 5 
Demographic Variables on All Parti cipants (N=46) 
Treatment Control 
mean (SD) mean (SD) 
Variable {n = 20) (n = 20) t ratio p_ value 
Age, yrs 55.95 (8.781) 50.50 (14.54 8) 1.434 0.160 
Years since diagnosis 5.75 {4.983) 6.60 (3.926) 0.599 0.553 
Treatment Control 
percent percent Degrees of 
Variable (n = 20) (n = 20) 2 P.. value freedom X 
Gender .000 1.000 1 
Female 90.0 90.0 
Male 10.0 10.0 
Marital Status .404 .525 1 
Married 50.0 60.0 
Not Married 50.0 40.0 
Ethnicity 2.500 .114 1 
White 90.0 70.0 
Other 10.0 30.0 
Education .625 .429 1 
High school grad/GED 25.0 15.0 
Some college/graduate 75.0 85.0 
Current Employment Status 5.675 .059 2 
Work full-time 35+ hr 35.0 55.0 
Work part-time <35 hr 35.0 5.0 
Other 30.0 40 .0 
(table continues) 
Vl 
\0 
Treatment 
percent 
Variable (n = 20) 
Income 
Less than $19,999 25.0 
$40,000 - $49,999 25.0 
$50,000 and over 50.0 
Living arrangements 
Home or Apt 95.0 
Other 5.0 
Number of people living with you 
1-2 person 50.0 
2.3 persons 50.0 
Treatment 
percent 
Diabetes-specific variable (n = 24) 
Insulin 
¾Yes 25.0 
Diabetes pills 
¾Yes 90.0 
Diabetes education 
¾Yes 80.0 
Control 
percent 
(n = 20) l 
4.386 
5.0 
50.0 
45.0 
.000 
95.0 
5.0 
1.00 
55.0 
45.0 
Control 
percent 
(n = 22) 
.000 
25.0 
.588 
95.0 
.370 
75.0 
P.. value 
.112 
1.00 
.752 
1.000 
.560 
.714 
Degrees of 
freedom 
2 
1 
1 
1 
1 
1 
(table continues) 
°' 0 
Treatment Control 
percent percent Degrees of 
Diabetes-specific variable (n = 20) (n = 20) I p value freedom 
Health care provider advise to meal 
plan 3.135 .077 1 
%Yes 85.0 60.0 
Health care provider advise to 
exercise .143 .705 1 
%Yes 80.0 75.0 
Follow a meal plan .000 1.000 1 
Never-sometimes 55.0 55.0 
Sometimes-always 45.0 45.0 
Do you test your blood sugar? 
2.105 .147 1 
%Yes 90.0 100.0 
Days per week test blood sugar .000 1.000 1 
None-3 25.0 25.0 
4-7 75.0 75.0 
Times per day .102 .749 1 
0-1 40.0 45.0 
2-4 60.0 55.0 
Significant p value :S .05 
0\ 
-
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or an apartment (95% treatment; 95% control). In regard to number of people living with 
participants, groups were relatively equal with 50% of treatment participants and 55% of 
control participants living with 0-2 people (p = .752). Again, the difference between 
groups regarding living arrangements was not significant (p = .291). All participants 
reported being insured. The majority of participants were insured under a group plan 
In tenns of diabetes-specific variables, the mean number of years diagnosed with 
diabetes was reported as 5.75 years for the treatment group and 6.60 years for the control 
group (p = .553; d = .850) . Most participants reported receiving formal diabetes 
education (80% treatment; 7 5% control; p = . 714 ). 
Most participants in both groups also reported testing their blood sugar i.e., 75% 
of the treatment group and the control group repo1iedly tested 4-7 days per week. A 
much smaller number repo1ied testing either zero to three times (25% both treatment and 
control; p = 1.000). The majority in both groups tested their blood sugar 2-4 times per 
day (40% treatment; 45% control;p = .749). An equal number of participants in both 
groups reported using insulin to control blood sugar levels (25% treatment ; 25% control). 
While a smaller number of participants reported using insulin, the vast majority reported 
taking an oral medication to control blood sugar (90% treatment; 95% control: p = .560) . 
The majority of both treatment and control groups reported their health care 
provider had advised them to exercise (80% treatment; 75% control;p = .705). 
Similarly, the majority of both treatment and contro l groups reported their health care 
provider had advised them to follow a meal plan (85% treatment; 60% control; p = .077). 
While not statistically significant, it is notable that a slim majority of controls compared 
to the treatment group subjects reported they have been advised to follow a food plan. 
Finally, 55% of both the control group and treatment group reported they never 
follow a food plan. 
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Overall, there are no major differences between the treatment and control group in 
tenns of demographic variables, both in general and diabetes-specific variables. No 
statistical differences between groups in regard to demographic variables were found . It 
is then assumed that the blind random assignment of subjects to groups was adequate in 
creating equivalent groups in regard to demographic variables . Additionally, it is 
important to note that during the intake procedures participants were asked if they were 
currently participating in any type of weight loss activity or currently taking any weight 
loss medications . All participants reported they were not currently participating in weight 
loss activities nor were they taking medications . 
Outcome Variables 
Independent sample t-tests were conducted for baseline mean scores on all 
outcome variables to determine equivalence between groups. For reference, Table 3 
provides a comprehensive list of all outcome variables . Results of the independent 
sample t-tests are provided in Tables 6, 7, 8, and 9 below. Groups were found to be 
equivalent at baseline on all outcome measures except HbA1c and the Diet Adherence 
(DA) subscale of the Diabetes Care Profile. 
Table 6 
Independent t Comparisons for BML Weight, and HbA1c Outcome Variables (N = 40) 
BMI 
Weight 
HbA 1c 
Measure 
*Significant p value s .05 
Table 7 
Baseline t 
.322 
.261 
2.156 
Independent t Comparisons for Diabetes Care Profile Scales (N = 40) 
Measure Baseline t 
Section IV 
Understanding Management Practice -.213 
Section V 
Support Needs -.299 
Support Received -.470 
Support Attitudes 1.133 
Section VI 
Control Problems .678 
Section VII. Social and Personal Factors -.865 
Section VIII 
Positive Attitude .473 
Negative Attitude -1.268 
Self-care Ability .305 
Importance of Care .583 
Self-care Adherence .266 
Section IX Diet Adherence -3.252 
Section X 
Long-term Care Benefits 1.694 
Section XI 
Exercise Barriers 1.086 
Section XII 
Monitoring Barriers -.404 
*Significant p value s.05 
p-value 
.749 
.796 
.037* 
p-value 
.832 
.767 
.641 
.265 
.502 
.393 
.639 
.213 
.762 
.563 
.792 
.002* 
.098 
.284 
.689 
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Table 8 
Independent t Comparisons for Short Form 36 Scales (N = 40) 
Measure Baseline t p-value 
Physical Function .111 .912 
Role-Physical .550 .585 
Bodily Pain .420 .677 
General Health -.495 .624 
Vitality 1.098 .279 
Social Functioning -.949 .349 
Role-emotional -1.776 .084 
Mental Health -.646 .522 
Physical component 
summary .411 .684 
Mental component 
summary -1.105 .276 
*Significantp value :'.S .05 
Table 9 
Independent t Comparisons for Diabetes Empowerment Scale (N = 40) 
Measure Baseline t p-value 
Managing psychosocial 
aspects of diabetes -.128 .898 
Assessing dissatisfaction 
readiness to change .571 .571 
Setting/achieving diabetes 
goals -.602 .551 
*Significant p value :'.S .05 
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Individual HbA 1c scores were converted to z-scores in order to identify outliers. 
The z-scores for cases with an absolute value of 3 are considered outliers and two cases 
were identified. These two scores were then converted to M +3SD in order to pull in the 
outliers so as not cause violations of normal distribution. Independent sample t-tests were 
again conducted and it was found that the groups were still not equivalent (t = 2.156, p = 
.037) . HbA 1c is an average of blood glucose levels over a 2-3 month period (as described 
in Chapter I). Therefore HbA 1c was used as a covariate in the remaining analyses of 
outcome variables. 
The independent t test for the Diet Adherence subscale showed a significant 
difference at baseline (t = -3.252,p = .002), indicating that the two groups were not 
equivalent at the outset as the treatment group reported higher scores on this measure 
initially . The Diet Adherence scale represented a central theme in the outcome of this 
study. Therefore, this variable was of importance and was controlled in the data analysis, 
but did not yield any changes in statistical significance of any of the outcome measures . 
Primary Analys .es 
In order to identify differential effects between the two treatment providers, 
therapist was coded as a covariate and then included in the analysis. No significant 
differences were found between the two treatment providers on any outcome variables . 
The results of the primary research questions posed in this study are presented 
below. These four questions seek to quantify change in regard to participants BMI, 
weight, Hbalc, diabetes-specific quality of life (Diabetes Care Profile-DCP) and diabetes-
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specific self-efficacy (Diabetes Empowerment Scale-DES). All outcome measures except 
BMI and weight were assessed at both baseline and treatment end. BMI and weight were 
assessed at baseline, treatment end and at a 2-month follow-up. Thus the treatment 
design for Hbalc, DCP and DES was a 2 (group) by 2 (time) design and the treatment 
design for BMI was a 2 (group) by 3 (time) design. The research design utilized a 
randomized controlled pretest-posttest control group experimental treatment with 
repeated measures. 
Statistical analyses were conducted using repeated measures factorial ANOV A for 
each variable to determine whether effects existed by either time , group or time by group 
interaction . For BMI and weight , a 2 by 3 AN OVA was applied and for HbA 1 c, DCP, 
SF-36 and DES, a 2 by 2 ANOVA was applied . The fact that a repeated measures design 
was utilized allowed for measurement of outcomes for both the treatment and control 
groups both at time 1 (baseline), prior to the start of the intervention , as well as at time 2 
(following the intervention for the treatment group and following the waiting period of 
care-as-usual for the control group) and time 3 (2-month follow up measure of BMI and 
weight only). As mentioned in the preliminary analysis section, results indicated that 
groups were not equivalent at pre-test for HbA 1c and Diet Adherence subscale, therefore, 
all analyses were conducted using HbA 1c and Diet Adherence subscale as covariates. 
In addition, descriptive statistics including means and standard deviations were 
calculated. In addition change scores were calculated as well as effect sizes to capture the 
magnitude of change for both treatment and control groups at baseline, treatment end and 
follow-up for BMI and weight. For all other outcome variables, results are reported for 
baseline and treatment end. The effect size was calculated using a modification of 
Glass's guidelines for calculating d based on the need to devise a common denominator 
for the treatment and control group. The following formula was used: 
~1-X2 
(S1 + S2 + S3 + S4) 
Cohen's effect size categorization system (1988) was used for comparing effect" 
sizes with .20 for "small" effect, .50 as "medium" effect and .80 as "large" effect. 
Description of Tables 
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In Tables 10 and 11 the BMI and weight results are listed . Table 10 includes the 
means and standard deviations for the treatment and control groups at baseline (Tl), 
treatment end (T2) and follow-up (T3) . Table 11 displays the repeated measures 
ANOV A for the three time points including the respective F, p-values and eta2 values for 
time, group and time-by-group interactions . The eta2 statistic is an effect size calculated 
in relation to the repeated measures ANOV A. The final two columns of this table report 
the results of the simple contrasts for time between Tl vs. T3 and T2 vs. T3. All 
statistically significant scores at the p < .05 level are highlighted by asterisks . For 
convenience, results of the HbA 1c analyses are included in Tables 10 and 11 although it 
was not measured at follow-up (T3). 
Results for the three instruments (which include the remaining outcome variables) 
utilized in this study (DCP, SF-36, DES) are presented in separate tables in this section. 
There are two tables per measure. The first table for each measure lists the name of the 
Table 10 
Baseline, Treatment End and 2-month Follow--up, Mean and Standard Deviations(SD)for Body Mass Index, Weight and HbA1c 
Outcome Variables (N = 40) 
2-month 2-month 
· Baseline (Tl) Treatment End Follow-up (T3) Baseline (Tl) Treatment End Follow-up 
Measure Ml(SD) (T2) Ml(SD) M/(SD) M/(SD) (T2) M/(SD) (T3) M/(SD) 
37.724 36.556 36.590 38.685 38.887 38.890 
BMI (9.011) (8.842) (8.735) (9.841) (9.532) (9.536) 
229.20 222.00 222.25 234.00 234.90 235.25 
Weight (59.849) (58.447) (57.837) (56.459) (55.585) (54.678) 
6.415 . 6.455 7.490 7.390 
HbA1c (1.075) (l.01~2__ (2.025) (1.926) 
0\ 
\0 
Table 11 
ANOVA Results and Simple Contrasts of BMI, Weight and HbA 1c Outcome Variables (N=40) 
ANOV A Results Sim12le Contrasts for Time 
Tl vs. T2 T2 vs. T3 
Treatment Timex 
Time Partial Group Partial Group Partial Partial 
Measure F(p) Eta2 F(p) Eta2 F(p) Eta2 F (p) Eta2 
.850 .906 13.190 16.766 
BMI (.432) .023 (.414) .051 (.000)* .268 (.000)* .318 
.514 .949 11.346 16.024 
Weight (.600) .014 (.397) .053 (.001)* .240 (.000)* .308 
HbA1c 1.247 .008 1.563 
(.27_1) .033 (.9322 .000 (.219) .041 
*Significant p-value < .05 (Dunn's procedure-adjusted familywise error rate: significant if p-value < .03) 
Scheffe adjustments for simple contrasts: F > 4.3 
(Tl= Baseline, T2 = Treatment End, T3 = 2-month Follow-up) 
F (p) 
.102a 
(.751) 
.01la 
(.917) 
a Nonsignificant results expected and represents desired outcome of no change in weight and BMI during maintenance. 
Partial 
eta2 
.003 
.000 
--J 
0 
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outcome variable analyzed, followed by the means, standard deviations, change scores 
and effect sizes for both the treatment and control groups at baseline (Tl) and treatment 
end (T2). Table 10 displays the results of the repeated measures ANOVA for Tl and T2 
including the respective F, p values, and effect sizes for time, group, and time-by-group 
interactions. All statistically significant scores at the p < .05 level are highlighted by 
asterisks. 
Statistical Outcomes for BMI, Weight, and HbA 1c 
BM! and Weight Outcomes 
Research question 1 was posed as follows: Does a cognitive-behavioral treatment 
added to standard care-as-usual lead to a decrease in BMI and weight? The Body Mass 
Index (BMI) (as described in detail in Chapter II) is a ratio of weight and height. Figure 1 
represents graphically the difference between groups on the BMI outcome between 
baseline (Time l=Tl), Treatment end (Time 2=T2) and 2-month follow-up (Time 3=T3). 
Because groups were not equivalent at baseline for HbA 1c, it was included in the analysis 
as a control variable. A significant difference was found between treatment and control 
groups for BMI (F = 21.711, p = .000) and is reported in Table 11. In order to adjust the 
familywise error rate for the multiple simple main effects, Dunn's procedure was utilized. 
Simple main effects were found to be significant on the adjusted alpha level of .03. 
39 .00 
38 .50 
~ 
"C 
_E 38 .00 
en 
en 
"' :;; 
~ 37 .50 
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CD 
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36 .50 
__ ..J>------------t> i,..--------
2 
Time 
- - · control group 
- treatment group 
Figure I. Body Mass Index time by group interaction . 
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Two months following completion of the 12-week intervention for the treatment group, 
both groups were again measured only on the BMI and weight outcome variables. The 
most significant change occurred between baseline and treatment end for both BMI and 
weight loss (treatment participants: average weight loss 7.2 pounds ; control group : 
average weight gain .9 pounds). However , the simple contrasts for time revealed that the 
effects did not significantly diminish between treatment end and follow-up . Treatment 
participants gained an average of .25 pounds and the control group remained the same. 
Neither the change in weight nor BMI between treatment end and follow-up were 
significant (weight F = .154, p = .696, BMI F = .093, p = .762). It is important to note 
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no change in the weight and BMI variables was the anticipated treatment group outcome 
during the follow-up /maintenance period. In order to account for actual group differences, 
simple contrasts were again calculated for each group separately and reported in Table 8. 
Both BMI and weight outcomes for the treatment group were statistically significant at 
treatment end (T2) and the effects were sustained through follow-up (T3). A familywise 
error adjustment was calculated for the simple contrasts using the Scheffe adjustment. With 
this procedure, the F-test of a simple contrast is significant if F exceeds 
4.3 which was calculated using the foliowing formula: 
(dfl * F(alpha; dfl; df2)) / df3 
In order to understand the magnitude of any differences between the two groups at 
baseline and follow-up, effect sizes was calculated for all scores and reported as partial 
eta2. According to Glass's categorizations, the effect size for both BMI (.27) and weight 
(.24) was "small" in the time by group condition. 
HbA 1c Outcomes 
Research question 2 was posed as follows: Does a cognitive-behavioral treatment 
added to standard care-as-usual improve glycemic control as measured by HbA I c? HbA le 
mean scores, while not equivalent at pretest (treatment= 6.415, control = 7.520), showed 
no statistical significance at posttest (treatment= 6.455, control= 7.390) . (F = 1.563, p = 
.213 ). Results of HbA 1c analysis are included in Table 10 and 11. However, two 
participants in the control group had pretest HbA 1c levels above 12 which indicated very 
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participant was hospitalized for several weeks and her score decreased at posttest by 2.3, 
a much larger change than any other participant score. The other participant score 
remained unchanged. As mentioned above, all analyses were conducted with the 
baseline HbA 1c controlled as a covariate. 
Diabetes Care Profile and Short Form-36 Outcomes 
Research question 3 was posed as follows: Does a cognitive-behavioral treatment 
added to standard care-as-usual change diabetes-specific quality of life as measured by 
the Diabetes Care Profile and Short Fonn-36? Another outcome of interest was whether 
the intervention had an impact on diabetes-related quality of life as assessed by change 
scores in the Diabetes Care Profile (DCP). The DCP is used to assess social and 
psychological factors related to diabetes and its treatment. The DCP contains 15 primary 
scales that yield 15 weighted average scores but does not yield a total score. Only the 
scales with significant results will be discussed below. 
A repeated measures analysis of variables was conducted to determine if any 
change in scores between groups was statistically significant. Results of the DCP are 
displayed in Table 12 and 13. The repeated measures analyses of the DCP variables 
showed the change in scores did not reach statistical significance . However , the 
treatment group means scores on the DCP subscales did show improvement between 
baseline and follow-up. In fact, 12 of the 15 subscales showed an improvement in that 
nonsignificant results between treatment end and 2-month follow-up (T2 vs. T3) were 
expected. The treatment group was to intentionally maintain weight loss and thus 
Table 12 
Baseline, Follow-up , Mean(SD) and Change Scores for Diabetes Care Profile Outcome Variables (N = 40) 
Treatment Group (n = 20) Control Group (n = 20) 
Baseline Follow-up Pre-Post Baseline Follow-up 
Measure Ml(SD) Ml(SD) Change/(d) M/(SD) Ml(SD) 
Section IV. Understanding 
Management Practice 2.38 (1.57) 2.88 (1.38) -0.50/-0.34 2.28 (1.55) 3.04 (1.58) 
Section V 
Support Needs 3.33 (1.18) 3.70 (1.16) -0.37 /-0.32 3.22 (1.20) 3.12 (1.37) 
Support Received 2 .83 (1.08) 3.34 (1.34) -0.53/-0.42 2.63 (1.57) 2.41 (1.45) 
Support Attitudes 3.63 (0.68) 3.73 (0.82) -0.09/"0. l 2 3.92 (0.9) 4.00 (0.76) 
Section VI Control Problems 2.11 (0.96) 2.31 (0.92) -0.23/-0 .23 2.28 (0.78) 2.15(0.71) 
Section VII. Social and Personal 
Factors 2.66 (0.81) 2.41 (0.72) 0.26/0 .33 2.43 (0.85) 2.34 (0.86) 
Section VIII 
Positive Attitude 2.93 (0.82) 3.10 (0.89) -0.17 /-0.20 3.06 (0.92) 3.18 (0.82) 
Negative Attitude 2.98 (0.96) 2.73 (0.89) 0.25/0.27 2.63 (0.77) 2.58 (1.04) 
Self-care ability 2.56 (0.70) 3.13 (0.72) -0.56/-0.80 2.64 (0.85) 2.93 (0.87) 
Importance of Care 4.53 (0.52) 4.40 (0.64) 0.13/0 .22 4.63 (0.56) 4.49 (0 .50) 
Self-care Adherence • 2.78 (0.65) 3.18(0.68) -0.13/-0 .61 2.84 (0.65) 3.10 (0.82) 
Section IX Diet Adherence 2.23 (0.97) 2.9i (0.84) -0.68/-0.75 1.24 (0.98) 1.94 (1.27) 
Section X. Long-term Care Benefits 4.35 (1.04) 4.66 (0.658) -0.31/-0.35 4.79 (0.40) 4.66 (0.43) 
Section XI. Exercise Barriers 2.63 (0.740) 2.29 (0.78) 0.34/0.45 2.91 (0.88) 2.67 (0.83) 
Section XII Monitorin!i; Barrier_§_ _ _!_.~3 (0.93) ___ t59 co.88) 0.237/0.25 _ _J_._71_(0.69) 1.66 (0.90) 
*Significant p-value :S .05 
Pre-Post 
Change/(d) 
-0.77 /-0.49 
0.10/0.08 
0.22/0.26 
-0.084/-0 . l 0 
0.14/0.19 
0.09/0.10 
-0 .12/-0.14 
0.042/0.05 
-0 .29/-0 .34 
0.13/0.26 
-0.26/-0.35 
-0.70/-0.62 
0.13/.31 
0 .24/0.28 
0.24/0.07 
-.J 
V1 
Table 13 
ANOVA Results for Diabetes Care Profile Outcome Variables (N = 40) 
ANOV A Results 
Partial Treatment Group Partial 
Time F(e) Eta2 F(e) Eta2 
Section IV. Understanding 
Management Practice .931 (.341) .025 .010 (.922) .001 
Section V 
Support Needs .502 (.483) .014 .006 (.941) .000 
Support Received 1.945 (.172) .051 .286 (.600) .017 
Support Attitudes 1.437 (.238) .038 1.702 (.209) .091 
Section VI. Control Problems 2.717 (.108) .070 .394 (.539) .023 
Section VII. Social and Personal 
Factors .006 (.940) .000 .046 (.834) .003 
Section VIII 
Positive Attitude 1.156 (.289) .031 2.164 (.160) .113 
Negative Attitude 10.494 (.003)* .226 10.432 (.005)* .380 
Self-care Ability 1.405 (.244) .038 1.107 (.307) .061 
Importance of Care 3.833 (.058) .096 3.517 (.078) .171 
Self-care Adherence 1.321 (.258) .035 1.289 (.272) .070 
Section IX Diet Adherence 2.256 (.142) .057 5.086 (.037)* .220 
Section X. Long-term Care Benefits .881 (.354) .023 .387 (.542) .022 
Section XI. Exercise Barriers .078 (.782) .002 2.304 (.147) .119 
Section XII Monitoring Barriers .019 (.891) .001 1.237 (.281) .068 
Significant p-value > .05. 
Time X ~roue F(e) 
.641 (.429) 
.230 (.635) 
.580 (.450) 
.013 (.911) 
1.169 (.287) 
.684 (.414) 
.238 (.629) 
.246 (.623) 
.714 (.404) 
.035 (.852) 
.172 (.681) 
.086 (.772) 
1.805 (.187) 
.061 (.806) 
l.309_Q_60) 
Partial 
Eta2 
.017 
.006 
.016 
.000 
.031 
.019 
.007 
.007 
.019 
.001 
.005 
.002 
.047 
.002 
.035 
--..l 
°' 
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Figure 2. Effect sizes for change scores on Diabetes Care Profile subscales 
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scores between baseline and follow-up, reflecting effect sizes of interpretable magnitude. 
The subscale reflected effect sizes ranging from small (.20) to large (.80) for the 
treatment group. It is also important to note that the control group also demonstrated 
change in scores that yielded small to medium effect sizes ranging from .28 to .62 on five 
of the 15 subscales. For clarity, the following scales show improvement when scores 
decrease and thus the magnitude of change is reflected as a positive number for effect 
size: Control Problems; Social and Personal Factors; Negative Attitude; Exercise Barriers 
and Monitoring Barriers. 
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The Short Fonn-36 (SF-36), a generic health-related quality of life measure, was 
embedded in the Diabetes Care Profile (DCP). The SF-36 is sometimes embedded in 
longer, health-specific measures because of its widespread use and acceptance and its 
strong reliability and validity . The SF-36 results will be reported separately because it is 
a measure that is scored independently of the DCP. The SF-36 contains eight primary 
scales as well as two component summary scales . The two summary scales are derived 
by factor analyses of correlations between the eight scales to identify a separate 
"physical" component of health status and a "mental" component of health status. 
Results of the SF-36 are displayed in Tables 14 and 15. 
Like the means scores of the DCP, the treatment group means scores on the SF-36 
showed improvement between baseline and follow-up , however, none of the results of the 
repeated measures ANOV A proved to be significant. Several of the subscales showed a 
notable change in scores between baseline and follow-up which translated into effect 
sizes of interpretable magnitude. The subscale effect sizes are represented in Figure 3 
and subscales with notable effect sizes are discussed below. 
Role Physical 
The Role-Physical scale assesses an individual's difficulties in performing their 
work responsibilities or other daily activities as a result of physical health concerns (Ware 
et al., 2002). The mean scores between baseline and follow-up increased 18.75 for the 
treatment group and increased 1.25 for the control group. Although the repeated 
measures ANOV A showed no statistical difference, the effect size calculated was .46, 
Table 14 
Baseline, Follow-up , Mean(SD) and Change Scores for Short Form-36 Outc ome Variables (N = 40) 
Treatment GrouE (n = 20) Control Groue (n = 20) 
Baseline Follow-up Pre-Post Baseline Follow-up 
Measure M/(SD) Ml(SD) Change/(d) Ml(SD) Ml(SD) 
Physical Function 61.50 (24.714) 66.25 (27.904) -4.75/-0.18 60.50 (31.908) · 63.25 (27.828) 
· Role -Physical 45.00 (41.039) 63.75 (40.127) -18. 7 5/-0.46a 52.50 (45.087) 53.75 (45.360) 
Bodily Pain 50.85 (23.944) 52.20 (24.638) -1.35/-0.06 47.85 (21.189) 54.20 (31.675) 
General Health 49.15 (19.066) 53.75 (26.111) -4.6/-0.20a 52.60 (24.686) 51.55 (26.045) 
Vitality 44.25 (19·.076) 46.00 (21.679) -4.6/-0 .07 35.75 (28.895) 39.50 (26.798) 
Social Funct ioning 59.38 (28.641) 70.00 (28.504) -10.62/ -0.37a 68.13 (29.657) 67.50 (34.745) 
Role-emotional 40.00 (39.883) 58.33 (44.426) -18.33/0.43a 63.33 (43 .124) 65.00 (42.543) 
Mental Health 60.20 (19 .138) 60.80 (20.046) -0.6/-0.03 64.60 (23.692) 67 .00 (22.845) 
Physical component 39.85 (9.553) 42.27 (11.243) -2.42/-0 .23a 38.42 (12.240) 39.45 (12.952) 
summary 
Mental component 40 .65 (11.349) 43.44 (11.037) -2.79/-0 .23a 44 .92 (13.037) 45 .56 (13.203) 
summar· · 
a Effect size of~ .20 
Pre-Post 
Change/(d) 
-2.75/-0.09 
-1.25/-0.03 
-6.35/-0 .24a 
1.05/0.04 
-3.75/-0.13 
0.63/0 .02 
-1.67/-0.04 
-2.4/-0.10 
-1.03/-0.08 
-0.64/-0.05 
-..J 
\0 
Table 15 
ANOVA Results for Short Form-36 Outcome Variables (N = 40) 
Partial Treatment Group 
Measure Time F (p) Eta2 F (p) 
Physical Function 1.126 (.296) .030 1.847 (.192) 
Role-Physical .255 (.617) .007 .008 (.930) 
Bodily Pain .935 (.340) .025 3.552 (.077) 
General Health 2.035 (.162) .053 .682 (.420) 
Vitality 2.539 (.120) .066 1.556 (.229) 
Social Functioning .021 (.885) .001 .393 (.539) 
Role-emotional .892 (.351) .024 .198 (.662) 
Mental Health .069 (.794) .002 1.265 (.276) 
Physical component 
summary .185 (.670) .005 .885 (.360) 
Mental component 
summar .001_ (.982) .000 .026 (.873) 
--
*Significant p-value :S .05 
Partial 
Eta2 
.098 
.000 
.173 
.039 
.084 
.023 
.012 
.069 
.050 
.002 
Timex group 
F(p_) . 
.998 (.325) . 
1.683 (.203) 
1.682 (.181) 
1.346 (.254) 
12.226 (.085) 
4.628 (.038)* 
2.698 (.109) 
.479 (.493) 
.742 (.395) 
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Figure 3. Effect sizes for change scores on Short Form-36 subscales 
which demonstrates a medium effect of the treatment intervention . 
Bodily Pain 
The Bodily Pain Scale accounts for the intensity of pain and individual 
experiences as well as the extent to which the pain interferes with the ability to perform 
normal work (Ware et al., 2002). This scale measured no demonstrable effect for the 
treatment group but did have a small effect size for the control group (.24). This result 
would indicate that although the treatment did not appear to produce a change in this 
outcome variable, the passage of time may account for the result in the contro l group. 
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General Health 
The General Health Scale measures an individual's perception of his or her 
personal health and belief that it will either improve or worsen over time (Ware et al., 
2002) The treatment group effect size was small (.20) for the treatment group. 
Social Functioning 
The social functioning scale assesses the degree to which physical or emotional 
concerns interfere with an individual's ability to engage in normal social activities 
(Wareet al., 2002). The treatment group mean scores changed 10.62 and represented a 
small effect size (.372). 
Role Emotional 
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The Role-Emotional scale measures an individual's difficulties with work or daily 
activities due to emotional concerns. The mean score difference between baseline and 
follow-up was 18.33 for the treatment group and 1.67 for the control group. Again, the 
repeated measures ANOV A showed no statistical difference in scores, but a medium 
effect size of .43 was demonstrated. 
Physical Component Summary 
The eight scales of the SF-36 have been found to form two separate higher order 
clusters, derived from the physical and mental health variance they have in common 
(Ware et al., 2002). This scale summarizes the physical component of the eight scales 
and includes: physical functioning, role-physical, bodily pain, and general health. The 
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mean score differences between baseline and follow-up for the treatment group yielded a 
small effect size (.23). 
Mental Component Summary 
The second summary score, the mental health component summary, consists of 
the remaining primary scales: vitality, social functioning , role-emotional and mental 
health . The treatment group mean score differences for this scale were also small yet 
yielded a small effect size (.23) . Overall 6 of the 10 SF-36 scales showed a small to 
medium effect of treatment. 
Finally , Table 16 presents the comparison of the results of the SF-36 analysis of 
this sample to nom1s of a group also diagnosed with type 2 diabetes . This table compares 
the means of this study sample to the nonns of a group of individuals with type 2 diabetes 
(N=54 l ). It is important to note that the median scores for the scales are also represented 
on this table for comparison. The effect size calculations reveal a small to medium effect 
size on all but the Mental Health Summary Scale. This finding indicates that overall, this 
group of participants report somewhat worse to notably worse subscale scores compared 
to this normative group. The Mental Health Summary Scale revealed a large effect size 
(.94) demonstrating significantly worse mental health scores compared to the normative 
group. 
Research question 4 was posed as follows: Does a cognitive-behavioral treatment 
added to standard care-as-usual improve diabetes related self-efficacy as measures by the 
Diabetes Empowerment Scale? The research study question posed whether diabetes-
Table 16 
Short-Form 36 Mean Comparisons between Study Sample and Normativ e Group 
Normative group Type 
Study group mean 2 Diabetes mean (SD) 
SF-36 Version 1 Scale (SD) (N=541) 
Physical Functioning (10 items) 61.00(28.16) 67.69((28 .66) 
Role Physical ( 4 items) 48.75(42 .72) 56.75(41.72 ) 
Bodily Pain (2 items) 49.35(22 .37) 68.52(26.48) 
General Health (5 items) 50.86(21.84) 56.11(21.12) 
Vitality (4 items) 40 .00(24 .55) 55.73(21.58) 
Social Functioning (2 items) 63.75(29.12) 82.04(24.96) 
Role Emotional (3 items) 51.67(42 .67) 75.60(36 .63) 
Mental Health Index (5 items) 62.40(21.37) 76.74(18.32) 
Physical Health Summary Scale 39.13(10.86) 41.52(11.27) 
Mental Health Summary Scale . 42.78(12 .26) . -- - ____ 51.90(9 .55) 
a Effect size of 2: .20 
50tn Percentile 
(median) for SF-36 
Scale Norms 
75 
75 
74 
52 
55 
100 
100 
84 
43 .72 
54.56 
Effect Size 
-0.23 
-0.19 
-0.73 
-0.25 
-0.73 
-0.73 
-0.65 
-0.78 
-0.21 
-0.94 
00 
~ 
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related self-efficacy would change due to the treatment. The Diabetes Empowerment 
Scale (DES) is a measure of diabetes-related psychosocial self-efficacy. The DES 
contains three scales which were derived from a behavior change model (Anderson, 
Funnell, Fitzgerald, & Manero, 2000) . The results of the analyses are contained in 
Tables 17 and 18. The independent t tests analyses of the three scales showed no 
statistical differences between the treatment and control group scores at baseline and at 
follow-up. A repeated measures ANOVA was conducted on the three scales and no 
significant differences were found. When considering effect size , scale 1, "Managing 
psychosocial aspects of diabetes" showed a small effect size (.29) for the treatment group. 
Table 17 
Baseline, Follow-up, Mean(SD) and Change Scores for Diabetes Empowerment Scale Outcome Variables (N = 40) 
Treatment Grou,El_n = 20) Control GrouE. (n = 20) 
Baseline Follow-up Pre-Post Baseline Follow-up Pre-Post 
Measure M/(SD) M/(SD) Change/(d) M/(SD) M/(SD) Change/(d) 
Managing psychosocial 
aspects of diabetes 2.405 (.533) 2.230 (.6602) 0.l 75/.29a 2.380 (.689) 2.335 (.498) 0.045/0.08 
Assessing dissatisfaction 
and readiness to change 2.172 (.450) 2.189 (.390) -0.017/-0.04 2.250 (.411) 2.22 (.436) 0.03/0.07 
Setting and achieving 
diabetes goals 2.295 (.463) 2.24 (.684) 0.055/Q.Q9 __ 21_29_J.627) _2_.2_~_(.430) -0 .1/-0.17 
a Effect size of~ .20 
00 
0\ 
Table 18 
Independent t Comparisons and AN OVA Results for Diabetes Empowerment Scale Outcome Variables (N = 40) 
Partial Treatment Partial Timex group 
Measure Time F(p) Eta2 Group F(p) Eta2 F(p) Partial Eta2 
Managing psychosocial 
aspects of diabetes 2.450JJ26) .064 .240 (.6~ 1)_ -- .014 ____ .988 (.051) .000 
Assessing dissatisfaction 
readiness to change .112 (.740) .003 .237 (.633) .014 .055 (.816) .002 
Setting/achieving 
diabetes goals .590 (.447) .016 .004 (.951) .000 .366 (.549) .010 
*Significant p-value :S .05 
00 
--l 
CHAPTER V 
DISCUSSION 
Summary 
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The aim of this study was to determine if a cognitive behavioral treatment for 
weight loss would lead to improvement in a range of type 2 diabetes related outcomes 
including: Body Mass Index (BMI), glycosolated hemoglobin (HbA 1c), diabetes-specific 
quality oflife, general quality oflife and diabetes-related self-efficacy. The results of this 
research study, a randomized controlled intervention , demonstrated that a cognitive-
behavioral intervention can assist overweight individuals with type 2 diabetes in losing 
weight and maintaining it for two-months. The treatment group demonstrated a 
significant drop in BMI between baseline and the end of the 12 weeks of treatment 
compared to the control group. Between end of treatment and the 2-month follow-up 
there was a small mean increase in BMI, however it was not statistically significant. As 
was predicted, the control group gained weight over the entire course of the study. 
However, other primary outcome variables including a blood glucose measure (HbA 1c), 
quality of life and self-efficacy measures, showed that the groups were comparable 
overtime. 
Independent t tests were computed for all demographic variables and all outcome 
measures to determine if groups were equivalent at baseline. All variables, except HbA 1c 
and the Diabetes Care Profile (DCP) Diet Adherence (DA) subscale, were not statistically 
significant. Repeated measures analyses were conducted both with and without using the 
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baseline HbA 1c and DA subscale as covariates, due to group differences at pretesting. 
Controlling HbA 1c and DA did not change the significance of outcomes. While the 
repeated measures analyses did not yield significant results for HbA 1c, quality of life and 
self-efficacy measures, the effect sizes calculated on the change in scores indicated the 
intervention may have had a clinically-meaningful weight loss impact and helped 
improve some aspects of quality of life. 
The treatment did yield small to medium effect sizes on some of the subscales of 
the quality of life and self-efficacy outcome measures. The findings will be discussed in 
light of existing type 2 diabetes literature. Implications, limitations and recommendations 
for future research will also be discussed. 
Discussion 
Equivalence of Groups at Baseline 
The researchers' random assignment of participants to groups was largely 
successful i.e., for the most part, the treatment group and control group were equivalent at 
pretesting. It is noteworthy that the groups were not equivalent on two important 
variables: HbA 1c and the Diet Adherence (DA) subscale of the DCP. However, as noted 
in the results section, the difference in I-Iba 1 c was accounted for by two outlier cases. 
When these were omitted from analyses, additional t-tests showed the groups were then 
equivalent at baseline. 
The other variable, Diet Adherence (DA), is worthy of discussion because 
adherence to diet is one of the primary factors in restricting calories for the purpose of 
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weight loss. In order to better understand what the DA subscale measures, Table 19 
includes the eight items which make up the scale. Two questions stand out from the 
others in regard to diet adherence. First, within the treatment group, a majority (90%) of 
participants reported that they had been told by their doctor to follow a meal plan, while 
just 60% of control group participants avowed being told. Also, 55% of the treatment 
group reported they actually follow a meal plan whereas 25% of the control group 
reported they follow a plan. While this difference was statistically significant , it did not 
change the significance of the primary outcome variable , BMI, when the DA variable was 
controlled statistically. It appears that the lack of equivalence between groups on this 
variable may be due to the characteristics of this sample. 
Primary Outcom es 
Body mass index. BMI was the primary outcome variable in this study of weight 
loss . A significant effect of the intervention was observed for the treatment group whose 
mean weight loss was 7.2 pounds. The control group reported an average gain of .9 
pound. The percent of weight lost in the treatment group was 3% in a 12 week period 
which is quite !audible, relative to the normative literature in this area (Norris, et al., 
2005). 
Most weight loss studies incorporate diet, exercise and broadly defined behavioral 
therapies and few studies explicitly describe cognitive-behavioral therapy as a treatment 
intervention. Kalendona and DeLucia (1999) found that a group receiving cognitive 
therapy (CT) did not lose significantly more weight than a behavioral modification group. 
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Table 19 
DCP Diet Adherence Subscale Questions 
1. Has any health care provider or nurse told you to follow a meal plan or diet? 
2. How often do you follow a meal plan or diet? 
3. Have you been told to follow a schedule for your meals and snacks? 
4. Have you been told to weight or measure your food? 
5. Have you been told to use food group lists to plan your meal? 
6. How often do you follow the schedule for your meals and snacks? 
7. How often do you weigh or measure your food? 
8. How often do you (or the person who cooks your food) use the exchange lists or 
food group lists to plan your meals? 
However, the CT group reported significant differences in adaptive weight-loss 
cognitions and continued to lose weight through the 6-month follow-up. 
In weight loss studies for adults with type 2 diabetes , using at least one dietary, 
physical activity, or behavioral intervention, a 3% weight loss was sustained at 1-2 year 
follow-up (Norris et al., 2005) . In diabetes prevention studies, also using at least one 
dietary, physical activity or behavioral intervention, the mean weight loss was 3 .1 % of 
baseline body weight after an average follow-up of 1-2 years (Norris et al., 2004).The 
Diabetes Prevention Program (2004) set a goal for participants to lose 7% of body weight 
during the 1 year treatment arm of the program . The average weight loss was 4.5% and 
49% of participants reached the 7% goal. At the end of a 2-year follow-up, 3 7% had 
sustained the 7% weight loss goal. 
The groups were again assessed on weight loss/BMI variables after a 2-month 
maintenance period. The treatment group BMI slightly increased (.03) as did mean 
weight (.25 pounds) and the control group remained unchanged. The treatment group 
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was instructed to stop attempting to lose weight and to "practice" maintaining weight 
based on the skills taught in treatment. In conducting the data analyses, this lack of 
change in weight and BMI variables translated into nonsignificant results . However, no 
change in the weight and BMI variables was the anticipated treatment group outcome for 
the 2-month follow-up /maintenance period. Thus, this nonsignificant finding is 
meaningful and supports the theoretical implications of maintenance strategies for weight 
loss. It is uncertain and umeported whether other programs intentionally instruct 
participants to stop losing weight, therefore, this finding may be a more accurate appraisal 
of wei ght loss maintenance. 
The weight gain in the control group during the treatment study was expected . 
Resea rch indicates that individuals who are overweight or obese will tend to gradually 
gain weight over time if no intervention is attempted (Perri & Corsica, 2002). Research 
indicates that a loss of excess weight equal to 5-15% of body weight is sufficient to 
improve health and decrease diabetes complications (Perri & Corsica, 2002) . Individuals 
typically can lose 5-15% of body weight within a 6 month period with a moderate 
restriction in calories (-500 /day). It is speculated that with a longer treatment period, 
participant could reach the goal of 5-15% weight loss. 
HbA1c. An expectation in conducting the present study was that greater weight 
loss would be associated with another physiological health benefit - decreases in HbA 1c 
levels. Certainly, while some studies have shown weight loss and decreases in HbA 1c to 
be positively correlated, a few studies have shown no correlation (Norris, et al., 2004). 
For instance, Norris, et al., (2004) reviewed 22 studies evaluating the effect of a weight 
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loss intervention in adults with type 2 diabetes. With a total of 4,659 participants and 
follow-up periods of 1 to 5 years, Norris et al. concluded that the changes in weight 
generally corresponded to minimal changes in HbA 1c, but the between-group-pooled 
estimates were generally not significant. 
In the present study, change in HbA 1c scores was not significant, however, scores 
rose slightly for the treatment group (.04) and decreased in the control group (-.13). Also, 
any differences between groups cannot be attributable to the use of insulin or the use of 
oral diabetic agents because the percent of participants using insulin was identical (25%) 
and there was a negligible difference between groups in use of pills (treatment= 90%, 
control = 95%). The lack of change in scores could also be due to the limited time 
intervention of 12 weeks. HbA 1c measures average blood glucose levels over a two to 
three month period and a change in HbA 1c may require a longer period of intervention 
(Ellis et al., 2004). \Vhile conflicting reports exist regarding the necessity of tight glucose 
control, most standards of care consider tight glucose control a goal of treatment 
(Shaughnessy, 2003). 
Diabetes care profile. Another important hypothesis in the present study was that 
weight loss and improved glucose control would in tum, be reflected in more global 
indicators of one's quality oflife. The Diabetes Care Profile, a diabetes-specific quality 
oflife measure was employed in this study to assess this domain. None of the 15 
subscales demonstrated statistical significance, though several subscales revealed notable 
effect sizes. This lack of statistical significance relative to the size of effect is observed 
frequently when small sample sizes are utilized. Overall, the treatment group scale scores 
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increased more than the control group scores and yielded effect sizes for 12 of the 15 
scales. Though the sample size was small, it is possible that the cognitive-behavioral 
treatment had an effect that can be construed best in terms of the four constructs 
associated with this measure, namely: patient attitudes, patient beliefs, adherence to self-
care and difficulties of diabetes self-care, with the cognitive-behavioral treatments used in 
the study. Table 20 outlines the range of effect sizes in the four DCP constructs and the 
treatment group demonstrated a small to medium magnitude of effect in all four domains 
The ability to perform self-care behaviors is a cornerstone of diabetes treatment and 
social and psychological factors are hypothesized to underpin the establishment and 
maintenance of these behaviors (Sarkar et al., 2006). Also included in this table are the 
goals of treatment that are hypothesized to overlap with these constructs. The treatment 
group revealed effect sizes in all four domains whereas the control group demonstrated 
change in only the adherence domain. However, it must be interpreted in light of the fact 
that this group gained weight over the course of the study. When considering the impact 
of treatment on these four constructs, it is not a stretch of the imagination to see that the 
goals of treatment overlap with these domains. The cognitive-behavioral (CB) 
intervention sessions were designed to not only achieve weight loss but also to maintain 
the effects of weight loss, and to elicit changes in cognitive responses and behavioral 
skills in personally relevant areas. 
CB treatments conceivably help patients modify mechanisms that maintain the 
target behavior (Cooper, Fairburn, & Hawker, 2003). In the present study, this involved, 
among other things, improvement in identifying and moderating unrealistic goals; 
Table 20 
Comparison of Diabetes Care Profile Theoretical Constructs and CB Treatment Goals 
DCP Constructs and Sample Questions 
Patient Attitudes 
-Positive Attitude Scale 
• I am able to keep my weight under control. 
-Negative Attitude Scale 
• I find it hard to do all the things for my diabetes. 
Patient Beliefs 
- Importance of Care Scale 
• Jt is important to keep my weight under control. 
- Long-term Benefits Scale 
• Taking the best possible care of diabetes will delay 
or prevent kidney problems . 
Adherence to Self-care 
- Self-Care Adherence Scale 
• I do the things I need to do for my diabete s. 
- Diet Adherence Scale 
• How often do you weigh or measure your food? 
Difficulties of Self-care 
- Exercise Barriers Scale 
• How often do you have trouble getting enough 
exercise because it takes to much effort? 
- Monitoring Barriers Scale 
• When you don't test forsugar as often as 
recommended, how often is it because you forgot? 
C-B Treatment Goals 
- Identify and moderate unrealistic weight goals 
- Problem Solving Training 
- Identify and encourage changes in domains other than 
eating 
- Emphasize need for acceptance and change 
- Identify and moderate unrealistic weight goals 
- Addressing obstacles to weight maintenance 
- Educate about health risks of obesity 
- Addressing beliefs about exercise and activity 
-Cognitive aspects of eating 
- Identify and moderate unrealistic weight goals 
- Establish monitoring of eating habits and of weight 
changes 
- Problem solving training 
- Adherence to principles of health eating 
- Identify and moderate bimiers to weight-loss 
- Problem solving training 
- Identify and moderate barriers to exercise 
-Addressing beliefs about exercise and activity 
Range of Effect Size 
Treatment Control 
.20 -.27 None 
.22 - .35 None 
.61 - .75 .35 - .62 
.25 - .45 None 
\0 
Vl 
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modifying attitudes about weight maintenance; addressing barriers to weight-loss; and 
directly identifying and assessing patients' primary goals. Other studies using CB for 
weight-loss have used similar strategies which have lead to changes in weight, shape and 
eating concern (Diabetes Prevention Program , 2002; Nauta et al., 2001). 
It appears that these goals of treatment may translate into improvements in other 
areas of functioning. It is likely also that the social support received through the 
individual sessions may contribute to the improvement in functioning as well. While the 
loss of excess weight could lead to increases in physical functioning , it appears that 
changes in beliefs about the self, goal-setting skills , addressing general problem-solving 
strategies and experienci ng success in progressing toward a goal (weight loss), could be 
related to increased functioning in work and social arenas. 
It is interesting to note that while the DCP has demonstrated adequate reliability 
and validity in measuring meaningful domains related to diabetes-specific quality of life 
in other studies, no studies could be identified that used the DCP to measure change in 
perceived quality of life (Bachman et al., 2003) . The DCP has been used in cross-
sectional studies and in studies assessing the reliability and validity of the DCP for use 
with minorities (Cunningham et al., 2004). The lack of statistical significance in all 
domains of the DCP in the present study could be due to the small sample size. Also, a 
longer treatment period may be necessary to elicit change between baseline and follow-
up. The results of this study may be an indication that the DCP is not a suitable 
measurement tool for interventions aimed at psychosocial change. The creators of the 
DCP suggest that the instrument should be suitable for intervention studies where 
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outcome measures are needed to measure the impact of an intervention on patient 
functioning (Fitzgerald, et al., 1996). Testa, (2000), however, expressed concern that 
quality oflife measures must meet performance standards corresponding to the purpose of 
analysis. "An evaluative analysis must employ scales that are responsive to changes and 
differences in the underlying quality of life construct" (Testa, 2000). With no research 
available showing the DCP's sensitivity to change, it is uncertain if this measures is 
suitable for intervention studies. 
A more likely explanation is that the intervention did not lead to significant 
change in scores because the cognitive-behavioral intervention used was not focused on 
changing diabetes-specific attitudes and behaviors as it was to change weight-relat ed 
attitudes and behaviors. There is some overlap in these two domains and some of the 
questions represented both diabetes and weight-loss behaviors. The scores on questions 
regarding diet, exercise, problem solving, as well as topics regarding psychological issues 
such as anxiety and depressive symptoms could have been impact ed through treatment. 
Also , some of the diabetes-specific domains may have been impacted simply by 
participating in the study where participants received increased social support and may 
have become more motivated to improve diabetes-specific self-care behaviors. There 
were diabetes-specific attitudes and behaviors that were not directly addressed in this 
study. For example, no attention was given to whether or not participants were 
measuring blood glucose as recommended and several questions within the DCP asked 
about blood glucose monitoring and control. 
Diet Adherence Scale change scores. As mentioned above, the Diet Adherence 
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Scale in the Diabetes Care Profile represents an important construct in weight loss 
behaviors. Both the treatment group and control group scores improved on this scale 
(treatment= .675, control= .704). Improvement in scores for the control group may be 
due to threats to internal validity including testing and a particular morale issue associated 
with the control group. The testing threat may be due to the fact that participants 
completed two questionnaires in which many of the questions inquired about dietary and 
exercise behaviors. The expectation of improvement in these domains may have caused 
the increase in scores for both groups . The improvement in scores may also be due to the 
"care as usual" participants received from their health care professionals . 
The researcher's subjective impression is that lower morale within the control 
group may also have played a role in change scores. That is, several participants assigned 
to the wait-list group expressed concern and even disappointment about waiting for 
treatment. This disappointment may have translated into attempts to lose weight 
irrespective of being assigned to the waitlist. Upon inspection of individual weight 
changes in the control group, 30% had lost weight (~pounds). 
Unrelated to specific threats to validity may be the fact that participants responded 
to the call to participate in a weight-loss study because they were highly motivated to 
make the necessary changes to lose weight. The changes that generally lead to at least 
short-term weight loss are caloric restriction and increases in energy expenditure. These 
can be easily implemented outside the confines of the research study, especially given that 
the control group was not dissuaded to lose weight, but to simply wait to fully participate 
in 12 weeks. 
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It is noteworthy that while both the treatment and control group mean scores 
improved on the DA variable, the treatment group mean BMI decreased (-1.16) while the 
control group mean BMI increased (.20). This incongruence of outcomes lends itself to 
the conclusion that the control group participants reported a significant change in 
behavior, reflected in the DA subscale, but the BMI scores do not correlate with this 
change. It might be speculated that there is perhaps a fundamental problem with the 
validity of the Dietary Adherence selfreport measure i.e., obese individuals might 
generally misreport or underreport eating behavior (Lara, et al., 2004). 
Short Form 36. With many of the domains of the DCP measuring diabetes-
specific attitudes and behavior another speculation of the present author was that the SF-
36, a general measure of quality of life, would be a qualitatively different and possibly 
better measure of quality of life for this study. Unfortunately, none of the eight SF-36 
scales demonstrated statistically significant differences between baseline and follow-up. 
As was the case with the DCP, several of the SF-36 scales did show a notable magnitude 
of change as reflected in effect sizes. As is the case with other discrepancies between the 
absence of statistically significant results to absolute effect sizes, the present sample size 
and thus the power to detect statistically significant change was inadequate for this study. 
It is possible that the lack of effect of treatment on quality of life could be due, in 
part, to the fact that this sample had lower scores an every scale of the SF-36 compared to 
the normative sample listed in Table 8. These lowers scores could represent a selection 
bias in which the participants either view themselves as, or are actually less able, to 
perform the kinds of self-care behaviors which might elevate one's quality of life; this of 
100 
course is considered to be a critical cornerstone of diabetes treatment (Sarkar et al., 2006). 
This sample appears to suffer from lower levels of overall functioning which may be due 
to comorbid disease states of type 2 diabetes and obesity (average BMI at baseline was 
38.4). Support for this speculation comes from related studies . For example, Fontaine 
(2002) and Kolotkin, Crosby, and Williams (2002) reported that, in general, obese 
persons who seek treatment for their weight, repo1i greater impairment on health-related 
quality of life . 
The treatment group change scores do show improvement in certain other 
domains of life functioning e.g., Role-Physical (R-P) , Social Functioning (SF) and Role-
Emotional (R-E). The treatment group also demonstrat ed a small magnitude of change in 
both the Physical and Mental component summary scales . It is worth discussing the 
similarities between these three subscales (where participants showed the most 
improvement). These three scales (R-P, SF and R-E) all measure capacity of individuals 
to participate in work, other , or social activities and impairment in these domains can be 
due to physical or emotional problems. Mean change scores increased by as much as 18 
points on a 100 point scale. It appears that, like the DCP results, the goals of the 
cognitive-behavioral treatment and the social support may translate into improvements in 
social, work and other areas of functioning. 
Self-efficacy outcomes. Self-efficacy was an important outcome for which 
treatment was expected to yield significant results, but did not. Specifically, it was 
expected that diabetes-specific self-efficacy would improve due to the focus on changes 
in cognition, improvement of behavioral skills and other personal factors related to health 
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outcomes. It was thought that through actual successful performance of targeted 
behaviors, confidence in the participants' ability to perform health behaviors would 
increase and in tum would lead to increased likelihood to continue to perform targeted 
behaviors (Bandura & Cervone, 1983) . It was speculated that this increase in confidence 
would be reflected in scores in the Diabetes Empowerment Scale (DES). 
While statistical significance was not reached, again effects sizes suggest the 
possibility of some effect of treatment on the improvement of one scale of the DES , 
within this small sample . The scale "Managing Psychosocial Aspects of Diab etes 
reflected a small effect size. This scale focuses on the ability to ask for help when needed 
and the ability to moti vate and support the self in caring for diabetes. Again, this dom ain 
appears similar to the domains measured in the DCP and SF-36 regarding support and 
social and personal factors that demonstrated change in scores in those measures. Other 
studies have found an association between diabetes-specific self-efficacy, diet adherence 
and other self-management behaviors (Sarkar et al., 2006) . 
Also, development of a collaborative relationship in treatment could enhance self-
efficacy . Instead of an expert giving advice to a passive recipient, the participant fully 
participates in the development of the session agenda and leads in the discussion of the 
monitoring records. It is hypothesized then that empowerment of the individual to 
participate would provide experiences in new ways of behaving which could lead to 
increased self-efficacy (Copper et al., 2004). 
It appears the lack of significance cou ld be due to several factors. First, as with 
the DCP, the Diabetes Empowerment Sca le (DES) focuses on change in attitude 
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regarding diabetes-specific behaviors . Behaviors and cognitions targeted in this studied 
were more focused on weight-loss than in changing diabetes-specific behaviors. 
Anderson and colleagues (2000) stated that domain specific goals along with related 
performance feedback are necessary to enhanced motivation. Also, for self-efficacy 
scores to show effectiveness of treatment, items on the measure must be very specifically 
related to the construct it is measuring. The DES contains diabetes-specific behaviors, but 
this study did not provide specific goals or performance feedback tied to specified 
behaviors measured by the DES. For example, the DES asks "In general, I can think of 
ways to overcome barriers to my diabetes goals". Goals regarding weight-loss and related 
topics were the focus of the study, but not specific barriers to diabetes goals per se. 
Also, the iack of clear distinction between questions as well as lack of clarity of 
intent of questions may have led to the lack of statistical significance. Sample questions 
are listed in Table 21. During both baseline and follow--up assessments, some 
participants expressed confusion about the meaning of questions on this measure. 
Comments wen~ also made about the lack of differentiation between questions. Also, the 
mean baseline scores for the treatment group were in the 2-point range which is 
equivalent to agreement with the statement. The only way to improve scores on this 
measure is to strongly agree (score of 1) with the statement. It appears this measure has a 
ceiling effect and may not have the sensitivity to measure change in these three domains 
(Gall, Borg, & Gall, 1996). 
Finally, data were not collected from the control group upon completion of an 
equivalent 12-week intervention. This was due to time constraints and high attrition in 
Table 21 
DES Subscales and Sample Items 
Subscale 
Managing Psychosocial Aspects of 
Diabetes 
Assessing Dissatisfaction and Readiness to 
Change 
Setting and Achieving Diabetes Goals 
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Sample Items 
- In general, I believe that I can ask for 
support for having and caring for my 
diabetes when I need it. 
- In general, I believe that I can support 
myself in dealing with my diabetes . 
- In general, I believe that I know what 
part(s) of taking care of my diabetes that I 
am dissatisfied with. 
- In general, I believe I know what pari(s) 
of taking care of my diabetes that I am 
satisfied with. 
- In general , I believe that I am able to think 
of ways of overcoming barriers to my 
diabetes goals works best for me. 
- In general, I believe that I can decide 
which way of overcoming barriers to my 
diabetes goals works best for me. 
the control group. It is speculated that the high attrition rate in the control group is an 
artifact of waning motivation from being placed on a wait list for treatment. 
Threats to internal validity. As mentioned above , testing and morale problems 
with the control group could be possible threats to the internal validity of the study 
findings. Other potential threats to internal validity include experimental mortality and 
imitation of treatment. Both the treatment and control groups experienced the same 
attrition rates. However, it is not known why participants exited the study. It is possible 
that those participants who ended treatment were unable or unwilling to complete 
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treatment, whereas, participants who exited the wait-list group did not receive treatment 
thus the characteristics of treatment did not affect their reasons for leaving the study. 
Thus those participants who left treatment may have characteristics in common that if 
they were to continue treatment, may change the findings of this study. Because thirty 
percent of wait-list participants lost weight during the care-as-usual period, it is possible 
that imitation of treatment was a factor that threatened the validity of the findings. 
Also, the effects of social desirability may have been a variable in treatment 
outcomes considering the treatment provider was also the researcher. Paiiicipants met 
with the researcher weekly and were aware the treatment provider was also gathering data 
for the research study. It is possible that participants tried harder in order to please the 
researcher. 
Generalizability of findings. It is important to note that this study utilized a 
convenience sai11ple and not a representative sample. All participants were drawn from 
the general geographical vicinity of Salt Lake City, Utah. All participants were patients 
of University of Utah Community Clinic physicians and all had health insurance. The 
lack of a representative sample decreases the generalizability of the findings, however, 
the study was conducted in a naturalistic setting within the actual community clinics 
where patients would likely attend treatment. Thus, it is difficult to precisely indentify 
how generalizable the outcomes of the study are because factors weigh on both good and 
poor generalizability. 
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Implications and Limitations 
The primary implication of this study is that a time-limited cognitive-behavioral 
intervention for weight loss in adults diagnosed with type 2 diabetes can lead to initial 
modest weight-loss of 3% of baseline body weight. When considering the current 
outcomes reported in weight loss studies for adults with type 2 diabetes, this study's 
findings are similar. 
A longer intervention period in this study would likely lead to the desired 5-15% 
weight loss that is associated with improved health outcomes (Klein et al., 2004; 
Warn.kin, 2005) . Although a 12-week intervention is too short a time period to reach the 
optimal 5-15% weight loss, maintenance of any weight loss is advantageous. Ideally, a 
follow-up period of one year or more would provide a good measure of the success of 
addressing ongoing weight maintenance . Other studies have concluded that a 
maintenance period with ongoing support is required for sustaining weight lost (Cooper, 
Fairburn, & Hawker, 2005). 
Another implication is that this treatment, although it did induce weight loss in 
participants, failed to yield changes in HbA 1c, Other studies have yielded reduced blood 
glucose levels which correlated with a decrease in weight. However, treatment periods 
were, on average, greater than twenty weeks (Norris et al., 2005). Longer treatment 
periods then, with larger sample sizes would most likely yield more accurate results. A 
large scale diabetes study found that tight blood pressure control was more predictive of 
fewer microvascular incidents than was tight glucose control (Shaughnessy & Slawson, 
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2003). Therefore, including blood pressure as an outcome may be as important as blood 
glucose levels. 
Secondary implications of this study included the lack of statistical significance in 
the results from the quality of life and self-efficacy measures. It was expected the 
measures would assess the impact of the treatment on these domains. In retrospect, a 
reasonable speculation is that possible mismatch of measures to treatment goals existed in 
the present study, which led to the failure to validly assess the effects of treatment. 
However, because some scales of the measures did yield notable effect sizes , some 
measures used in this study might have lacked sensitivity . If so, there may be a need to 
develop more sensiti ve measures that can detect changes in quality of life and self-
efficacy when intervention studies intending to measure change in these constructs are 
employed. Also, an intervention study of this kind would have greater power to detect 
effects with a larger sample size. 
A limitation of this study is the impact of utilizing a control group that must wait 
for treatment. Participants made remarks about their frustration over waiting for 
treatment. As mentioned earlier, it must be considered that the desire and motivation to 
participate in treatment may have led to participants engaging in weight loss activities. It 
may be more appropriate to compare differential effects of two treatments rather than a 
wait-list control group. When considering the main interest in this study was to 
investigate weight maintenance outcomes, comparing treatments with and without a focus 
on maintenance strategies would likely produce meaningful results. 
Finally, a recognized limitation of this study is the possible conflict of interest and 
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bias inherent in a study when the researcher also provides the intervention as is the case 
in this study. The findings must be considered in light of this potential bias. Some of the 
conflicts possible include: patient's desire to please providers, researcher disappointment 
with patient's level of participation, and introduction of data collection bias (Weber et al., 
1997). 
This conflict is always a compelling topic for those who embrace the scientist-
practitioner model. However, there is much need to translate basic science into clinical 
benefit for patients and scientist-practitioners can provide that bridge (Yanos & Ziedonis, 
2006). Yanos and Ziedonis further stated that while non clinicians tend to have stronger 
methodological skills, they may miss many real world issues that often inspire innovative 
and relevant research. It is therefore necessary to be ever vigilant of ethical and practical 
conflicts that may invariably arise because of these dual roles. 
Recommendations 
In order to evaluate the efficacy of this treatment intervention, it would need to be 
duplicated with a larger sample size, a longer time for treatment and an extended follow 
up period. A follow-up period of 1 year or more would provide the most substantial 
findings of whether this type of treatment can affect change over time for the seemingly 
intractable problem of obesity. Thus, one key recommendation for clinicians is that 
application of a cognitive-behavioral intervention that follows the short time frame used 
in the present study is not recommended. The impact of treatment on quality of life is a 
construct needing attention especially in populations with chronic diseases. Individuals 
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with both type 2 diabetes and obesity have the symptoms and complications of these 
chronic conditions to contend with and it is necessary to consider what impact that both 
the act of undergoing treatment and the outcome of treatment have on quality of life. 
When working with populations suffering with obesity and comorbid conditions it 
is advisable that the formulation and provision of treatment may best be provided through 
a team approach (Perri et al., 1992). A team that includes physicians, nutritionists, 
exercise physiologists, psychologists and others could create a more comprehensive 
approach to treating obesity. Given that obesity is correlated with many known disease 
states , a comprehensive approach to treatment would be akin to prevention. Although 
costs may be high initially , it is possible that paying now would likely cost less , in te1ms 
of dollars and lives, than paying later. 
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APPENDICES 
Appendix A: 
Physician Presentation 
Efficacy of certain strateg ies for weight loss in adults 
with type 2 diabetes 
Prindpal Investigator 
Donald McCl1ln M.O. 
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Diabetes 
• The prevalence of type 2 diabetes 
among Americans of all ages is 
increasing at an ep idemic rate . 
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Obesity 
• Obesity is a primary risk factor for the 
development of and an impedance to the 
treatment of Type 2 diabetes . 
- An estimated 85% of adults with type 2 
diabetes are overweight or obese. 
- Weight loss improves insulin sensitivity and 
glycemic control. 
Obesity Trends* Among U.S. Adults 
BRFSS, 1991,1996,2004 
(*BMJ :e30, or .tbout 30 lbs overweight for 5'4" person) 
j ONo Data DE] <10% ffl 10%-14% • 15%-19% D 20%-24% • ?:25% I 
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Conclusion 
• There is little research investigating 
effective weight loss treatments and 
weight loss maintenance strategies for 
people with type 2 diabetes . 
- For those who do lose weight , research 
indicates poor weight loss maintenance 
outcomes for all overweight and obese 
individuals who lose . weight. 
• 95% regain lost weight within 5 years. 
Cognitive Behavioral 
Intervention 
• Cognitive behavioral interventions hold the 
most promise of effective weight loss 
treatments and of subsequent 
maintenance strategies for sustaining the 
lost weight . 
- Typical weight loss of 5-15% of body weight is 
usually achieved within 4-6 months (1-2 
lbs/week). 
- Focus on learning weight maintenance skills 
during weight loss phase. 
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Purpose of Study 
• The purpose of this study is to investigate 
the efficacy of certain interventions for 
weight loss in adults with type 2 diabetes. 
• Study characteristics 
- Random assignment of 80 participants to 3 
groups 
• Cognitive behavioral intervention 
• Self-monitor ing 
• Comparison group/no treatment 
- 12-week treatment 
Physician referral to research 
project 
• Physician can directly refer patient to 
project 
• Physician permission to participate 
- Diagnosis of Type 2 diabetes 
-BMI ~27 
- Health permits restriction of caloric intake to 
about 1500 calories. 
- Health permits increase in physical activity 
•lncreas e number of daily steps taken 
- Goal of 5,000-7 ,000 steps 
•lncreas e intentional exerc ise 
Main Treatment Protocol 
• Two aspects to treatment 
- Moderate Weight-Loss 
• Cognitive and behavioral barriers to weight loss 
- Address motivation 
- Address adherence 
- Acquire behavioral skills and cognitive responses 
needed for effective weight control 
- Maintenance 
• Acceptance and change beliefs about weight 
• Maintenance skills 
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Measures and statistical 
analyses 
• BMI 
• HbA 1c 
• Diabetes Quality of Life Questionnaire 
• Diabetes Attitude Questionnaire 
• Weekly Summary of Self-Care Activities 
Scale 
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Appendix B: 
Flyer placed in University of Utah Community Clinics 
and Utah Diabetes Center 
INVESTIGATING THE EFFECTIVENESS OF CERTAIN TREATMENT 
OPTIONS FOR WEIGHT LOSS 
To qualify for the study, participants must meet the following criteria: 
1) Have a diagnosis of Type 2 Diabetes 
2) Have a Body Mass Index Greater than 27 (approximately 20 pounds or more of 
excess weight) 
3) Have physician's permission to participate in the study 
4) Have the ability to participate in a research study for 12 weeks 
Possible Benefits: 
1) No-cost weight loss treatment 
Open enrollment until August 31, 2006 
Study ends November, 2006 
For more information or to enroll in the study 
Please contact Kathy Wickersham 
(801) 712-9904 
or 
(435) 882-8818 
Study Location 
University of Utah 
Greenwood Health Center 
7495 South State Street 
Midvale, Utah 
IRB # 15389 
Appendix C: 
Radio Advertisement 
Have you been diagnosed with type 2 diabetes and are you 20 pounds or more 
overweight? The University of Utah is conducting a research study investigating the 
effectiveness of certain treatments for weight-loss in adults with type 2 diabetes. 
Permission to participate from your University of Utah clinic physician is required. 
Research participants will receive no-cost weight-loss treatments. 
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The study will be conducted at the community clinics; will last 12 weeks and begins 
September 1. To enroll, contact Kathy Wickersham at (801) 712-9904. 
Appendix D 
12-week Treatment Module Outline 
Week 1: Module I: Starting Treatment 
• This is a preparatory session before weight loss is initiated. 
• Assessment and orientation (Assessment checklist) 
o Develop a collaborative working relationship 
o Take a history of the weight problem 
o Describe in outline the cognitive-behavioral perspective on weight control. 
o Orient the patient to the f01m and style of treatment. 
o Address motivation 
o Address premature discontinuation of treatment 
o Start self-monitoring of food and drink intake and calorie counting 
o Forewarn regarding calorie restriction 
o Start weekly weighing 
Week 2: Module I: Session 2 
• Weigh the patient and record weight 
• Jointly review self-monit01ing records 
• Set agenda for session collaboratively 
• Work through agenda topics 
• Introduce energy-restricted diet 
• Educate about health risks associated with obesity 
• Educate about unhealthy methods of weight control 
• Educate about principles of health eating 
• Agree on homework assignments 
• Summarize the session 
Week 3: Module II: Establishing and Maintaining Weight Loss 
• Same activities as week 2 
• Assess compliance with the energy restricted diet 
• Education about weight regulation 
• Address social eating 
• Address activity level and exercise 
• Develop problem-solving skills 
Week 4: Module III: Addressing Barriers to Weight Loss 
• Same activities as week 2 
• Introduce Barriers to Weight Loss Checklist 
Week 5: Module IV: Increasing Activity 
• Same activities as week 2 
• Introduce Increasing Overall Activity topic 
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• Introduce monitoring physical activity 
Week 6: Module V : Addressing Body Image Concerns 
• Same activities as week 2 
• Introduce concept of body image as distinct from physical appearance 
• Assess and identify body image concerns 
• Introduce monitoring body image concerns 
• Introduce procedures for addressing problematic thoughts and beliefs 
Week 7: Module VI: Addressing Weight Goals 
• Same activities as week 2 
• Questioning the Desired Weight and modifying weight loss goals 
• Introduce topic of benefits of moderate weight loss 
• Emphasize need for acceptance and change 
Week 8: Module VII: Addressing Primary Goals 
• Same activities as week 2 
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• Address goals, other than weight loss , that patients are hoping to achieve as a result of 
losing weight 
Week 9: Module VIII: Healthy Eating 
• Same activities as week 2 
• Introduce general strategies to encourage healthy eating 
Week 10: Module IX: Weight Maintenance 
• Same activities as week 2 
• Prepare patients for weight maintenance 
• Define a target weight range and establish a weight monitoring system 
• Introduce topic of ling-term weight maintenance skills 
• Introduce topic of responding to changes in weight 
• Review Treatment 
• Phase out self-monitoring 
• Introduce topic of addressing weight change in the future 
• Address possible future attempts to lose weight 
• Prepare a personal weight maintenance plan 
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Appendix E: 
Phone Script for Data Collection 
1st Contact: 
Hello, my name is _____ _ 
I'm calling on behalf of the University of Utah and Dr. McClain and Utah State University and 
Dr. Stein. We want to thank you for participating in our study of the relationship of weight-loss 
strategies and type 2 diabetes. I'm calling today to get your total calories and total steps since 
Collect data and then coordinate date for next phone call. 
Ongoing phone contacts: (CB group) 
Hello, this is 
------
I'm calling to record your calorie and step information since your last clinic visit. 
(Collect data and thank them for the infom1ation. Coordinate the next date for you to call.) 
Appendix F 
Treatment Participant Handouts 
HANDOUT A 
RECORDING YOUR EATING 
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The importance of recording can not be stressed too much. It is vital if treatment is to succeed. 
Recording will help you identify exactly which aspects of your behavior you need to change, and it 
will help you make these changes. 
At this stage you need to record everything that you eat and drink. A simple description will 
do. To do this, you will need to carry your records with you . The following instructions are to help 
you complete the records . 
• 
• 
• 
• 
• 
• 
Column 1 is for noting the exact time of day you ate or drank the items concerned . You 
should write things down as soon as possible afterward. 
Column 2 is for giving a simple description of what was eaten and drunk . You should record 
absolutely everything consumed . Please identify meals with brackets . 
Column 3 is for noting where you were at the time. If at home, please note the room . 
An asterisk should be placed in column 4 beside anything you ate or drank that you viewed 
as excessive. This should be your view not other people's. 
Column 5 is for noting calories . 
Column 6 is for noting other points of relevance (e.g., your thoughts or feelings, the 
circumstance, or context in which they eating occurred). You should also note your weight in 
this column each time that you weigh yourself. 
Please remember to bring your records to each treatment session. 
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HANDOUTB 
A BLANK MONITORING RECORD 
DAY: DATE: 
Food and Drink 
Time Consumed Place * Calories Comments 
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HANDOUTC 
A BLANK MONITORING RECORD 
DAY : DATE: 
Food and Drink 
Time Consumed Place * Calories Comments 
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HANDOUTD 
A BLANK MONITORING RECORD 
DAY : DATE: 
Food and Drink 
Time Consumed Place * Calories Comments 
HANDOUTE 
ENERGY BALANCE 
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The key points 
• To have a stable weight, your energy intake (what you eat as food and drink) must equal 
the energy you burn up (what you need to keep your body processes going and for 
physical activity) . 
• Weight problems developed when your energy intake (calories) exceeds the energy you 
are burning up over a sustained period of tirp.e. 
• This positive energy balance ( excess energy) is stored in the body mainly as fat. 
• Excess weight (fat) is only lost when you create a negative energy balance so that your 
body draws on its energy (fat) stores. 
• A sustained reduction in your energy intake (as food and drink) is needed to produce 
weight loss . 
• In principle your rate of weight loss could be accelerated by increas ing the energ y you 
burn up as a result of physical activity, but in practice the additional benefits are not 
great. On the other hand , regular physical activity does help weight maintenance . 
• Once you reach your target weight range, you will need to adjust your eating and activity 
levels to stabilize your weight. This is an important skill that requires practice . 
Why do some people develop weight problems? 
• There are two main reasons and often they both apply: 
• Eating too much ( energy intake too high) 
• Not being active enough (not burning enough energy) 
• Metabolic, hormonal or other medical problems are rarely relevant, although people vary 
somewhat in the amount of energy their body needs to keep running. 
• Weight problems tend to run in families. This can be due to the family environment or to 
genetic factors or both. 
• Genes have a definite influence on body weight, so if you come from a family in which 
many people have significant weight problems, you are likely to be genetically vulnerable 
to similar difficulties. 
• 
• 
• 
Psychological factors lead some people to overeat. Some people are worried in response 
to stress or when they are unhappy or bored, whereas others find that their appetite is 
diminished. Extreme dieting can also encourage overeating. 
Poor eating habits can also be learned (at home, school or work, or do to another 
circumstance). A particular problem in our society today is that most people eat too much 
high-fat food, largely because it is readily available and tastes good. 
As a society we are also much less active than we used to be. Many people have jobs that 
involve little activity and people are much less active at home. 
HANDOUTF 
REVIEW SESSIONS 
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Now that your appointments will be at 2-week intervals, it is important to have weekly between 
session, appointments with yourself. This might seem odd but it can be extremely valuable. The 
purpose of these review sessions is to ensure that you remain alert to your progress and any 
problems that you might be having . They also help you maintain momentum between our 
sess10ns. 
These review sessions are important and should be given priority. It is best to schedule 
them in advance like a treatment session. It is helpful if each session has the following structure: 
• Review of your progress based on your most recent monito1ing records and any 
change in your weight. In doing this you should take account of the "homework" that 
was agreed at our last session. 
• Identify everything that you have achieved over the last week. It is important to give 
yourself credit for your achievements. 
• Set yourself one or two specific goals for the forthcoming week. 
It is also very important to continue to weigh yourself at weekly intervals and record your 
weight on your graph . 
At each appointment we will discuss how you have managed with the review and the goals 
that you set yourself. 
Making a habit of assessing your progress in this way will prepare you for the future when 
you will no longer be coming for treatment. 
HANDOUTG 
SOCIAL EATING 
134 
Eating out or with other people can pose additional challenges when you're trying to control your 
calorie intake. Planning ahead is important. In particular, it is helpful to ensure that you have 
thought about how to deal with all the practical issues related to social eating and your attitude to 
keep your calorie limit. Most situations can be successfully tackled if you have a plan for dealing 
with them . On the other hand, if you're caught unawares you are at greater risk of experiencing 
problems . 
Here are some specific tips for dealing with eating out: 
A. Practical Strategies 
General 
• Plan far enough in advance, as you may want to adjust your eating in the days before (and/or 
after) the event to "bank" calories . You will also often need to plan a strategy to deal with the 
specific situation (see below). 
• Think about the difficulties you will encounter. Consider the following : 
• The amounts and types of food that will be provided 
• Social pressures to eat 
• The availability of "extras" ( e.g., pre meal appetizers, after-dinner chocolates) 
• Alcohol 
• It may be useful to think about how you have dealt with similar situations in the past. 
In all the situations mentioned below it is helpful to plan in advance . This gives you time to 
anticipate any difficulties that might arise and how to cope with them. Here are some practical tips 
that may help. Note that not all will suit you or the situation. 
Restaurants 
• Participate in the choice of restaurants if possible; look at the menu in advance, or possibly 
telephone the restaurants to ask about the availability of low fat or low calorie dishes. 
• If possible, ask for food to be served without extra butter, and for dressing and sauces to be 
served separately so you can control the amount you have. Consider asking for a smaller 
portion of the main dish with extra vegetables or salad. 
• Be wary of set menus. They may include dishes that are not choices for people who are 
trying to lose weight, but are also difficult to resist when you have already paid for them. 
• Try asking for fresh fruit as a dessert, or maybe share a dessert with somebody else. 
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Buffets 
• 
• 
• 
• 
Look carefully at what is available before you actually put anything on your plate. Identify a 
few foods that you would really enjoy (rather than trying a bit of everything) and choose 
some low-calorie options such as salad or rice to fill you up. 
Try using a side plate rather than a full-size dinner plate . 
Handout G (Continued) 
Treat it as you would a sit-down meal. Visit the buffet table only once, and then when you 
have eaten get rid of your plate as soon as possible. 
Alternatively, ask someone else to bring you some food, and tell them what you would like . 
Entertaining In Your Own Home 
• 
• 
• 
• 
Consider whether you are obliged to provide a high-fat, high-calorie meal. Many people are 
either watching their weight or being careful about their diet for health reasons . A lower-fat 
meal is just as likely to be welcomed by guests and certainly does not indicate poor 
hospitality. 
Single-portion foods, such as individual chicken pieces, are often easier to manage and avoid 
the difficulty of having tempting leftovers. 
If you do have food left over, either give it to guests to take with them or freeze it 
immediately. 
If you tend to pick while preparing food, try immersing used dishes and utensils immediately 
into soapy water or chewing gum while you cook. 
Eating at Someone Else's House 
• 
• 
• 
• 
• 
If possible, try to find out in advance what will be served. If you know the host/hostess well, 
consider contacting them in advance to explain your situation and ask if it would be possible 
for him or her to help. You could perhaps find out what he or she is planning to serve so that 
you can decide in advance what you will eat, and plan your day accordingly. 
It may be possible to offer to take a dish with you, so that you know there will be at least one 
low-calorie option. 
Offer to help serve so that you can control your portion size, or ask for a small portion . 
Fill your plate with salad or vegetables, and take only small amounts of high-calorie dishes . 
This helps to control the calories and avoids drawing attention to your weight control efforts. 
Asking for recipes may be a good ( and socially acceptable) way of finding out what went into 
a meal so as to calculate the calories you consumed. 
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B. Other Issues 
Pressured to Eat 
If you tend to feel under pressure to eat more than you had planned, tried to work out exactly what 
makes you feel this way. Are you concerned that people will be offended if you do not eat everything 
you are offered, or that you will draw attention to yourself if you do not eat as much as everyone 
else? See if you can work out precisely what the problem is, it will be easier to think of ways to cope. 
For example, if you're concerned that your host will be offended if you do not eat much, you might 
decide it would be helpful to practice saying "No" politely but firmly. You can test out whether 
politely declining foods is likely to cause offense. You might do this by thinking about how you 
would feel if you were the host and someone declined food in this way; or by watching carefully to 
see if other people always eat large portions of everything available, and how others react if they do 
not. If you are concerned about drawing attention to yourself by not doing what everyone else is 
doing you might observe the reactions of others to people who, for example are not drinking alcohol, 
perhaps because they are driving, or perhaps simply because it is their preference not to do so. Ask 
yourself whether you think it would be reasonable to react negatively to such situations and whether 
you would do so. 
Feeling Deprived 
Although planning ahead to make the most of your calories is helpful, it is not uncommon to feel that 
social events revolve entirely around high calorie food and drink and to think that not being able to 
eat or drink everything that you would like will make these events less enjoyable. You could test this 
view to see whether you really enjoy occasions less if you limit your food and alcohol. Also, you 
could try focusing on those nonfood aspects of social events that make them enjoyable ( e.g., talking 
to friends, and having time to relax, not having to wash the dishes) so that food and drink becomes 
less important aspect of social events. 
Coping with Unexpected Occasions 
Sometimes invitations to eat arrive unexpectedly -someone drops in and suggests having lunch 
together, or friends come around with take-out, or somebody suggests going for a meal after a movie. 
It is helpful to take a few minutes to think clearly about how to handle the situation. You may 
decide to join in on the meal, and cut down on calories later in the day or the next day. Alternatively, 
if you have already planned what you're going to eat, you may need to respond differently: perhaps 
by suggesting another time when you could have a meal together or explaining that you will just have 
a small amount as you have already eaten. You may wish to experiment with different possibilities 
and find out which one works best for you. 
HANDOUTH 
PLANNING FOR VACATIONS 
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Vacations can pose additional challenges when you are trying to control your calorie intake. You 
may be in unfamiliar surroundings where the food choices may be quite different from home, and 
you may have less control than usual over the preparation of food. 
Planning ahead is important. In particular, it is helpful to ensure that you have thought about 
how to deal with both the practical issues related to eating, as well as how you might feel about 
keeping a calorie limit. Most situations can be successfully tackled if you have a plan for dealing 
with them. On the other hand, if you're caught unawares you are a greater risk of encountering 
problems. 
General 
Vacations are a time to relax and enjoy yourself, and sometimes people see this as incompatible with 
restricting their consumption of food and drink. It is worth considering how you can make the most 
of your vacation without undoing all the hard work you have put into losing weight. The first task is 
to decide on your goal over the vacation. Do you want to continue losing weight or to maintain your 
current weight? If you intend to stick to your calorie goal with the aim of continuing to lose weight, 
be clear and realistic about how you will achieve this goal. If you think that it is not realistic to stick 
to your calorie goal, it may be best to work out a slightly higher calorie limits with your therapist for 
the vacation, with the aim of maintaining your weight. 
In making decisions about your goals, it may be helpful to consider what, besides being able 
to drink and eat freely, will be enjoyable about the time away. A vacation may provide an ideal 
opportunity to practice the new habits you have learned and experiment with the possibility that you 
have an enjoyable time while still limiting your intake of food and alcohol. 
Here are some specific practical issues to consider when planning ahead. 
Monitoring Food and Weight 
• 
• 
Will you monitor your food and weight while you are away? If so, how? Will scales be 
available for weighing food and for checking your weight? 
When will you do your weekly reviews? Can you set aside time with yourself? Would it be 
helpful to send (fax or e-mail) your weekly review to your therapist while you are away? 
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Arrangements for Travel 
• How long will your journey take from door to door? What meals would you normally eat 
during this time? Will you be traveling over night or on a long haul flight? If so, how might 
this affect your eating pattern? 
• What food will be available? Is it worth taking your own to ensure you have control over 
what you eat? Are you likely to be tempted by the availability of snack foods at gas stations, 
airports, or trains? Will your food choices be determined by circumstance (e.g., food on an 
airplane)? If so, would it be worthwhile ordering a special meal? . 
• What time will it be when you arrive at your destination (and at home on your return 
journey)? Can you arrange personal food to be available ( e.g., by leaving a meal in the 
freezer at home)? 
• How can you make it easy to keep monitoring while you travel? Many people find it difficult 
to resume monitoring after a break, so working out how to monitor through unusual 
situations is worthwhile. Making sure you have your monitoring sheets handy is important, 
and calculating in advance anything you take with you can make monitoring easier during the 
Journey. 
General Arrangements When Away 
• 
• 
• 
We'll food be provided? Will you be eating out, preparing your own food, or a combination 
of these? How will you cope with the particular arrangements? Do you anticipate any 
difficulties? Planning ahead is likely to be helpful in these situations. 
How will your requirements fit in with the rest of the party? 
What types of food will be available? 
Alcohol 
• Does your alcohol intake tend to increase when on vacation? How do you intend to manage 
this? 
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HANDOUT! 
SPECIAL OCCASIONS 
Controlling your calorie intake on special occasions (such as parties, birthdays, weddings, and other 
celebrations) can be difficult. Such occasions provide a good opportunity to practice the new habits 
you are learning and to experiment with the possibility of having an enjoyable time without eating 
too much. This handout summarizes many of the strategies that we recommend for coping with 
special occasions. It also suggests new and different ways to think about the role of food on special 
occas10ns. 
Goals 
It is generally best to stick to your usual weekly calorie goal (as an average over the week). Be clear 
and realistic about how you will achieve this. Eating nothing all day in anticipation of a party is 
likely to lead to overeating later on. Instead, eating lightly the day before or after may be a better 
plan. Completely avoiding food that you like may also be a mistake. It is usually a good idea to plan 
to eat such food and incorporate it into your day's eating plan . 
Plan Ahead 
The single most important strategy for dealing with any special occasion is planning ahead. This is 
especially important if there will be extra food around for over a period of several days, and ifthere 
will be more than one special meal or party. High-calorie foods and alcohol drinks often seem to be 
an integral part of these events, so it is especially important that you make plans to deal with these 
challenges. It is generally helpful to make a plan for each day, and you may need to plan several days 
in advance when celebrations go on for several days. 
Monitor 
It is very important to continue to monitor. This will keep you informed about how your strategies 
are working and help you to adjust your plans as necessary. It will also help you to keep focused on 
your goals. 
Alcohol 
It is especially important to have a plan for dealing with alcohol: not only does it add calories, but it 
tends to weaken the resolve to eat moderately. 
Focus on Other Pleasurable Aspects of Special Occasions 
Although many social events may seem to center on high-calorie food and drinks, consider whether it 
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is possible to celebrate without consuming these in large quantities. It may be helpful to think about 
ways of making celebrations enjoyable that do not involve eating (or at least eating large quantities 
of food) and trying these out. Try paying attention to the features of social occasions that make them 
enjoyable. This may lead you to conclude that eating moderate quantities of food would not spoil 
your enjoyment. Some people even discover that they enjoy occasions more when they eat and drink 
less . 
Dealing with Pressure to Eat 
You may feel under pressure to eat more than you had planned. This can happen for many reasons : 
the sheer abundance of food may attract you; you may feel people will be offended if you do not eat 
much: or you may feel that you will be 'the odd one out' if you do not join others in eating and 
drinking all that is offered. It is always easier to cope with such situations if you have made a plan in 
advance. It also is helpful to practice refusing food lightly but firmly. You do not have to eat to 
please others, and people rarely noticed what you are eating and drinking. 
Gifts of Food 
On special occasions people may buy chocolates, sweets, cake, or other things for you. If this is 
likely, would it be worth asking them to buy something else instead? If you feel you cannot make this 
request yourself, perhaps your partner or a relative or friend can discreetly advise others that you 
would prefer not to be given food. Also it would be helpful to consider how to cope if you receive 
such food unexpectedly. Could you give it to someone else? 
Snacks 
Sometimes on special occasions there is a wide variety of snacks on display . Having bowls of nuts, 
chocolates, and other high-calorie snacks is likely to be a temptation beyond most people's 
endurance, so plan how best to cope with this situation . When such situations are under your control, 
you may decide to do things differently. 
• 
• 
• 
• 
If you are providing snacks: 
Plan the shopping carefully and limit the amount of extra food bought. 
Keep snacks in sealed containers, and only set out small quantities for specific occasions . 
Have alternative, lower-calorie snacks such as raw vegetables with low-calorie dip, fruit, 
plain (unsweetened or unbuttered) popcorn, and breadsticks. 
The strategies suggested in Handout G on social eating are also relevant to many special 
occas10ns. 
HANDOUTJ 
PROBLEM SOLVING 
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As discussed in the session, effective problem solving involves six basic steps together with a final 
review step. The six steps are as follows: 
Step 1. Identify the problem as early as possible. 
Step 2. Specify the problem accurately. 
Step 3. Considered as many solutions as possible. 
Step 4. Think through the implications of each solution. 
Step 5. Choose the best solution or combination of solutions. 
Step 6. Act on the solution. 
Then, afterward, review the whole problem-solving process to see if you could have done it any 
better. You will improve with practice. 
HANDOUTK 
BARRIERS TO WEIGHT LOSS CHECKLIST 
Below is a list of commonly encountered barriers to weight loss. Please consider which (if any) apply to you, and place a check in the 
relevant column. 
Accuracy of recording: 
Is absolutely everything written down? 
Do you accurately measure you portions? 
Do you carefully calculate calories? 
Weighing and weekly reviews: 
Are you weighing yourself once a week? 
Are you holding weekly review sessions? 
Your eating pattern (i.e., when you eat): 
Do your eating habits vary greatly from day to day? 
Do you eat regular meals and snacks through the 
day? 
Do you skip any meals? 
Do you go for long periods without eating? 
No To some 
extent Yes 
....... 
+:>, 
N 
Do you tend to nibble or pick at food? 
Are there particular times of day (or particular days) 
when you are liable to overeat? 
Do you have "binges" (large or small)? 
Your portion size: 
Are you portion sizes on the large side? 
Do you take second helpings? 
Do you always "clean your plate"? 
Do you eat leftovers? 
Your choice of foods and drink: 
Are you prone to eat energy-rich (i.e., high-fat) foods? 
...... 
+::,. 
\.;.) 
--, 
HANDOUT K (CONTINUED) 
Are you actively avoiding any foods? 
How you eat: 
Are you someone who eats very rapidly? 
Do you eat in places other than the kitchen or dining 
room? 
Do you eat while driving or engaged in other 
activities? 
Is you eating planned in advance ? 
Do you eat directly from packets or containers? 
Other obstacles to weight loss: 
Have you lost your motivation to lose weight ? 
Are you prone to stress-related eating? 
Are you liable to eat when bored? 
Does thinking in black-and-white terms undermine 
you attempts to lose weight ? 
Are you facing other obstacles to losing weight? 
...... 
.j:,.. 
.j:,.. 
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HANDOUTL 
MONITORING YOUR LEVEL OF ACTIVITY 
The first step in increasing your level of physical activity is to measure how active you are now. To 
do this you need to measure the three forms of activity disused in treatment. 
Inactivity 
At the end of each day recall as accurately as you can how many hours you have spent sitting or lying 
down. Do this for a 24-hour period (midnight to midnight) projecting forward for the few hours 
remaining in the day. Then record the number in an "activity box" drawn on the back of the day's 
monitoring record (see below). If you sit down at work, it may be best to keep a running total of the 
time spent sitting in column 6 of your monitoring record. 
Lifestyle Activity 
This term refers to incidental physical activities that are part of day-to-day life. It includes walking, 
standing, climbing stairs, household chores, light gardening, ordinary cycling, and gentle swimming. 
With the exception of cycling and swimming, we recommend quantifying these activities in 
an appropriate way (in terms of the number of steps taken) using a pedometer. 
If you have pedometer, you should wear the pedometer at all times except when in bed and 
engaging in formal exercise (see below). You should put it on first thing in the morning. To 
remember to do this, attach it to something you use first thing in the morning (e.g., a comb or hair 
brush) and return the reading to zero by pressing the reset button. Attach the pedometer to a belt for 
article of clothing at the side of your hips. Then, last thing at night, note the number of steps recorded 
in the day's activity box. Please note that you should ignore any calorie table that may come with the 
pedometer as such figures are generally misleading . 
Formal exercise 
At the end of each day you should also record in the activity box the number of minutes spent 
engaged in formal exercise. To be classed as formal exercise, the exercise should involve exertion to 
the point that your pulse and breathing rates are increased. Such exercise includes jogging, moderate-
to-fast swimming, brisk walking, and fast cycling. 
HANDOUTLCONTINUED 
Activity Box 
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The activity box summarizes your level of activity over the previous 24 hours. It should be 
drawn on the back of the day's monitoring record and completed at the end of the day. It should 
look like this: 
Inactivity (hours) 8 hours in bed, 3 hours sitting 
Lifestyle activity (steps) 3,860 steps 
Formal exercise (minutes and type) None today 
HANDOUTM 
THE BODY IMAGE CHECKLIST 
Instructions: please answer these questions as they have applied to you over the PAST 4 WEEKS. Please place a check in the 
appropriate column. 
Over the past 4 weeks ... 
Questions about avoidance: 
Have you avoided seeing yourself in mirrors (or 
window reflections)? 
Have you avoided weighing yourself? 
Have you dressed in a way to disguise your 
appearance? 
Have you avoided your shape being seen by others 
(e.g., swimming pools, communal changing rooms, 
etc.)? 
Have you avoided taking part in physical activities 
because of your shape? 
Have the avoided shopping for clothes? 
Have you avoided being seen at home naked (e.g., 
when undressing or bathing)? 
Not at all Sometimes Frequently 
Not 
applicable 
....... 
.j:,. 
-...l 
Have you avoided wearing clothes that show the 
shape of your body? 
Have you avoided (or limited) close physical contact 
because of your dislike of your shape (e.g., shaking 
hands, sexual contact, hugging, kissing)? 
Have you avoided wearing close that show your skin 
(e.g ., short-sleeved shirts, shorts)? 
Have you avoided social occasions because of your 
shape? 
Questions about checking : 
Have you studied your overall appearance in the 
mirror? 
Have you weighed yourself? 
Over the past 4 weeks .. . 
Have you measured parts of your body? 
Have you assessed your size in other ways? 
Have you pinched yourself to see how much fat 
is there? 
General questions : 
Not at all Sometimes Frequently 
Not 
applicable 
,_. 
~ 
00 
Have you felt unhappy about your shape? 
Have you worried about the size of particular 
parts of your body? 
Have you worried about your body wobbling? 
Have you felt ashamed or embarrassed about 
your body and public? 
Have you felt that other people were noticing 
your shape? 
Have you felt that your body was disgusting? 
Have you thought that other people were being 
critical of you because of your shape? 
Have you felt that you take up too much room 
(e.g:, when sitting on a sofa or bus seat)? 
Have you sought reassurance that your shape is 
not as bad as you think it is? 
Have people made critical comments about your 
shape orappearance? 
HANDOUT M (CONTINUED) 
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A BLANK BODY IMAGE DIARY 
Record on the body image diary times when : you were thinking negatively about your body; you avoided situations because of the way 
you felt about your body; you were checking your body in an inappropriate way. 
Situation Feelings Thoughts Behavior Consequences Alternative Thoughts 
....... 
V, 
0 
HANDOUTO 
A COMPLETED BODY IMAGE DIARY - EXAMPLE 1: AVOIDANCE 
Record on the body image diary times when: you were thinking negatively about your body; you avoided situations because of the way 
you felt about your body; you were checking your body in an inappropriate way. 
Situation 
Being asked by my child 
to accompany him on a 
bike ride. 
Feeling? 
Anxious about what 
to say, sad and 
miserable about the 
situation. 
Thou_ghts 
The whole street will 
see me looking 
ridiculous on a bicycle. 
I will wobble. I cannot 
ride my bike until my 
body looks better. This 
is another thing I 
cannot do because of 
the way I look. 
Behavior 
Told my son that I 
could not go. Made up 
an excuse (lied). 
Conse_quences 
Not able to do things with 
my son, always putting 
things off until I get 
thinner. 
Alternative Thoughts 
It is me who thinks I will look 
ridiculous and disgusting. I am 
assuming everyone will think this; I 
do not actually know what everyone 
thinks. 
In the past I have been surprised that 
people have not always been thinking 
what I thought they were-in this 
case perhaps I could find out. If I saw 
someone who was overweight riding 
a bicycle I would not think they 
looked ridiculous-I would think it 
was healthy exercise . 
So why do I have to wait until I lose 
weight? Other people seem to be able 
to do it who are even heavier than 
me. Besides, I used to enjoy riding a 
bicycle, and it is good exercise . By 
. saying I cannot do it, I will deprive 
myself of the opportunity of doing 
exercise that might make me feel 
better about myself. I should try to 
ride and find out what happens. 
>---' 
V, 
>---' 
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A COMPLETED BODY IMAGE DIARY - EXAMPLE 2: REPEATED CHECKING 
Record on the body image diary times when: you were thinking negatively about your body; you avoided situations because of the way you felt about 
your body; you were checking your body in an inappropriate way. 
Situation 
Getting dressed in 
the morning . 
Feelings 
Really miserable, 
disgusted and angry 
with myself. 
Thoughts 
My hips and bottom 
are so big, I do not 
look nice in these 
clothes-in fact 
nothing looks good on 
me. I always look 
terrible . 
Behavior 
I try on several 
outfits in the hope 
that they will hide 
my hips and 
bottom. I check 
myself in the mirror 
several times and 
from all angles to 
see if I look any 
better. I eventually 
choose an outfit 
that is slightly 
better but not much. 
Consequence s 
Once again, I'm late 
for work because it 
takes so long to dress, 
and I still spend all 
day worrying about 
how I look. I 
repeatedly go to the 
restroom to check 
myself in the mirror-
still don ' t like what I 
see. When I buy 
clothes, I only 
consider whether they 
will hide my hips and 
bottom-I don't 
bother considering 
anything else . 
Alternative Thoughts 
Rationally, I know my shape 
cannot really have changed 
noticeably overnight. I felt OK 
at work yesterday, so the fact 
that I feel low today is not 
because I am fatter, but because 
I am upset about something else. 
I know . that anyone who 
scrutinizes themselves in a 
mirror could find things about 
· their appearance that they want 
to change . Constantly examining 
myself in the mirror just makes 
me feel worse especially as I 
only look at the problem areas I 
have-I don't bother about my 
hair and eyes , which are OK. So 
I will try to stop doing that. I am 
doing what I can to help 
myself-I have already lost 
some weight, although it has 
been slower than I would like . 
Now I will just make the best of 
where I am at the !moment. I may 
try buying some new clothes that 
I feel really good in. 
>--' 
Vl 
N 
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A COMPLETED BODY IMAGE DIARY-EXAMPLE 3: NEGATIVE THOUGHTS 
Record on the body image diary times when: you were thinking negatively about your body; you avoided situations because of the way you felt about 
your body ; you felt about your body; you were checking your body in an inappropriat e way. 
Situation 
Sitting in dentist's 
waiting room looking 
at clothes in a fashion 
magazine. 
Feelings 
Envious of 
models looking 
good in great 
clothes, miserable 
and disgusted 
with my body. 
Thoughts 
I never looked good 
in clothes. I cannot 
fit into any decent 
clothes anyway. It 
is not fair, the 
women in those 
magazines are so 
thin an attractive, 
and my body is so 
fat and ugly. 
Behavior 
Felt so bad I bought 
a bar of chocolate 
on the way home to 
console myself. 
Consequences 
Felt even worse later 
because eating 
chocolate will make 
me even fatter and 
make the situation 
worse. 
Alternative Thou_ghts 
Just because I am not thin and 
perfect like a model does not 
mean that I am unattractive. I 
know people whom I regard as 
attractive and they don't look 
like models . I am comparing 
myself to an ideal no one can 
attain-photographs of models 
are touched up to remove 
imperfections. 
I always compare myself to 
people whom I think are more 
attractive than I am, and not to 
those who are Jess attractive. If 
someone else did that, I would 
think they were being unfair. 
Perhaps I am being unduly hard 
on myself because I never think 
of the things I'm good at. I 
know that society's ideals for 
shape are narrow, and I admire 
people who are not so influenced 
by them. Thinking the way I do 
is not helpful, because it resul ts 
in my eating the wrong things, 
which only makes things worse. 
>-' 
Vl 
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YOUR WEIGHT GOALS 
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We have begun to discuss your weight goals. As "homework" we would like you to set aside 
some time before the next session to consider the issues listed below . We suggest you write 
out your answers (perhaps in note form). 
You will remember that we discussed your "desired" weight , the weight that you 
think that you really ought to achieve. Please answer the following questions with reference 
to your desired weight. Please answer them in this order: 
1. Origins of your desired weight: 
• Why do you want to be this specific weight? 
• Is there anything particularly special about this weight? 
2. Other weight goals in the past: 
• Have you had other weight goals in the past? 
• Why were they different from your present goal ? 
3. Achievability of the your desired weight: 
• When were you last at your desired weight? 
• How hard do you think it would be to stay at this we ight? 
4. Important of reaching your desired weight: 
• How important to you is reaching your desired weight? 
• If it is important, why is it important? 
5. Consequences of reaching your desired weight: 
• How would your life differ if you reached your desired weight ? 
• What could you do that you cannot do now? 
Or, if you have previously been this weight , how was your life different when you were at 
this weight? 
When answering the two parts of question 5 consider the following eight aspects of 
daily life: 
Attractiveness (to yourself and other) 
Leisure activities (e.g., sports) 
Work 
Self-esteem and self-confidence 
6. Consequences of not reaching your desired weight 
Clothes size and choice 
Health and fitness 
Social life 
Personal relationships 
• How would you feel if you do not reach your desired weight? 
• What effect would it have on your daily life? 
PLEASE REMEMBER TO BRING YOUR ANSWERS TO YOUR NEXT SESSION. 
• 
• 
• 
• 
• 
• 
• 
• 
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ACCEPTANCE AND CHANGE - VERSION 1 
Some aspects of the problem of being overweight can be changed; some cannot. 
A good treatment should help people change what can be changed and accept what cannot. 
Body weight is somewhat genetically determined, and it is therefore only partly under one's 
control. 
It is possible to make fairly dramatic short-term changes in weight by severe ly cutting down food 
intake , but a great deal of research has shown that such changes cannot be sustained in the long 
te1m. 
There is currently no treatment for being overweight (other than gastrointestinal surgery) that 
results in the weight loss of more than 10-15% of the initial body weight, and the weight loss is 
generally regained. Typically a third of the lost weight is regained within one year and almost all 
of it is regained within five years. This is true of all nonsurgical treatments (e.g., dietary 
treatments, very-low-calorie diets, behavior modification , and appetite suppressant drugs) as well 
as combinations of these treatments. 
If you lost 10-15% of your starting weight, you would weigh ______ _ 
For most people, their desired weight is far lower than the weight a 10-15% loss would be. As a 
result they view the treatment (and/or themselves) as having failed , whereas it is really an 
achievement to lose this amount of weight and keep it off. 
The benefits of a 10-15% weight loss can include the following: 
• Improved appearance and decreased waist size (and ther efore clothing size) 
• Enhanced sense of general well-being and self-e steem 
11 Decrease in many of the negative effects on health association with obesity (e.g., high blood 
pressure, high blood lipids , high blood sugar) as well as the risk of developing these problems 
• Improved sense of physical well-being 
• Simultaneously treatment can address other personal goals, and generally this has very 
positive effects on quality of life. 
Implications for You 
• 
• 
• 
You can change your weight to an important extent (10-15% weight loss), although the 
weight loss may well not be as great as you would wish . 
You can directly address other personal goals, but it is essential that you accept what cannot 
be changed (your weight range, your overall shape). 
If you do not succeed in accepting what cannot be changed, you are going to be at risk of the 
following: 
• Undervaluing what you have achieved in treatment 
• Believing that you cannot control your weight at all 
• Not being fully committed to keeping off the weight that you have lost, a major cause of 
weight regain 
BOTH ACCEPTANCE AND CHANGE ARE ESSENTIAL FOR SUCCESSFUL 
WEIGHT CONTROL. 
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ACCEPTANCE AND CHANGE - VERSION 2 
• Some aspects of the problem of being overweight can be changed; some cannot. 
• A good treatment should help people change what can be changed and except what 
cannot. 
• Body weight is, to an important extent, genetically determined, and it is therefore only 
partly under one's control. 
• It is possible to make fairly dramatic short-term changes in weight by severely cutting 
down food intake, but a great deal of research has shown that such changes cannot be 
sustained in the long term. 
• There is currently no treatment for being overweight ( other than gastrointestinal surgery) 
that results in the weight loss of more than 10-15% of the initial body weight, and the 
weight lost is generally regained . Typically a third of the lost weight is regained within 
one year and almost all of it is regained within five years. This is true of all nonsurgical 
treatments (e.g., dietary treatments, very-low-calorie diets, behavior modification, and 
appetite suppressant drugs) as well as combinat ions of these treatments. 
• Many people who try to lose weight do not lose as much weight as they would like. As a 
result they view the treatment (and/or themselves) as having failed. In reality it is an 
achievement to maintain any weight loss, however small. For people who have been 
gaining weight, to stop gaining weight is in itself an achievement. 
• The benefits of a 10-15% weight loss can include the following: 
• Improved appearance and decreased waist size (and therefore clothing size) 
• Enhanced sense of general well-being and self-esteem 
• Decrease in many of the negative effects on health associated with obesity (e.g., high 
blood pressure , high blood lipids, high blood sugar) as well as the risk of developing 
these problems 
• Improved sense of physical well-being 
• Simultaneously treatment can address other personal goals, and generally this has 
very positive effects on quality of life. 
Implications for You 
• Although your weight loss may well not be as great as you would wish, you should see it 
as a team that you have stopped gaining weight, and have lost a certain amount of weight. 
• You should be aware of any other positive changes that you have made during the course 
of this treatment, such as addressing other personal goals. 
• It is essential that you accept what cannot be changed (your weight range, your overall 
shape) . 
• If you do not succeed in accepting what cannot be changed , you are going to be at risk of 
the following: 
• Undervaluing what you have achieved in treatment 
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• Believing that you cannot control your weight at all 
• Not being fully committed to keeping off the weight that you have lost, a major cause 
of weight regain 
BOTH ACCEPTANCE AND CHANGE ARE ESSENTIAL FOR SUCCESSFUL 
WEIGHT CONTROL. 
HANDOUTU 
RESPONDING TO CHANGES IN WEIGHT 
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Each week you should inspect your weight maintenance graph, focusing on the past 4 
weeks' readings. This will constitute your weekly review. This review involves: 
• Weighing yourself, 
• Plotting your latest weight on your weight maintenance graph, and 
• Carefully appraising the data 
If there has been a change in your weight, you need to do the following: 
1. Identifying and evaluate the change in your weight. 
Questions to ask: 
• Is it a sudden leap or gradual trend? 
• Is your body weight now outside the "tramlines"? 
Action to take: 
• Inspect your weight graph, focusing on the past four readings. 
2. Identify the explanation for any change in your weight (In terms of energy intake and 
expenditure). 
Questions to ask: 
• Is it due to changes in eating? 
• Is it due to change an activity? 
• Is ill health, pregnancy or medication contributing? 
Action to take: 
• To collect information, you should carefully monitor your energy intake (food 
and drink). Often it is wise to resume calorie counting (and, therefore weighing 
food) for a while. Common causes of weight gain include an insidious increase 
in proportion size (which often goes undetected), picking up the , a change in 
food choice (with increased energy intake of energy-dense foods), and stress-
related eating. 
• You should also consider the possible role of physical activity. Have you given 
up certain lifestyle activities ( e.g., going for walks, playing sports, and going 
swimming)? 
3. Identify the background cause(s) of any change in behavior. 
Questions to ask: 
• Is there an obvious explanation for the change? 
• Is it due to slipping into "bad habits"? 
Action to take: 
• You should consider what factors in your life might be contributing to the change 
in your behavior. These are generally readily identified ifthere has been a recent 
change. More gradual changes can be more difficult to pinpoint. 
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4. Devise and implement a plan for addressing weight gain. 
You should devise a plan for correcting the weight gain. There will need to be two 
phases. 
HADNOUT U (CONTINUED) 
• First, you will need to establish an energy deficit to bring you weight back into 
the middle of the tramlines. This will usually involve restricting you food intake 
for some weeks (to, say, 1,500 calories). 
• Second, once the increase has been corrected, you will need to make further 
adjustments to stabilize your weight. Generally these will involve changes in 
both energy intake and physical activity following the guidelines which have 
been provided. You will also need to discontinue monitoring your food intake. 
You will need to continue regularly monitor your weight. 
5. Devise and implement a plan for dealing with the background cause(s) of the change 
in behavior. 
You will also need to address the background columns. This is best done using the 
formal problem-solving approach . As with the changes in eating and activity, you will 
need to regularly evaluate your progress and adjust your plans accordingly. 
HANDOUTV 
DRAFT MAINTENANCE PLAN 
Make some notes under the following headings . 
1. Reasons I do not want to regain weight: 
2. 
3 . 
4. 
a. 
b. 
C. 
d. 
Good habits to keep up ( eating) : 
a. 
b . 
C. 
d. 
Good habits to keep up (activity) : 
a. 
b. 
C. 
d. 
Danger areas to be aware of: 
a. 
b. 
C. 
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Useful Websites 
The following table has been adapted from a similar table published in a chapter titled 
"Obesity and the Internet" by K.R. Fontaine and D . B. Allison from Fairburn and Brownell 
(2002). 
Website 
American Diabetic Association 
(\vww .eatri ght.org) 
American Obesity Society 
(w\vw.obe sity.org) 
International Obesity Task Force 
(www .iotf.org) 
National Association to Advance Fat 
Acceptance (www.naafa.org) 
National Heart, Lung and Blood Institute 
(www.nh1bi.nih.gov) 
National Institute of Diabetes and Digestive 
and Kidney Diseases (www.niddk.nih.gov) 
North American Association for the Study 
of Obesity (www.naaso.org) 
Shape Up America! (www.shapeup.org) 
Description 
Provides infonnation on nutrition and 
weight control. 
Provides education for general public and 
health professionals and advocates for rights 
of obese persons. 
Provides education and advocacy for obesity 
to be viewed as a world wide epidemic. 
Advocates on behalf of obese persons to 
improve quality of life and reduce 
discrimination. 
Provides resources for health professionals 
and the general public. 
Provides information on weight loss and 
control for health professionals and the 
general public. Includes information about 
physical activity for overweight people. 
Interdisciplinary society that develops, 
extends, and disseminates knowledge in the 
field of obesity. 
Provides general information on weight 
control and physical activity. 
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Principles of Healthy Eating 
1. Temporal Pattern of Eating 
a. Eat at regular intervals throughout the day 
i. 3 meals a day and one or more planned snacks 
ii. Without "nibbling" outside these planned times 
iii. A pattern of regular eating helps to reduce the risk of overeating. 
b. Evening snacks can be especially important 
1. Minimize feelings of deprivation 
11. Make the snack appetizing-even a highlight of the day's eating 
2. Food Choice 
a. Eating a broad range of food 
i. Protects against binge eating 
ii. Improves overall health 
b. Less food but good food 
c. Which foods contribute most to calorie intake 
d. Energy dense foods 
1. Fat has 9 calories per gram 
11. Carbohydrate and protein has 4 calories per gram 
3. Eating Style 
a. Whenever possible, plan eating 
b. Eat in a set place at home and sitting down 
c. Savor food 
4. Cognitive Aspects of Eating 
a. Rigid dieting may lead to extreme reaction to breaking any of own rules 
b. Flexible dieting with guidelines rather than rules 
Appendix G 
Diabetes Care Profile 
ID# 
Name 
Today's Date 
Diabetes Care Profile 
Michigan Diabetes 
Research and Training Center 
DCP2.0 
© 1998 The University of Michigan 
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Section I - Demographics 
Please answer each of the following questions by filling in the blanks with the correct answers or 
by choosing the single best answer . 
Note: For this survey, a Health Care Provider refers to a doctor, nurse practitioner, 
or physician assistant. 
Q 1. Age: __ years old 
Q2 . 
Q3 . 
Q4. 
Birth date: / / 
------
(Month / Day I Year) 
Zip Code: ____ _ 
Sex: D1 Male D2 Female 
Q5. What year were you first told you had diabetes? (Please enter the year) ____ _ 
Q6 . What is your marital status? (check one box) 
D1 Never married 
D2 Married 
D3 Separated/Divorced 
D4 Widowed 
Q7. What is your ethnic origin/race? (check one box) 
D1 White 
D2 Black 
D3 Hispanic 
D4 Native American 
Ds Asian or Pacific Islander 
D6 Arabic 
D1 Other 
Q8. Where do you live most of the year? (check one box) 
D1 Your home, apartment or condo 
D2 Senior citizen apartment/condo 
D3 Home of a relative/friend 
D4 Retirement home 
Ds Adult foster care 
D6 Nursing home 
D1 Other 
Q9. How many people live with you? (check one box) 
Do I live alone 
D1 1 person 
D2 2 people 
DJ 3 people 
D4 4 people 
Ds 5 or more 
QlO. How much schooling have you had? (Years of formal schooling completed) 
(check one box) 
D1 8 grades or less 
D2 Some high school 
0 3 High school graduate or GED 
D4 Some college or technical school 
Os College graduate (bachelor's degree) 
D6 Graduate degree 
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Q 11. Which of the following best describes your current employment status? ( check one box) 
D 1 Working full-time, 35 hours or more a week 
D2 Working part-time, less than 35 hours a week 
0 3 Unemployed or laid off and looking for work 
0 4 Unemplo yed and not looking for work 
Os Homemaker 
D6 In school 
D1 Retired 
Os Disabled , not able to work 
0 9 Something else ? (Please specify) : 
Q12 . How would you describe the insurance plan(s) you have had in the past 12 months ? 
( check all that apply) 
0 1 An individual plan - the member pays for the plan premium 
0 2 A group plan through an employer , union , etc. - the employer pays all or part 
of the plan premium 
0 3 U.S. Governmental Health Plan (e.g., Military , CHAMPUS , VA) 
D4 Medicaid 
Os Medicare 
0 6 I have not had an insurance plan in the past 12 months 
Q13 . What type(s) of insurance plans have you had in the past 12 months? 
(check all that apply) 
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0 1 Indemnity or fee-for-service plan (i.e., you choose which health care provider you 
see for care without financial penalty) 
0 2 Health Maintenance Organization (HMO) (i.e., you must have a primary care 
provider who must refer you to specialty care if needed) 
Prefen-ed Provider Organization (PPO) (i.e., you have lower co-payments when 
you see a preferred provider within the network , but you can see a provider 
out-of-network for a higher co-payment) 
0 4 Point of Service (POS) (i.e., you must have a primary care provider; you have the 
option to self-refer to an in-network specialist , or you can see an out-of-network 
specialist with a higher co-payment) 
Os Other (please specify) : ______ _ 
0 6 I have not had an insurance plan in the past 12 months. 
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Ql4. Do you test your blood sugar? (check one box) 
D1 No D2 Yes 
j 
Q 14a. How many days a week do you test your 
blood sugar? 
__ ( days / week) 
i 
Ql4b. On days that you test, how many times 
do you test 
your blood sugar? 
__ (times I day) 
i 
Q14c. Do you keep a record of your blood 
sugar test 
results? (check one box) 
01 No D2 Yes 
0 3 Only Unusual Values 
Section II - Health Status SF-36 
QI. In general, would you say your health is: (check one box) 
D1 
Os 
Excellent Very Good Good Fair 
Q2. Compared to one year ago, how would you rate your health in general now? 
(check one box) 
D1 Much better now than 1 year ago 
D2 Somewhat better now than 1 year ago 
D3 About the same 
D4 Somewhat worse now than 1 year ago 
Os Much worse now than 1 year ago 
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Q3. The following questions are about activities you might do during a typical day. 
A. 
B. 
C. 
D. 
E. 
F. 
G. 
H. 
I. 
J. 
Does your health now limit you in these activities? If so, how much? 
( circle one answer on each line) 
Yes, Yes, 
Limited ALimited A 
Lot Little 
Vigorous activities, such as running, lifting heavy 1 2 
objects, participating in strenuous sports? 
Moderate activities, such as moving a table, pushing a 1 2 
vacuum cleaner, bowling , or playing golf? 
Lifting or carrying groceries? 1 2 
Climbing several flights of stairs? 1 2 
Climbing one flight of stairs? 1 2 
Bending, kneeling, or stooping? 1 2 
No, Not 
Limited 
At All 
3 
3 
3 
,, 
.) 
3 
3 
-- - ---- -
Walking more than a mile? 1 2 3 
Walking several blocks? 1 2 3 
Walking one block? 1 2 3 
Bathing or dressing yourself? 1 2 3 
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Q4. 
A. 
B. 
C. 
D. 
QS. 
A. 
B. 
C. 
Q6. 
During the past 4 weeks, have you had any of the following problems with your work 
or other regular daily activities as a result of your physical health ? 
( circle one answer on each line) 
Yes No 
Cut down the amount of time you spent on work or other 1 2 
Activities 
Accom_Qlished less than you would like 1 2 
Were limited in the kind of work or other activities 1 2 
Had difficulty performing the work or other 1 2 
activities (for example, it took extra effort) 
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During the past 4 weeks, have you had any of the following problems with your work 
or other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)? ( circle one answer on each line) 
Yes No 
Cut down the amount of time you spent on 1 2 
work or other activities 
Accom12lished less than you would like 1 2 
Didn't do work or other activities as carefully 1 2 
as usual 
During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbors, or groups? 
(check one box) 
Os 
Not at all Slightly Moderately Quite a bit Extremely 
Q7. How much bodily pain have you had during the past 4 weeks? (check one box) 
Os 
None Very Mild Mild Moderate Severe Very Severe 
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Q8. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)? (check one box) 
Ds 
Not at all A little bit Moderately Quite a bit Extremely 
Q9. These questions are about how you feel and how things have been with you during the 
past 4 weeks. For each question please give the one answer that comes closest to the 
way you have been feeling. 
How much of the time during the past 4 weeks: ( circle one answer on each line) 
All Most A Good Some A Little None 
of the of the Bit of the of the of the of the 
Time Time Time Time Time Time 
A. Did you feel full of pep? 1 2 3 4 5 6 
B. Have you been a very nervous 1 2 3 4 5 6 
person? 
---- ---- -
C. Have you felt so down in the 1 2 3 4 5 6 
dumps that nothing could 
cheer you up? 
D. Have you felt calm and 1 2 3 4 5 6 
peaceful? 
E. Did you have a lot of energy? 1 2 3 4 5 6 
F. Have you felt do\\rnhearted 1 2 3 4 5 6 
and blue? 
G. Did you feel worn out? 1 2 3 4 5 6 
H. Have you been a happy 1 2 3 4 5 6 
person? 
I. Did you feel tired? 1 2 3 4 5 6 
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QlO. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting with friends, relatives, etc.)? 
(check one box) 
D1 All of the time 
D2 Most of the time 
DJ Some of the time 
D4 A little of the time 
Os None of the time 
Q 11. Please choose the answer that best describes how true or false each of the following 
statements is for you. ( circle one answer on each line) 
A. I seem to get sick a little easier 
than other people. 
B. I am as healthy as anybody I know. 
C. I expect my health to get worse. 
D. My health is excellent. 
Ql2a. Which are you? (check one box) 
D1 Male 
D2 Female 
Definitely Mostly 
True True 
1 2 
1 2 
1 2 
1 2 
Not Mostly Definitely 
Sure False False 
3 4 5 
3 4 5 
3 4 5 
3 4 5 
Q12b. How old were you on your last birthday? (check one box) 
D1 Less than 35 
D2 35-44 
D3 45-54 
D4 55-64 
Os 65-74 
D6 75-84 
D 1 85 and older 
Q 13. Have you ever filled out this form before? ( check one box) 
D1Yes 
D 2No 
D3 Don ' t remember 
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Section III - Education / Advice Received 
Q 1. Has your health care provider or nurse ever told you to take special care of your feet? 
(check one box) 
0 3 Not Sure 
Q2. Has your health care provider or nurse ever told you to follow an exercise program ? 
(check one box) 
03 Not Sure 
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Q3. Has your health care provider or nurse ever told you to follow a meal plan or diet? 
(check one box) 
0 3 Not Sure 
Q4. Have you ever received diabetes education? (for example: attended a series of classes or 
series of meetings with a diabetes educator) ( check one box) 
D 3 Not Sure 
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Section IV - Understanding 
Ql. How do you rate your Poor Good Excellent 
understanding of: ( circle one 
answer for each line) 
a) overall diabetes care 1 2 3 4 5 
b) coping with stress 1 2 3 4 5 
c) diet for blood sugar control 1 2 3 4 5 
d) the role of exercise in diabetes 1 2 3 4 5 
care 
e) medications you are taking 1 2 3 4 5 
f) how to use the results of blood 1 2 3 4 5 
sugar monitoring 
g) how diet, exercise, and 1 2 3 4 5 
medicines affect blood sugar 
levels 
h) prevention and treatment of 1 2 3 4 5 
high blood sugar 
i) prevention and treatment of 1 2 3 4 5 
low blood sugar 
j) prevention of long-term 1 2 3 4 5 
complications of diabetes 
k) foot care 1 2 3 4 5 
1) benefits of improving blood 1 2 3 4 5 
sugar control 
m) pregnancy and diabetes 1 2 3 4 5 
Section V - Support 
Ql. I want a lot of help and support from my family or friends in : 
( circle one answer for each line) 
Strongl Somewha 
y t Neutral 
Disagree 
Disagre 
e 
a) following my 1 2 3 
meal plan. 
b) taking my 1 2 3 
medicine. 
c) taking care of 1 2 3 
my feet. 
d) getting enough 1 2 3 
physical activity. 
e) testing my 1 2 3 
~ 
sugar. 
f) handlin g my 1 2 3 
feelings about 
diabetes. 
Q2.My family or friends help and support me a lot to: 
( circle one answer for each line) 
Strongly Somewh 
Disagree at Neutral 
Disagree 
a) follow my meal 1 2 3 
plan. 
b) take my medicine. 1 2 3 ! 
c) take care of my 1 2 3 
feet. 
d) get enough 1 2 3 
physical activity. 
Somewha 
t 
Agree 
4 
4 
4 
4 
4 
4 
Somewh 
at 
Agree 
4 
4 
4 
4 
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Does 
Strongl Not 
y Apply 
Agree 
5 NIA 
5 NIA 
5 NIA 
5 NIA 
5 NIA 
5 NIA 
Does 
Strongl Not 
y Apply 
Agree 
5 NIA 
5 NIA 
5 NIA 
5 NIA 
e) test my sugar. 
f) handle my feelings 
about diabetes. 
2 3 
2 3 
Q3 .My family or friends: (circle one answer for each line) 
Strongly Somewha 
Disagree t 
Disagree 
a) accept me and my diabetes. 1 2 
b) feel uncomfortable about 1 2 
me because of my diabetes . 
c) encourage or reassure me 1 2 
about my diabetes. 
d) discourage or upset me 1 2 
abou t my diabetes . 
e) listen to me when I want to 1 2 
talk about my diabetes . 
f) nag me about diabetes . 1 2 
4 5 
4 5 
Somewhat 
Neutral 
Agree 
3 4 
3 4 
3 4 
3 4 
3 4 
3 4 
Q4. Who helps you the most in caring for your diabetes? (check only one box) 
D1 Spouse 
D2 Other family members 
0 3 Friends 
D4 Paid helper 
Os Doctor 
D6 Nurse 
07 Case manager 
Os Other health care professional 
0 9 No one 
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NIA 
NIA 
Strongl 
y 
Agree 
5 
5 
5 
5 
5 
5 
Section VI - Control Problems Scale 
For the following questions , please check the appropriate response. 
QI.How many times in the last month have you had a low blood sugar (glucose) reaction 
with symptoms such as sweating, weakness, anxiety, trembling, hunger or headache? 
D1 0 times 
D2 1-3 times 
D3 4-6 times 
D4 7-12 times 
Os More than 12 times 
D6 Don't know 
Q2.How many times in the last year have you had severe low blood sugar reactions such as 
passing out or needing help to treat the reaction? 
D1 0 times 
D2 1-3 times 
D3 4-6 times 
D4 7-12 times 
Os More than 12 times 
D6 Don't know 
Q3,How many days in the last month have you had high blood sugar with symptoms such 
as thirst , dry mouth and skin, increased sugar in the urine, less appetite, nausea , or 
fatigue? 
D1 0 days 
D2 1-3 days 
D3 4-6 days 
D4 7-12 days 
Os More than 12 days 
D6 Don't know 
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Q4.How many days in the last month have you had ketones in your urine? 
01 0 days 
02 1-3 days 
0 3 4-6 days 
04 7-12 days 
Os More than 12 days 
06 Don't test 
Q5. During the past year, how often did 
your blood sugar become too high 
because: (circle one answer for each 
line) 
a) you were sick or had an 
infection? 
b) you were upset or angry? 
c) you took the wrong amount of 
medicine? 
d) you ate the wrong types of 
food? 
e) you ate too much food? 
f) you had less physical activity 
than usual? 
g) you were feeling stressed? 
Neve 
r 
l 
1 
1 
1 
1 
1 
1 
Sometime 
s 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
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Don't 
Ofte Know 
n 
5 DK 
<:: DK .J 
5 DK 
5 DK 
5 DK 
5 DK 
5 DK 
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Q6. During the past year, how often did 
your blood sugar become too low Don't 
because: ( circle one answer for each Neve Sometime Ofte Know 
line) r s n 
a) you were sick or had an 1 2 3 4 5 DK 
infection? 
b) you were upset or angry? 1 2 3 4 5 DK 
c) you took the wrong amount of 1 2 3 4 5 DK 
medicine? 
d) you ate the wrong types of 1 2 3 4 5 DK 
food? 
e) you ate too little food? 1 2 3 4 5 DK 
f) you had more physical activity 1 2 3 4 5 DK 
than usual? 
g) you v,aited too long to eat or 1 2 3 4 5 DK 
skipped a meal? 
h) you were feeling stressed? 1 2 3 4 5 DK 
Section VII - Social and Personal Factors Scale 
For the following questions, please circle the appropriate response. 
Never Sometimes 
Q 1. How often has your diabetes kept you 
from doing your normal daily activities 
during the past year (e.g., couldn't: go 
to work, work around the house, go to 
school, visit friends)? 
Q2. My diabetes and its treatment 
Strongly keep me from: ( circle one answer 
for each line) Disagree 
a) having enough money. 1 
b) meeting school, work, 1 
household, and other 
responsibilities. 
c) going out or traveling as 1 
much as I want. 
d) being as active as I want. 1 
e) eating foods that I like. 1 
f) eating as much as I want. 1 
g) having good 1 
relationships with people. 
h) keeping a schedule I like 1 
( e.g., eating or sleeping late). 
i) spending time with my 1 
friends. 
j) having enough time 1 
alone. 
2 3 
Neutral 
Disagree 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
4 
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Don't 
Often Kno 
w 
5 DK 
Agree Strongly 
Agree 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
Q3 . Paying for my diabetes treatment 
and supplies is a problem. 
Q4 . Having diabetes makes my life 
difficult. 
Strongly 
Disagree Disagree Neutral 
2 3 
Strongly 
Disagree Disagree Neutral 
2 3 
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Strongly 
Agree Agree 
4 5 
Strongly 
Agree Agree 
4 5 
Section VIII - Attitudes Toward Diabetes Scales 
(Positive Attitude, Negative Attitude, Care Ability, 
Importance of Care, and Self-Care Adherence) 
For the following questions, please circle the appropriate response. 
( circle one answer for each line) 
Strongly 
Disagree Disagree Neutral Agree 
Ql. I am afraid of my diabetes. 1 2 3 4 
Q2. I find it hard to believe 1 2 3 4 
that I really have diabetes. 
Q3. I feel unhappy and 1 2 3 4 
depressed because of my 
diabetes. 
Q4. I feel satisfied with my 1 2 3 4 
life. 
QS. I feel I'm not as good as 1 2 3 4 
others because of my 
diabetes. 
Q6. I can do just about 1 2 3 4 
anything I set out to do. 
Q7. I find it hard to do all the 1 2 3 4 
things I have to do for my 
diabetes. 
Q8 . Diabetes doesn't affect my 1 2 3 4 
life at all. 
Q9. I am pretty well off, all 1 2 3 4 
things considered. 
QlO. Things are going very well 1 2 3 4 
for me right now. 
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Strongly 
Agree 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
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Ql 1. I am able to: (circle one answer Strongly Strongly 
for each line) Disagree Disagree Neutral Agree Agree 
a) keep my blood sugar in good 1 2 3 4 5 
control. 
b) keep my weight under 1 2 3 4 5 
control. 
c) do the things I need to do for 1 2 3 4 5 
my diabetes ( diet, medicine, 
exercise, etc.). 
d) handle my feelings (fear, 1 2 3 4 5 
worry, anger) about my 
diabetes. 
Ql2 . I think it is important for me to: Strongly Strongly 
( circle one answer for each line) Disagree Disagree Neutral Agree Agree 
a) keep my blood sugar in good 1 2 ,., 4 5 
' 
.) 
control. 
b) keep my weight under 1 2 3 4 5 
control. 
c) do the things I need to do for 1 2 3 4 5 
my diabetes ( diet, medicine, 
exercise, etc.). 
d) handle my feelings (fear, 1 2 3 4 5 
worry, anger) about my 
diabetes. 
Never 
Q13. I keep my blood sugar in 
good control. 
Q14. I keep my weight under control. 
Q15. I do the things I need to do for my 
diabetes ( diet, medicine, exercise, 
etc.). 
Q16. I feel dissatisfied with life because 
of my diabetes . 
Ql 7. I handle the feelings (fear, worry, 
anger) about my diabetes fairly 
well. 
2 
Never 
1 
1 
1 
1 
Sometime 
s 
3 4 
Sometimes 
2 3 
2 3 
2 3 
2 3 
Don't 
Alway Know 
s 
5 DK 
Always 
4 5 
4 5 
4 5 
4 5 
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Section IX - Diet Adherence Scale 
Q 1. Has any health care provider or nurse 
told you to follow a meal plan or diet? 
Never 
Q2. How often do you follow a meal plan or 1 
diet? 
Q3. Have you been told to follow a schedule for 
your meals and snacks? 
Q4. Have you been told to weigh or measure 
your food? 
QS. Have you been told to use exchange lists or 
food group lists to plan your meals? 
Never 
Q6 . How often do you follow the schedule 1 
for your meals and snacks? 
Q7. How often do you weigh or measure 1 
your food? 
Q8. How often do you ( or the person who 1 
cooks your food) use the exchange lists 
or food group lists to plan your meals? 
Sometimes 
2 3 
D 1 No 
D1No 
D1No 
Sometimes 
2 3 
2 3 
2 3 
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Always 
4 5 
D2 Yes 
D2 Yes 
D 2 Yes 
Always 
4 5 
4 5 
4 5 
Section X - Long-Term Care Benefits Scale 
For the following questions, please circle the appropriate response. 
( circle one answer for each line) 
Q 1. Taking the best possible care Strong! 
of diabetes will delay or y Disagre Neutra 
prevent: Disagre e I 
e 
a) eye problems 1 2 3 
b) kidney problems 1 2 3 
c) foot problems 1 2 3 
d) hardening of the arteries 1 2 3 
e) heart disease 1 2 3 
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Strong! 
Agre y Agree 
e 
4 5 
4 5 
4 5 
4 5 
4 5 
Section XI - Exercise Barriers Scale 
For the following questions, please circle the appropriate response. 
(circle one answer for each line) 
Ql. How often do you have trouble 
getting enough exercise because: Rarely 
a) it takes too much effort? 1 2 
b) you don't believe it is useful? 1 2 
c) you don't like to do it? 1 2 
d) you have a health problem? 1 2 
e) it makes your diabetes more 1 2 
difficult to control? 
Sometime 
s 
3 
3 
3 
3 
3 
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Often 
4 5 
4 5 
4 5 
4 5 
4 5 
Section XII - Monitoring Barriers and Understanding Management Practice Scales 
Q 1. How many days a week have you been told to test: 
a) urine sugar? 
b) blood sugar? 
__ (days per week) D 9 Not told to test 
__ (days per week) D 9 Not told to test 
If you do not test for sugar, skip Question No. 2. 
For the following questions, please circle the appropriate response. 
( circle one answer for each line) 
Q2. When you don't test for sugar as often 
as you have been told, how often is it 
because: Rarely 
Sometime 
s 
Often 
- ·- · - - - - -
a) you forgot? 1 2 3 4 5 
b) you don't believe it is useful? 1 2 3 4 5 
c) the time or place wasn't right? 1 2 3 4 5 
d) you don't like to do it? I 2 3 4 5 
e) you ran out of test materials? I 2 3 4 5 
f) it costs too much? 1 2 3 4 5 
g) it's too much trouble? I 2 3 4 5 
h) it's hard to read the test results? 1 2 3 4 5 
i) you can't do it by yourself? 1 2 3 4 5 
j) your levels don't change very 1 2 3 4 5 
often? 
k) it hurts to prick your finger? 1 2 3 4 5 
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Q3. Have you ever received diabetes education? D 1 No 
If No , skip Question No. 4 
For the following questions, please circle the appropriate response. 
( circle one answer for each line) 
Q4 . How do you rate your understanding of: 
Poor Good 
a) diet and blood sugar control 1 2 3 
b) weight management 1 2 3 
c) exercise 1 2 3 
d) use of insulin/pills 1 2 3 
e) sugar testing 1 2 3 
f) foot care 1 2 3 
g) complications of diabetes , 2 3 1 
h) eye care 1 2 3 
i) combining diabetes medication with 1 2 3 
other medications 
j) alcohol use and diabetes 1 2 3 
191 
Excellent 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
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Addition to Section I (Demographics) - Income Question 
Q 15. Which of the categories best describes your total annual combined household income from 
all sources? (check one box) 
Doi Less than $5,000 
Do2 $5,000 to $9,999 
Do3 $10,000 to $14,999 
Do4 $15,000 to $19,999 
Dos $20,000 to $29,999 
Do6 $30,000 to $39,999 
Do1 $40,000 to $49,999 
Dos $50,000 to $59,999 
Do9 $60,000 to $69,999 
D10 $70,000 and over 
Appendix H 
Diabetes Empowerment Scale 
University of Michigan Diabetes Research and Training Center 
DIABETES ATTITUDE QUESTIONNAIRE 
PLEASE ANSWER THE FOLLOWING QUESTIONS 
BACKGROUND: 
1. Sex: Male D Female D 
2. How old are you? _ __ years old 
3. How long ago were you told by a doctor that you had diabete s? __ years 
4. Which type of diabetes did your doctor say that you have? 
D insulin-dependent diabetes , also called juvenile or type 1 diabetes 
D non insulin-dependent diabetes, also called adult onset or type 2 
diabetes (some people with non insulin-dependent diabetes 
take insulin) 
5. How often does your diabetes prevent you from doing your normal daily activities 
(could not work or go to school)? Circle one number. 
Never 
2 3 4 5 6 
Frequently 
7 
6. Have you ever attended a diabetes patient education program (a series of classes)? 
D No D Yes (If "Yes", how many years ago? 
7. How would you rate your understanding of diabetes and its treatment? Circle one number. 
Poor 
1 2 3 4 5. 6 
Excellent 
7 
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8. How much schooling have you completed? 
D 
D 
8th grade or less 
graduate 
some high school 
college or 
school 
9. Are you now taking diabetes pills? D Yes 
10. Are you now taking insulin? D Yes 
11. Have you always treated your diabetes with insulin? 
12. What is your height? __ feet inches 
13. How much do you weigh? ___ pounds 
D highschool 
D some 
technical 
D No 
D No 
D Yes D No 
14. Please circle the number that indicates how able you are to fit diabete s into your life in 
a positive manner. 
Not At 
All Able 
2 3 4 5 6 
Very 
Able 
7 
15. Please circle the number that indicates how comfortable you feel asking your doctor 
questions about diabetes. 
Not At All 
Comfortable 
2 3 4 5 
Very 
Comfortable 
6 7 
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Attitudes Toward Diabetes - DES 
In general, I believe that I: Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
1. ... lmow what part(s) of ( ) ( ) ( ) ( ) ( ) 
taking care of my diabetes 
that I am satisfied with . 
2. ... lmow what part(s) of ( ) ( ) ( ) ( ) ( ) 
taking care of my diabetes 
that I am dissatisfied with . 
3. ... lmow what part(s) of taking 
care of my diabetes that I am ( ) ( ) ( ) ( ) ( ) 
ready to change. 
4. ... lmow what part(s) of taking ( ) ( ) ( ) ( ) ( ) 
care of my diabetes that I am 
not ready to change . 
5. ... can choose realistic ( ) ( ) ( ) ( ) ( ) 
diabetes goals. 
6. ...lmow which of my 
diabetes goals are most ( ) ( ) ( ) ( ) ( ) 
important to me . 
7. .. . lmow the things about 
myself that either help or ( ) ( ) ( ) ( ) ( ) 
prevent me from reaching 
my diabetes goals. 
8. ...can come up with good ( ) ( ) ( ) ( ) ( ) ideas to help me reach my 
goals . 
9. ... am able to tum my 
diabetes goals into a ( ) ( ) ( ) ( ) ( ) 
workable plan. 
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In general, I believe that I: Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
10. ... can reach my diabetes goals ( ) ( ) ( ) ( ) ( ) 
once I make up my mind . 
11. . . . know which barriers 
make reaching my diabetes ( ) ( ) ( ) ( ) ( ) 
goals more difficult. 
12. ... can think of different 
ways to overcome barriers to ( ) my diabetes goals ( ) ( ) ( ) ( ) 
13. ... can try out different ways 
of overcoming barriers ( ) ( ) ( ) ( ) ( ) 
to my diabetes goals . 
14. ... am able to decide which 
way of overcoming barriers ( ) ( ) ( ) ( ) ( ) to my diabetes goals works 
best for me. 
15. ... can tell how I'm feeling ( ) ( ) ( ) ( ) ( ) 
about having diabetes . 
16. . . . can tell how I'm feeling 
about caring for my ( ) ( ) ( ) ( ) ( ) 
diabetes 
17. ... know the ways that 
having diabetes causes ( ) ( ) ( ) ( ) ( ) 
stress in my life . 
18. . . . know the positive ways 
I cope with diabetes-related 
stress . ( ) ( ) ( ) ( ) ( ) 
19. ... know the negative ways 
I cope with diabetes-related ( ) ( ) ( ) ( ) ( ) 
stress 
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In general, I believe that I: Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
20 . ... can cope well with diabetes- ( ) ( ) ( ) ( ) ( ) 
related stress . 
21. .. . know where I can get 
support for having and ( ) ( ) ( ) ( ) ( ) 
caring for my diabetes . 
22 . ... can ask for support for 
having and caring for my 
diabetes when I need it. ( ) ( ) ( ) ( ) ( ) 
23. ... can support myself in 
dealing with my diabetes. ( ) ( ) ( ) ( ) ( ) 
24 . ... know what helps 
me stay motivated to 
care for my diabetes . ( ) ( ) ( ) ( ) ( ) 
25. .. can moti·1ate myself 
to care for my diabetes. 
( ) ( ) ( ) ( ) ( ) 
26 . .. .know enough about 
diabetes to make self-care 
choices that are right for me. 
27. ... know enough about my-
( ) ( ) ( ) ( ) ( ) 
self as a person to make 
diabetes care choices that 
are right for me . ( ) ( ) ( ) ( ) ( ) 
28 . ... am able to figure out if it 
is worth my while to change 
how I take care of my 
diabetes. ( ) ( ) ( ) ( ) ( ) 
Appendix I 
Physician Referral/Permission to Participate 
University of Utah Diabetes/Weight-loss Study 
Referral /permission to participate in research study to evaluate certain weight-loss 
treatments 
Name 
---------------------
Address 
--------------------
Mo/yr Type 2 Diabetes Diagnosed 
-------
Any restrictions regarding caloric restriction (restrict to approximately 1500 kcal /day) 
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If none , please initial here for medical clearance to restrict calories 
--------
Any restrictions regarding exercise __________________ _ 
If none, please initial here for medical clearance to exercise / increase activity 
Diabetes Medications None 
------
---------
Oral glucose-lowering agent(s) _________ _ 
Insulin regimen ____________ ___ _ 
Other relevant meds 
--------------
Any weight-loss inducing agents _________ _ 
Lab Data Date oflast Al C AlC 
--------
----------
Comments 
-----------------------------
Date 
--------
Physician signature _____________ _ 
Address 
-------------------
City, State, Zip ______________ _ 
Telephone number ______________ _ 
Fax number 
-----------------
Please mail form to: 
Kathy Wickersham 
245 International A venue 
Tooele, UT 84074 
Dear Kathy. 
Appendix J 
Letter of Support 
..,.: 
~}, , ,J 
Tl-It •,,:_ •. • ~~-
lJ NJ VER $1 TY 
OF UTAH 
Jaouury 3, 2005 
I am writing to confinn the fact that I am wi llin g to cooperate in your study: " In vestigating t:he 
Effec t iveness of Certai n Treat m en t Options for Weight Loss. " As Director of the Division of 
E ndocrinology and bead of the U tah Diabetes Center at the Un iversity of Utah, I will ass ist you 
in patient recruitment from our Diabetes C lini c and provide space a t the Center for you to pur s ue 
you r in te rview s and interventions, pe ndi ng approval of the st udy by the lnsti utiona l Review 
Boards at our respective l Jniversitics . r an1 looki ng forward to working with you. 
Sincerely , 
., 1 4 ,, '.{Z-L~ 
:) v"V\. //1/l 
Don McClain MD, PhD 
Betillyon Professor of Medicine, 
Associate Director, Gene ra l Cl inical Research Cen ter 
Director, Division of Endocri no logy and Metabolism 
Division of Endocrinology, Metabolism, and Diabetes 
Dcpurtmcnt of Imctnill M<!dicinc 
School of Medidrie 
30 N. 2030 East 
Salt Lake Ciry, Uuh 84132 
(801} 5S1-77S5 • FAX (l>0i) 585-0956 
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Physician Referral/Permission to Participate 
University of Utah Diabetes/Weight-loss Study 
Referral /permission to participate in research study to evaluate certain weight-loss 
treatments 
Name ___________________ _ 
Address ___________________ _ 
Mo/yr Type 2 Diabetes Diagnosed ______ _ 
Any restrictions regarding caloric restriction (restrict to approximately 1500 kcal/day) 
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If none, plea se initial here for medical clearance to restrict calories _______ _ 
Any restrictions regarding exercise __________________ _ 
If none, please initial here for medical clearance to exercise/ increase activity 
Diabetes Medications _____ _ None ________ _ 
Oral glucose-lowering agent(s) _________ _ 
Insulin regimen _______________ _ 
Other relevant meds _____________ _ 
Any weight-loss inducing agents _________ _ 
Lab Data Date of last AlC _______ _ AlC ________ _ 
Comments ____________________________ _ 
Date ______ _ Physician signature _____________ _ 
Address __________________ _ 
City, State, Zip ______________ _ 
Telephone number _____________ _ 
Fax number ________________ _ 
Please mail form to: 
Kathy Wickersham 
245 International A venue 
Tooele, UT 84074 
